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Abstract 
Age-related deterioration and dysregulation of T cell function, termed 
‘immunosenescence’, may lead to increased mortality and morbidity in humans through 
greater susceptibility to infections and disease. Previous research from the group of 
Barnett, suggested that oxidative stress may play a role in the immunosenescence 
process, through resultant genomic instability, cell cycle delay and arrest. The aim of 
this research programme was to investigate the effect of the antioxidants, ebselen, N-
Acetyl L- Cysteine (NAC) or mitoQ or reduced oxygen (O2) tension on markers of T 
cell function and integrity using CD4+ T cell clones and ex vivo polyclonal human 
peripheral blood derived mononuclear cells or CD4+ T cells derived from healthy young 
and older aged donors.  
 
The results of this investigation revealed that 30µM ebselen or 7.5mM NAC 
supplementation significantly increased the lifespan and reduced levels of oxidative 
DNA damage in clones supplemented from a young in vitro age and in human 
peripheral blood mononuclear cells and CD4+ T cells ex vivo derived from either age 
group. The GSH:GSSG ratio was also significantly higher in supplemented clones and 
cells ex vivo. Ebselen or NAC were not able to bring about such biological effects in 
clones when supplemented from the midpoint of their in vitro lifespan. In this latter 
situation, age related changes in T cell physiology example: reduced DNA repair 
capacity, heat shock response and an accumulation of biomolecule damage may have 
contributed to these findings. Ebselen or NAC had similar antioxidant effects on 
polyclonal model system to those found for the in vitro clone model.  
 
MitoQ, a mitochondria targeted antioxidant, at 0.5µM or 1µM concentrations, protected 
T cell genomic DNA from endogenously produced and exogenously applied oxidative 
stress evident by significantly higher GSH:GSSG ratio and significantly decreased 
levels of oxidative DNA damage on supplementation. 0.1µM or 0.25µM mitoQ 
protected genomic DNA from oxidative stress applied exogenously. The antioxidant 
effect on genomic DNA may be due to saturating concentrations in the mitochondria 
and the presence of mitoQ in the cytosol. The inability of mitoQ at lower concentrations 
to protect DNA against endogenously produced ROS may indicate that these lower 
concentrations of mitoQ may be taken up by the mitochondria, but they were not able to 
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reduce free radical release from the mitochondria explaining no significant differences 
in endogenous DNA damage levels and is reflected in the lack of changes to 
GSH:GSSG ratio. It may also be that mitochondrial ROS may not be the only source of 
oxidative genomic DNA damage.  
  
Low O2 culture conditions of 2% O2 for T cells did not reveal an antioxidant potential in 
T cells ex vivo in a separate study evident by higher levels of oxidative DNA damage 
and lower GSH:GSSG ratio compared to T cells maintained at 20% O2 culture 
conditions. The results of this PhD investigation suggest a potential in vivo anti-
immunosenescent impact of these antioxidants at carefully selected concentrations. 
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1.1. Introduction 
1.1.1. Ageing 
Ageing can be described as a biological phenomenon resulting in changes in organs, 
tissues or cells in an organism leading to deterioration in their functional capacity in 
higher animals. Ageing has been described by biologists as a process with a significant 
genetic component, responsible for the varying lifespans among different species of 
animals, ranging from a few days to more than a hundred years. The ageing process 
causes changes in various cellular and tissue components resulting in altered 
physiological status leading to age related pathologies and ultimately death.  
 
Ageing commonly results in changes in biomolecular structure in human body. These 
changes results in several physiological changes (Table 1.1). The rate of physiological 
alterations with age varies in different individuals in human beings. Each body system 
is detrimentally affected by the ageing process. The changes in hair and skin are the 
most common examples of a visual sign of this process. Ageing results in thinning, 
sagging, wrinkles, lentigo spots, dryness, broken blood vessels in the skin, greying and / 
or loss of hair. Lesser production of dermal connective tissue proteins, collagen and 
elastin with age can result in decreased elasticity and wrinkling of the skin. Ageing is 
also associated with loss in hair follicles, responsible for greying of hair. Ageing also 
results in slowing of wound healing. 
 
In humans, ageing is further associated with a considerable deterioration of physical and 
psychological qualities of life and the appearance of a range of age related diseases such 
as cancer, heart diseases, dementia to name a few. Table 1.2 illustrates some of the age 
associated changes in systems in human body leading to pathological conditions 
(Barnett, 1994). Age related decline in the central nervous system may detrimentally 
affect intellectual functions, decrease orientation and may result in Alzheimer’s or 
Parkinson’s disease. The mucoskeletal system may also be affected resulting in 
sarcopenia (loss of muscle), thinning of cartilage in muscle joint resulting in 
osteoarthritis and overall bone loss.  
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Table 1.1 Physiological consequences associated with age related changes in 
biomolecular structure (Barnett, 1994) 
 
Biomolecule Changes / Alterations 
Some of the 
physiological 
consequences as a 
result of alteration 
Lipids Lipid peroxidation 
Oxidised membranes 
become rigid, lose 
permeability and finally cell 
death occurs 
Proteins Oxidation, Deamination 
Alterations in long-lived 
proteins may result in 
ageing or associated 
pathologies, oxidation of 
proteins can affect cellular 
homeostasis 
Carbohydrates 
Fragmentation, Glucose 
auto-oxidation 
Physical properties of 
connective tissues are 
altered and could result in 
osteoarthritis and age 
related joint disorders, 
Glycosylation of proteins 
can result in alteration of 
biological function 
Nucleic acid Strand breaks, base adducts 
Damage could affect 
transcription, translation 
and DNA replication, 
capacity of the cells to 
synthesise important 
proteins and polypeptides. 
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Table 1.2 Age associated alterations in human body systems leading to pathological 
conditions (Barnett, 1994) 
 
Body systems 
Some of the age associated 
pathological conditions in human 
body system 
Cardiovascular system Atherosclerosis, Coronary heart disease 
Central nervous sytem Parkinson’s disease, Alzheimer’s disease 
Endocrine system Non-insulin dependent diabetes 
Hemopoietic system Anemia 
Immune system 
General decline in immune function, T 
cells in particular 
Sense organs Cataracts, diabetic retinopathy, glaucoma 
Respiratory system Interstitial fibrosis 
Reproductive system Decreased spermatogenesis 
All systems Cancer 
Renal system Glomerulosclerosis 
 
A general decline in the function of the immune system, particularly T cells, has been 
found to result in increased occurrence of infectious and autoimmune diseases in elderly. 
It is a pre-requisite to investigate the complex changes in different sets of immune cell 
populations in a successfully aged population compared to an unsuccessfully aged 
population to implement better strategies to prevent age related illness culminating in 
death (Pawelec et al., 2000). 
 
Age related defects are often progressive and irreversible, resulting in an increase in the 
chance of death in all populations. The diseases of old age have led to an increase in 
physical and psychological decline in old aged people that result in them being a burden 
to their families and society. The world population has more than doubled in the last 
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half a century, evidenced by the rise in the number of people from two and a half billion 
in 1950s to approaching seven billion in 2010 according to a study carried out by the 
UN demographic society. Earlier demographic studies of ageing population has 
revealed an estimated 6% of the total world population were above the age of 65. The 
proportion is much higher in Europe (14%) and North America (13%) compared to 5% 
and 3% in Asia and Africa. Figure 1.1 shows the percentage of population of several 
developed countries above the age of 64 according a study carried out by an economic 
development organisation (OECD) in 2008. Further, a recent UN projection about the 
demographic changes have predicted a rise in share of populations over 60 years in 
developing countries as well (Algeria, Iran, South Africa, Egypt etc) from 5% to 15% in 
the near future. This means an increase in the number of old people with more pressure 
on the governments of the countries to address pensions, insurance demands and an 
increase in age related diseases. All these factors may contribute to the medical and 
economic burden of the country (Merson et al., 2006).  
 
 
Figure 1.1. Percentage of population above the age of 64 in some of the developed 
countries in the world according to a demographic study carried out by an 
economic development organisation (OECD) in 2008. 
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Successful ageing research may enable the development of treatments or even identify 
interventions to help prevent age related diseases. If successful, ageing research would 
enable us to increase the healthy span of life in elderly. Although some humans have 
proven longevity escaping age related diseases and maintaining good physical health 
towards the later stages of life, their immune system is different from an unsuccessfully 
aged human (Engberg et al., 2009). Some of the anti-ageing strategies include genetic 
manipulation or use of certain antioxidants (Ozawa, 1999). There have been different 
theories that have been proposed for explaining ageing. 
1.1.1.1. The Free Radical Theory of Ageing 
Reactive oxygen species (ROS) constitute free radicals and oxidants. Singlet oxygen is 
an example of an oxidant. ROS are highly reactive molecules that can originate from 
extracellular or intracellular sources and can damage cellular components in the body. 
ROS were first suggested as toxic agents by the group of Rebeca Gerschman 
(Gerschman et al., 1954). The Free Radical Theory of Ageing, first proposed by 
Denham Harman, postulates ROS, produced mainly via aerobic metabolic pathway in 
the mitochondrion, is the major source of intrinsic oxidative damage for the cell that 
ultimately results in ageing (Harman, 1956; Sastre et al., 2000; Muller et al., 2007; 
Gruber et al., 2008). ROS can cause cellular and tissue damage that impairs the function 
and proliferative capacity of the cells in vivo resulting ultimately in age related 
pathologies due to ageing (mainly as a result of the breakdown of protective 
mechanisms in the body) leading to death of the individual (Figure 1.2; Barnett, 1994). 
 
 
Figure 1.2. Free radicals leading to biomolecular damage resuting in ageing. 
 
  
 19
Although free radicals are seen as cellular damaging agents who are implicated in the 
aetiology and pathogenesis of degenerative diseases and ageing, they are involved in 
several intracellular signalling pathways generating huge amount of curiosity and 
interest in the field of ageing research. There are both endogenous and exogenous 
sources of free radicals (Table 1.3). 
 
Table 1.3. Some examples of endogenous and exogenous sources of free radicals 
(Freeman, 1984; Halliwell, 1987) 
 
Endogenous sources Exogenous sources 
Lipoxygenase, cycloxygenase, 
nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase in plasma 
membrane 
Drug oxidation (Acetaminophen, 
cocaine) 
Oxidases and flavoproteins as 
peroxisomes 
Oxidising gases (O2, Nitrogen dioxide 
(NO2)) 
Metal catalysed reactions Xenobiotic elements 
Haemoglobins, xanthine oxidase (XO), 
Monoamine oxidase (MAO) 
Cigarette smoke, combustion products 
 
The importance of free radicals in the field of ageing research has been strengthened 
further by their implication in several clinical conditions in humans. They are known to 
cause clinical conditions in skin, eye, and several other systems (Table 1.2) in human 
body. Solar radiation is an example of a source of free radical which could affect the 
skin in human beings.  
1.1.1.2. Mitochondrial Theory of Ageing 
The mitochondrial theory of ageing postulated by Harman in 1972, states that 
mitochondria are the major intracellular source of ROS. ROS contribute to cumulative 
damage to cellular constituents (Deoxyribonucleic acid (DNA), Ribonucleic acid (RNA), 
proteins and lipids) and this has been shown to play a role in ageing and eventual death 
(Harman, 1972; Brierley et al., 1997; Miquel, 1998; Barja, 2000; Brand, 2000; 
Berdanier and Everts, 2000; Cadenas and Davies, 2000; Kowald and Kirkwood, 2000; 
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Melov, 2000; Rustin et al., 2000; Sastre et al., 2000; Salvioli et al., 2001). The 
mitochondrial theory of ageing was further refined and developed by Jaime Miquel in 
1980 (Miquel et al., 1980).  
 
One of the unique features that distinguish mitochondria (Figure 1.3) from other cell 
organelles is the presence of their own DNA called mitochondrial DNA (mtDNA). 
Mitochondria are present in virtually all of the cells in the human body with the 
exception of red blood cells. Their number varies from 20 to 2500 per cell (Pike et al., 
1984). The term mitochondria introduced by C. Benda around the turn of the century 
means ‘thread like granules’. They are encapsulated by a double, outer and inner 
membrane. The inner membrane folds inwards to form extensions called cristae. Cristae 
protrude into the mitochondrial matrix and provide surface area necessary for 
mitochondria’s vital functions. The ribososmes in the mitochondrial matrix are smaller 
than those of the cytoplasm and contain large calcium phosphate granules. The mtDNA 
genome is located in the matrix. Mitochondria are regarded as the powerhouse of the 
cell and play an important role in apoptosis and the production of adenosine tri-
phosphate (ATP). ATP production within mitochondria occurs from the interaction of 
two metabolic cycles namely the tricarboxylic acid (TCA) cycle and the oxidative 
phosphorylation (OXPHOS) electron transport chain (ETC). Well functioning 
mitochondria is a pre-requisite for human life. Their number has been reported to 
increase with age and those surviving have been shown to increase in size after 60 years 
of age (Ozawa, 1997). The activity of mitochondrial enzymes involved in the ETC has 
been shown to decline with age. A decrease in the respiratory function of mitochondria 
in human tissues, increase in mtDNA damage and an exponential rise in the levels of 
the mutant form of 8-hydroxy-2-deoxyguanosine (dGTP), a product of free radical 
damage, are some of the age related moleculer changes observed within mitochondria 
(Hayakawa et al., 1993). 
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Figure 1.3. Electron microscopy of a human mitochondrion (Chapman and Hall, 
1994). 
1.1.1.2.1. Mitochondrial DNA genome 
The human mitochondrial genome has been fully sequenced (Figure 1.4; Anderson et 
al., 1981). It has a covalently closed circular double stranded genome of 16,569 bp. The 
mtDNA genome encodes for 22 transfer RNAs (tRNAs), two ribosomal RNAs (rRNAs) 
and 13 polypeptides. The polymorphic nature, maternal code of inheritance, relatively 
small genome and the lack of recombination of the mtDNA genome makes it an ideal 
template for pathogenic and anthropological studies venturing into human evolution, 
origin and patterns of migration (Torroni et al., 1992; Torroni et al., 1994; Torroni et al., 
1996; Cottrell et al., 2000; Ingman et al., 2000). Each mitochondrion contains between 
two to ten copies of mtDNA. Nuclear DNA (nDNA) is protected by histone proteins 
and various repair enzymes from free radicals or oxidants. mtDNA undergoes mutation 
five to ten times faster than nuclear DNA due to its proximity to the main site of ROS 
production, lack of protective histone proteins and an inefficient DNA repair 
mechanism (Richter, 1995). mtDNA damage often leads to the production of 8OHdG, 
an oxidised guanine base. A study carried out in ten healthy humans between the age of 
42 and 97 years, analysing three brain regions, revealed a ten fold increase in 8OHdG 
formation in mtDNA compared to nDNA in all the subjects investigated, except those 
above 70 years of age who had a 15-fold increase. The increase in 8OHdG formation 
was correlated with increase in mtDNA deletions. Increase of mtDNA damage with age 
may ultimately lead to cellular energy crisis due to their detrimental effects on the 
functionality of ETC enzyme complexes that produce ATP (Richter, 1995).  
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Figure 1.4. The 16,569 bp human mitochondrial DNA genome (Kyriakouli et al., 
2008). 
1.1.2. Immune system 
The immune system of the body protects individuals against foreign invaders such as 
pathogenic microorganisms and viruses. The immune system is made up of a network 
of cells, tissues and organs that protect the body. The conferred protection is called 
immunity. There are three types of immunity: innate, adaptive and passive immunity. 
Innate immunity (in detail in section 1.1.2.2) is the first line of defense system in the 
body, for example skin and mucous membranes that prevents pathogens or other 
invaders entering the body. Adaptive immunity (in detail in section 1.1.2.3) involves 
lymphocytes and develops throughout our lives and helps to protect against repetitive 
encounter of the same antigen. Passive immunity is gained from an external source and 
is temporary, for example: immunity conferred to an infant by antibodies in the 
mother’s breast milk. 
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1.1.2.1. Cells of the immune system 
The immune system comprises of several cells with assigned functions that protect the 
body against infectious organisms and invaders through a series of steps called the 
immune response. The majority of cells of the immune system, most importantly 
lymphocytes and phagocytes, are derived from stem cells in the bone marrow. 
Phagocytes circulate in the blood and develop into macrophages in tissues. 
Macrophages are tissue specific cells, for example alveolar macrophages in lungs and 
microglial macrophages in the brain. They scavenge non-functional cells in the body 
and engulf foreign pathogens, digesting their antigenic fragments. These antigens attract 
cytotoxic T cells that destroy the macrophages and the antigenic fragments facilitating a 
suicide attack. Lymphocytes enable the body to remember and recognise previous 
invaders and help the body to destroy them. The lymphocytes undergo maturation in 
primary lymphoid tissues, the thymus and the bone marrow. They circulate in the blood 
and through part of the lymphatic system such as lymph nodes, spleen and thymus. 
Lymph vessels are credited with the transportation and storage of lymphocytes within 
the body. The two major types of lymphocytes are T lymphocytes and B lymphocytes. 
Receptors on the surface of lymphatic cells help the cell to recognise a specific foreign 
antigen. They are very specific and can recognise only one specific antigen.  
 
T cells are produced in the bone marrow and mature in the thymus. T cells are 
differentiated into two types namely helper T cells (Th cells) and killer T cells. Th cells 
are the main regulators of the immune defense. They enable the activation of B cells and 
killer T cells by the production of proteins. Proteins are produced by the activation of 
Th cells by their recognition of antigen presented by phagocytes (Figure 1.5). Killer T 
cells are the major surveillance cells in the body due to their ability to search every cell 
and recognise traces of antigen in some of the cells they encounter. This enables them to 
attack mutated cells and cells infected by foreign pathogens. 
 
  
 24
 
 
Figure 1.5. 1) A bacterium is engulfed by a phagocyte 2) Phagocyte digests the 
bacteria and presents the antigen on its surface 3) Th recognises the antigen 
presented by phagocyte on its surface 4) Antigen recognition results in activation 
of the Th cells. 
 
The main function of B cells is to search for an antigen matching their receptors. Once 
proteins are produced by activated Th cells, B cells give rise to plasma cells and B 
memory cells. Plasma cells can produce antibodies capable of recognising the antigen 
bound to the B cell receptor enabling them to destroy any foreign pathogen. Antibodies 
produced by plasma cells are Y-shaped and have the ability to bind to multiple foreign 
antigens at the same time. B memory cells are associated with a prolonged lifespan and 
have the ability to recognise specific foreign pathogens that have attacked the body 
before. This strong memory associated with B cells enables them to confer immunity to 
the body against certain foreign antigens that were previously encountered (Figure 1.6). 
 
 
 
 
 
 
 
Phagocyte Bacterium Antigen Helper T cell Antigen 
1. 2. 3. 4. 
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Figure 1.6. 1) A B cell binds to an antigen matching its receptors 2) Th cells 
recognise an antigen present on the surface of phagocytes resulting in production 
of proteins that enable the activation of the B cell 3) B cell activation results in its 
division giving rise to a plasma cell and a B memory cell 4) Plasma cells produce 
Y-shaped antibodies that attach to antigen 5) B memory cells confer immunity to 
the body by recognising foreign antigens that were already encountered previously. 
 
Lymphatic cells express surface markers that broadly define their lineage and the stage 
of development. Haemopoetic cell markers are identified by cluster of differentiation 
(CD) numbers (Table 1.4). The two major sub-populations of T cells express CD4 and 
CD8. Lymphokines are secreted by CD4 and they act on other cells involved in immune 
responses. Cytotoxic CD8+ cells enable the lysis of infected cells. 
 
 
 
 
 
 
 
 
 
 
 
Helper 
T cell 
B cell 
Phagocyte Bacterium presenting 
antigen 
Plasma cell 
Antibodies 
B memory cell 
1. 2. 3. 
4. 
5. 
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Table 1.4. Some of the CD markers and their identity and function 
 
CD (Cluster of differentiation) Identity/function 
CD3 
T cell receptor (TCR) subunit 
(γ, δ, ε, ζ, η) − helps in antigen 
recognition and thereby activation of 
signal transduction pathways 
CD4 
Th cells – helps in activation of T cells on 
recognition of antigen presenting cells 
CD8 
Cytotoxic T cells (Tc cells)  - T cells 
exressing CD8 markers can bind tightly 
to MHC Class I molecules expressing 
antigens due to presence of pecific 
domains 
CD28 
Co-stimulatory TCR – required along 
with antigen specific signal for immune 
response 
CD34 
Bone marrow stem cell marker – 
Adhesion molecule helpful for T cells to 
enter the lymph nodes, expressed in 
endothelia in lymph nodes 
CD38 
Thymocyte activation marker – Regulates 
intracellular calcium by regulating the 
synthesis of cyclic ADP ribose 
CD45 
Leucocyte common antigen (LCA) – 
Protein tyrosine phosphatase receptor 
type C 
CD69 
Activation marker – cell surface 
glycoproteins involved in lymphocyte 
proliferation and differentiation 
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The two major types of immunity are detailed below. 
1.1.2.2. Innate Immunity 
The innate immune system deals with the day to day protection of the body from 
foreign pathogens. It is also referred to as the non-specific arm of the immune system 
and is credited with the release of cytokines and chemokines in the body. Natural Killer 
cells (NK), natural Killer T cells (NKT), macrophages and dendritic cells (DCs) are 
indispensable to the innate immune system. NK cells and NKT cells originate from the 
lymphoid progenitor cell; phagocytic cells (macrophages and DCs) originate from 
myeloid progenitor cells. The latter have the ability to bind to a variety of ligands due to 
the presence of surface receptors, which enable them to recognise pathogens. These 
receptors are called Toll like receptors (TLR) (Chaplin, 2003). TLR enable the 
stimulation of cells of the innate immune system, which acts in the following order: 
They recognise the pathogen, phagocytise it and eventually lyse it with complement 
molecules released by the innate immune system. DCs in the innate immune system 
have the ability to activate the adaptive immune system and to capture, process and 
present the antigen, through the major histocompatibility complex (MHC), to cells of 
the adaptive immune system. This forces the adaptive immune system to initiate a 
specific immune response against the antigen. Due to their efficiency, DCs are 
important in immune study for treating several infections. 
1.1.2.3. Adaptive Immunity 
The mechanism of immunity in the body starts with the innate arm of the immune 
system and terminates with its adaptive arm (Chaplin, 2003). The latter is more prone to 
the deleterious effects of ageing, compared to former. The adaptive arm primarily 
utilises the proteins and cells circulating in the body to provide protection from 
infections. T cell and B cell responses are a pre-requisite for the function of the adaptive 
immune system. B cells and antibodies are responsible for humoral responses that can 
present antigen to T lymphocytes and CTL or CD8+ T cells; CD4+ Th1 cells and CD4+ 
Th2 cells are the mediators of cellular responses. CD4+ Th1 cells enable activation of 
CTL, CTL recognise and eliminate infected cells and CD4+ Th2 cells help developing B 
cells. In adaptive immunity, DCs are attracted to the site of infection and phagocytose 
cell debris and apoptotic cell fragments, thereby intaking MHC molecules expressing 
peptides in the infected cell and migrate to the lymph nodes, resulting in interactions 
  
 28
with CD4+ Th1 cells and CD8+ T cells to form a trivalent complex. This complex 
enables DC maturation through cytokine and cell surface interactions between CD4+ 
Th1 and DCs that in turn results in interactions between DCs and CD8+ T cells resulting 
in the differentiation of CD8+ T cells into CTL. CTL migrate back to the site of 
infection along with the Th cells to instigate antigen specific killing of any infected cells 
presenting the antigen (Figure 1.7). CTL were pre-conditioned against the antigen and 
kill the infected cell through the secretion of cytotoxic granules or by stimulating certain 
receptors produced by the infected cells that enable its degradation (Chaplin, 2003). For 
an effective immune response, T cells are required to undergo rapid clonal expansion 
upon antigenic stimulation. Any factor which interferes with the ability of T cells to 
divide can therefore have the potential to contribute to a decline in T cell function 
resulting in a sub-optimal T cell mediated immune response. 
 
Figure 1.7. DCs are attracted to the site of infection and come in direct contact 
with infected cells. They phagocytose the cell debris and apoptotic cell fragments 
and migrate to the lymph node. DCs present the antigenic peptides expressed by 
MHC molecules on the cell surface for recognition by CD4+ Th1 cells and CD8+ T 
cells. This interaction results in the maturation of DCs. Interactions between DCs 
and CD8+ T cells result in differentiation of CD8+ T cells into CTL. CTL along 
with the activated Th cells migrate back to the site of infection resulting in antigen 
specific killing of any infected cells presenting antigen against which they are pre-
conditioned. 
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1.1.3. Ageing and the immune system 
Immunosenescence is a well characterised deterioration and dysregulation of T cell 
function with age. It can lead to increased mortality and morbidity in humans through 
greater susceptibility to infections and diseases (Pawelec, 2001). T cells are supposed to 
undergo rapid clonal expansion on antigenic stimulation to produce an effective 
immune response. DNA damage and mutation are some of the factors which may 
interfere with the ability of T cells to undergo replication. Defects in signalling 
pathways and decreased T cell response to antigens are some of the immunological 
abnormalities as a result of ageing (Gupta, 2003). A better understanding of the 
immunosenescence process may improve the healthy lifespan and quality of later stages 
of life. 
1.1.3.1. Clinical relevance of immunosenescence 
Clinical observations have indicated that severe and lethally infectious diseases, such as 
endocarditis, septicemia, tuberculosis are among those often contracted by elderly 
people due to lymphopenia (decline in immune function) (Ginaldi et al., 2001). It is 
often associated with high mortality rate in old aged individuals (Gupta, 2003). Clinical 
evidence indicates a significant decline in the ability to raise a primary immune 
response against un-encountered antigens (Fagnoni et al., 2000). Influenza is a major 
health problem among elderly people in industrialised countries to an extent that 90% of 
the deaths attributed to the influenza virus annually in the United States occur in people 
above 65 years of age (Castle, 2000). It was also noted that the extent of protection in 
response to influenza vaccine was considerably lower in old aged people, compared to 
young adults. The reasons for the increased rate of mortality may be due to one / or a 
number of immunological parameters (Table 1.5). 
 
Table 1.5. Immunological parameters affected by age (Ginaldi et al., 2001) 
 
Parameters Age associated alterations 
CD8+ cytotoxic cell fraction ↑  
T cell proliferative response ↓ 
CD4+ helper T cells ↓ 
CD19 B cells ↓ 
  
 30
The increase in cytotoxic CD8+ cell fraction results in a low CD4:CD8 ratio (Saurwein-
Teissl et al., 2002). A study carried out on individuals aged 86-92 years showed three 
times higher mortality in individuals having low T cell proliferative response to 
mitogens, low B cell number and low CD4:CD8 ratio compared to individuals 
exhibiting high T cell proliferative response to mitogens, high B cell number and high 
CD4:CD8 ratio (Ferguson et al., 1995; Wikby et al., 1998). 
1.1.3.2. Age associated alterations in the immune system 
A strong immune system is a must to support healthy ageing. Ageing of the immune 
system involves large modifications of humoral, cell-mediated and innate immunity. 
Some of these summarised in table 1.6. 
 
Table 1.6. Some of the age associated modifications of the immune system (Ginaldi 
et al., 1999; 2001; Meyer and Soergel, 1999; Pawelec et al., 1999) 
 
Modifications of the immune system with age 
↓ in number of naive T cells compared to memory T cells 
↓ of interleukin-2 (IL-2) production 
↓ in interferon-gamma-γ (IFN-γ) production 
↓ of IL-4 production 
↓  of production of pro-inflammatory cytokine IL-12 
↑ of production and secretion of IL-10 
↓ in function of neutrophils 
 
An age associated decrease in naive T cells of the cell mediated immune response 
results in decreased production of IL-2, high affinity IL-2 receptors and a reduced T cell 
proliferative response to previously un-encountered antigens. The decrease in number of 
naïve T cells with age results in the retardation of the ability of the body to respond to 
previously un-encountered pathogens. IFN-γ are cell signalling proteins that are anti-
viral agents and can fight tumours. It also increases the cell surface expression of MHC 
Class I and Class II molecules which enabled the activation of T cells to recognise the 
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antigens presented by them. IL-4 molecules enabling the differentiation of naïve T cells 
to Th2 cells and the production of IL-2 and TNF-α, which helps in combatting foreign 
pathogens, are also decreased with ageing of immune system. 
1.1.3.3. Age associated thymic involution  
The thymus is a structure present in almost all vertebrates. It is located beneath the 
upper portion of the sternum and mostly consists of lymphatic tissue and to a smaller 
extent epithelial tissue known as Hassall’s corpuscles. The human thymus increases in 
weight until puberty. Post-puberty, thymus gradually involutes and fat replaces 
lymphatic tissue of the thymus gland.  
 
Age associated changes to the thymus are observed both in humans and mice. Increased 
levels of sex hormones have been suggested to cause thymic involution 
(Derhovanessian et al., 2008). Haematopoietic stem cells (HSCs) are known to mature 
in thymus. Age associated thymic involution may affect their maturation. HSCs are 
characterised by their ability to self renew and to form multiple cell types. A 
compromised production or function of HSCs would affect the immune system as a 
whole. There is evidence for an association between HSCs decline and longevity 
(Geiger and Van, 2002). Hakim et al. (2005) demonstrated exceedingly low levels of 
thymic activity after the age of around 40 years in individuals after HSCs 
transplantation. The exact reason for thymic involution still remains unclear 
(Derhovanessian et al., 2008). Thymic involution is also responsible for the 
compromise of T cell differentiation with age. Thymic function is also likely to be 
compromised by the presence of any underlying disease and its therapy. 
1.1.3.4. Age associated alterations in T cell subsets 
Mature T cells are subject to changes during ageing as a result of several factors 
including antigen exposure, clonal expansion and contraction. The varying proportions 
of T cell subsets in young and aged individuals is a particular example of this age 
related alteration in T cells. Old aged human donors have increased proportions of 
CD4+CD45RO+ memory phenotype cells and less CD45RA+ naive phenotype cells 
compared to young donors (Hannet et al., 1992; Utsuyama et al., 1992; Gabriel et al., 
1993). The increased proportions of CD4+ CD45RO+ memory phenotype cells enable 
the human body to respond to antigens encountered previously and lesser proportions of 
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CD45RA+ naive phenotype cells in peripheral blood (Fagnoni et al., 2000) and immune 
organs such as lymph nodes (Lazuardi et al., 2005) would result in the impairment of 
ability to respond to new antigens (Koch et al., 2008). The functional integrity of both 
CD4+ and CD8+ T cell subsets decreases with age (Naylor et al., 2005; Hadrup et al., 
2006). This contributes to a significant decrease in the ability of elderly to respond 
adequately to relapsing infections as well as their ability to respond to persistent 
infections due to immune exhaustion (Zinkernagel et al., 1993). 
1.1.3.5. Ageing of T cells 
T cells are supposed to undergo rapid clonal expansion followed by clonal contraction 
to mediate an effective adaptive immune response. Prior to this step, T cells become 
activated by interactions with functional antigen presenting cells (APCs). The 
interactions of T cells with DCs depend on the number and structure of the cell-surface 
receptors and intracellular signalling pathways. Ageing is also associated with a 
decrease in the expression of the cell-surface molecule, CD28; commonly referred to as 
the biomarker for immunosenescence. The decrease in expression is attributed to the 
accumulation of CD28- T cells within the CD8+ T cell subset in peripheral blood of 
elderly. The loss of CD28 expression in vitro is attributed to T cells undergoing 
differentiation and entering a state of replicative senescence (Effros et al., 1994).  
1.1.3.6. Age associated defects in efficacy of vaccinations 
Depletion of T cell function with age is one of the main contributors detrimentally 
affecting the optimal efficiency of vaccines in the elderly. An age associated increase in 
pro-inflammatory factors contributes to poor response to vaccinations against pathogens 
causing influenza and pneumonia (Kovaiou et al., 2007). Shorter-lasting effects of 
vaccinations and low levels of responses to secondary antigens are some of the 
examples of depleted efficacies of vaccinations in elderly. Boosting the efficacy of the 
vaccine may enhance the NK cell system which may in turn be associated with better 
vaccine responses (Mysliwska et al., 2004). IL-2 pre-treated elderly subjects were better 
protected against influenza virus compared to controls (Provinciali et al., 1994). 
Efficiency of IL-2 in boosting efficacy of vaccines was also revealed in an IL-2 
supplemented liposomal vaccine study in 48 elderly people (Ben-Yehuda et al., 2003). 
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1.1.3.7. Impact of ageing on cancer and autoimmune diseases 
The reduced immune function in elderly, due to a compromised immune system, may 
result in increased cancer occurrence. The median age for the diagnosis of cancer in 
industrialised countries is approaching 70 years of age and is expected to increase (Ries 
et al., 2003). There is no evidence to show an increase in occurrence of cancer with age. 
Normally, individuals are exposed to pathogens throughout their life time and exposure 
beyond an optimal load may result in immune exhaustion (compromise in immune 
system) leading to immunosenescence. Cancer antigen load is also believed to have a 
similar effect ultimately leading to immunosenescence (Derhovanessian et al., 2008). 
 
The impaired and inappropriate reaction of the immune system to self antigens, causing 
cell and tissue damage and acute or chronic inflammation processes, can result in 
autoimmune diseases, sometimes called as ‘autoaggression’. Rheumatoid arthritis (RA) 
is the most common example of autoimmune disease occurring in elderly. But it has 
been shown to also occur in young adults or teenagers (Witkowski, 2007).  
1.1.3.8. Human T cell clones as a model for immune study 
The use of monoclonal human T cell populations was a milestone in the field of ageing 
research, enabling the manipulation of immunosenescence in vitro and shedding 
insights into T cell immunosenescence in vivo. The T cell clone model in vitro is well 
documented (Pawelec et al., 2000). The thorough understanding of the 
immunosenescence process may lead to the development of interventions aimed at 
lengthening the healthspan in old aged individuals. 
 
T cell clones in vitro are useful for the study of factors which contribute to T cell 
senescence and for investigating age associated changes over the lifespan (Pawelec et 
al., 2002). T cell clones can be maintained for extended periods in culture and have 
finite lifespans. At the end of the in vitro lifespan, T cell clones die by apoptosis. Since 
the T cell clone model is monoclonal, the behaviour of a single cell type can be 
followed. In polyclonal systems, changes observed may be due to alterations in the 
proportions of the different cells present (Pawelec et al., 2002). Also in a polyclonal 
population, calculation of longevities can only be done by examining individual 
components cloned separately. Otherwise, only the longevity of the last remaining 
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surviving clone from the original polyclonal population can be measured. This has been 
a confounding factor in fibroblasts, one of the most extensively studied cell type, where 
the data available do not imply to the average longevity of the entire population, but 
only to the longest lived clone present in the study population. It is essential to know the 
in vivo age of the starting T cell population in a meaningful study of T cell ageing in 
vitro. This is impossible in a polyclonal population. So the isolation of precursors and 
enabling them to differentiate into T cell clones in vitro is the only way to make sure 
that all T cells studied are of the same age at the beginning of the experiment (Pohla et 
al., 1993; Barnett and Barnett, 2000). 
 
In spite of all the advantages, the T cell clone model has its limitations. Whilst on the 
one hand, one of the major assets of the in vitro model is its monoclonality; this clearly 
is not a true reflection of the in vivo situation, which is predominantly polyclonal. 
Furthermore, to maintain human T cell clones in culture throughout their lifespan is a 
relatively labour intensive and not cost effective process. 
 
The growth characteristics and the longevity of human T cell clones depend on the age 
of the donor (Pawelec et al., 2006). Clones derived from neonates, young adults (20-30 
years (yr)) and elderly (70-90 yr) had 52, 40 and 32 population doublings (PDs) 
respectively (McCarron et al., 1987). Extensive research carried by our group revealed 
similarities in overall patterns of growth in T cells derived from different origins with 
different ages (Pawelec et al., 2002) (Table 1.7). 
 
Table 1.7. Longevity is expressed as a percentage of established clones that 
survive to 20, 30 or 40 PDs. Origins: CD3 (young), mature peripheral T cells 
from healthy 30 yr old donors; (old), perfectly healthy SENIEUR- compliant 
donors over 80 yr; (cent), centenarian donors >100 yr (Pawelec et al., 2006) 
 
Clones/Origins Percentage of clones 
reaching 
20PD    30PD    40PD 
Longest lived 
clone (PD) 
CD3 (young) 47 24 15 90 
CD3 (old) 48 26 16 77 
CD3 (cent) 41 23 17 80 
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Human T cell clones can be easily generated and maintained in culture (Pawelec, 1993). 
The procedure involves a limiting dilution procedure of the cell suspension to be cloned 
and microwell culture of the diluted cells on an irradiated feeder cell layer in the 
presence of IL-2. In long term culture systems, T cells are stimulated weekly via the 
TCR using gamma irradiated (80 Gy) RJK 853 feeder cells. RJK 853 is an Epstein-Barr 
virus (EBV)-transformed B lymphoblastoid cell line with a complete deletion in the 
gene encoding hypoxanthine guanine phosphoribosyltransferase (HPRT). The T cell 
clones are maintained in X-Vivo 10 (Bio Whitaker), a serum free medium specifically 
designed for the cloning and propagation of lymphocytes. They are also supplemented 
once in every three days with 400U/ml recombinant human IL-2. The RJK cells are 
irradiated to prevent the interference / cross reaction of their intracellular functions with 
the T cell recognition. The RJKs express receptors on their surface that can be 
recognised by T cells. The age of the T cell clones can be tracked by calculating the 
number of PDs the cell has undergone. A different B lymphoblastoid cell line or human 
peripheral blood mononuclear cells can also be used as feeder cells instead of gamma 
irradiated (80 Gy) RJK 853 cells. Many important similarities have been found between 
the T cell clone model of immunosenescence and T cell ageing in vivo (Pawelec et al., 
2002) (Table 1.8). 
 
Table 1.8. Similarities between T cell clones in vitro and T cell ageing in vivo 
 
Similarities between T cell clone model of immunosenescence and T 
cells ageing in vivo 
Age associated increase in DNA damage (Barnett et al., 1999; Hyland et al., 2000; 
2001) 
Decrease in telomere length 
Decreased telomerase induction (Bodnar et al., 1998) 
Decrease in DNA repair capacity (Annett et al., 2004; 2005) 
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1.1.4. The biological effects of oxidative stress 
1.1.4.1. Effect of oxidative stress on intracellular redox status 
Intracellular redox status is an important mechanism credited for its role as a mediator 
in apoptosis in many cell systems (Cotgreave and Gerdes, 1998; Hall, 1999). Recent 
findings indicate depletion of intracellular reduced glutathione (GSH), a main 
determinant of intracellular redox status, before the onset of apoptosis (Beaver and 
Waring, 1995; Macho et al., 1997; Ghibelli et al., 1998). Some of the main factors 
leading to depletion of GSH are mentioned in table 1.9. 
 
Table 1.9. Main factors leading to depletion of GSH 
 
Main factors leading to depletion of GSH 
The depletion of GSH could be due to increased oxidation of GSH to oxidised 
glutathione (GSSG) (Slater et al., 1996) 
Inhibition of GSH synthesis (Yang et al., 2000) 
Use of GSH by Glutathione transferases in detoxification of electrophilic compounds 
contributing to its depletion in the cell. 
 
 
1.1.4.1.1. Glutathione function and redox balance 
GSH is an abundant antioxidant in the cell (Cotgreave and Gerdes, 1998) which acts as 
an important biomarker of oxidative stress. It can exist in two forms: 1) Reduced 
monomer (GSH) 2) Oxidised dimer (GSSG). In normal conditions, GSH is present in 
cells at more than hundred fold concentration of GSSG. GSH is a major low molecular 
mass thiol in mammals (Halliwell and Gutteridge, 1999). The majority of GSH in plant 
and animal cells is present in the cytoplasm, where it is synthesised at concentrations 
between 0.5mM and 10mM. The reduced glutathione is a tripeptide with a free thiol 
group. It provides reducing equivalents for glutathione peroxidase (GPx) catalysed 
reduction of hydrogen peroxide (H2O2) and lipid hydroperoxides to water (H2O) and the 
respective alcohol. This reaction results in the oxidation of GSH to GSSG. GSSG is 
then recycled into GSH by glutathione reductase (GR) and NADPH (Figure 1.8).  
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The activity of reductase increases in response to increase in concentrations of GSSG 
during oxidative stress (Jones, 2002). Excess or free GSSG can be eliminated from cells 
either by glutathionylation or through specific transporters exporting GSSG out of the 
cell. 
 
 
 
Figure 1.8. Oxidation of GSH to GSSG by GPx and recycling of GSSG back to 
GSH by GR. 
 
GSH recycling and biosynthetic pathways ensure its availability by up-regulation during 
oxidative stress and nitrosative stress (Griffith, 1999; Kondo et al., 1999; Moellering et 
al., 1999). Intracellular GSH is mainly regulated by the transport and availability of 
cysteine. The consecutive action of two enzymes, glutamate cysteine ligase and 
glutathione synthase are the pre-requisite for the synthesis of GSH in cells. The 
GSH:GSSG redox couple maintains the redox environment of the cell, it is abundant in 
the cell (Schafer and Buettner, 2001) and it serves as an indicator of the cellular redox 
environment. In biological systems, even a moderate level of oxidation can result in the 
formation of GSSG and mixed disulfides between protein sulfhydryl groups and GSH 
that would hinder the redox status of the cell. The decrease in levels of GSH can result 
in an increase in levels of GSSG and thereby lowering the GSH:GSSG ratio, which has 
been suggested to be responsible for several human diseases such as; lung inflammation, 
amyotrophic lateral sclerosis, chronic renal failure, malignant disorders, diabetes, 
alcoholism, Parkinson’s disease, Alzheimer’s disease and cataract formation (Lomaestro 
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and Malone, 1995; Herzenberg et al., 1997; Navarro et al., 1997; Samiec et al., 1998; 
Spickett et al., 1998; Cecchi et al., 1999; Hadi Yasa et al., 1999; Navarro et al., 1999; 
Papp et al., 1999; Bonnefont Rousselot et al., 2000; Kharb, 2000; Lang et al., 2000; 
Mills et al., 2000; Pastore et al., 2001). The underlying mechanism behind the cause of 
diseases may be the reduction in capacity of cells to detoxify free radicals due to 
reduced levels of glutathione peroxidises enzyme system or GSH depletion may greatly 
inhibit immune function of the body, thereby, increasing its vulnerability to infection 
(Droge et al., 1994). Glutathione depletion has also been revealed to cause lipid 
peroxidation in patients suffering from Parkinson’s disease (Lohr and Browning, 1995). 
But it has been found that during ageing GSH levels appear to decline in a number of 
tissues which increases the possibility of the cells succumbing to stress (Maher, 2005). 
Oxidative stress can be detected by evaluating the changes in redox tone (GSH:GSSG 
ratio).   
1.1.4.2. Genetic damage in T cells ex vivo 
DNA damage and mutation have been shown to increase as a function of age ex vivo in 
cultured lymphocytes from healthy male subjects in three different age groups (35-39, 
50-54 and 65-69 years; Barnett and King, 1997). The basal levels of DNA damage were 
measured by the alkaline comet assay. Lymphocytes were also associated with an age-
related decline in DNA repair capacity due to their inability to repair H2O2 induced 
DNA damage. This age related retardation of DNA repair capacity might result in an 
accumulation of oxidative DNA damage within T cells which might in turn result in age 
related decline in replicative capacity. Interestingly, subjects from the 75-80 year age 
group did not show an increase in DNA damage and decrease in DNA repair capacity 
levels were similar to that of 35-39 year old subjects.  
 
Ageing was also associated with loss of X or Y chromosomes (Schneider, 1979), 
increase in development of micronuclei (French and Morley, 1985) and increase in 
frequency of mutations at various genetic loci (Morley et al., 1982; Trainor et al., 1984; 
Vijayalaxmi and Evans, 1984; Cole et al., 1988; 1991; Barnett and King, 1995; King et 
al., 1997). The mean mutant frequency at the HGPRT gene locus in lymphocytes 
isolated from healthy male subjects in the age group of 65-69 years was considerably 
higher than in the younger age groups of 35-39 years and 50-54 years (King et al., 1994; 
1997). The same can be said about chromosomal aberrations, when the frequency of 
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chromosomal aberrations in 75-80 year old subjects was fewer than in 50-69 year old 
subjects. It is also worth mentioning that the antioxidant status remained the same for 
age groups between 35-69 years. The factors above suggest DNA repair processes and 
antioxidant defense systems as major contributing factors for maintaining genomic 
stability in vivo, which in turn contribute to longevity (Barnett and Barnett, 1998). 
1.1.4.3. Genetic damage in T cells in vitro 
An increase in oxidative DNA damage (oxidised purine and pyrimidine DNA bases) in 
human CD4+ T cell clones in vitro as a function of age was revealed by Hyland et al., 
(2000; 2001; Figure 1.9). DNA damage measured using the alkaline comet assay 
showed a significant increase in its levels of prior to the end of their lifespan. This 
increase in damage with age might interfere with the ability of T cells to undergo rapid 
clonal expansion on antigenic stimulation to produce an effective immune response 
resulting in immune responses to be sub-optimal. Human CD4+ T cell clones were also 
associated with an age related decline in the efficiency of DNA excision repair capacity 
(Table 1.10) and mismatch repair capacity (Table 1.12). These results were obtained in 
human CD4+ T cell clones derived from healthy 26-year old and 45-year old donors, but 
there was no decline in either DNA excision (Table 1.11) or mismatch (Table 1.12) 
repair capacity in CD4+ T cell clones from a healthy 80-year old donor (Annett et al., 
2004; 2005). 
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Figure 1.9. DNA damage levels in 11 peripheral blood derived CD4+ T cell clones 
as a function of their in vitro lifespan using alkaline comet assay revealed a 
typically greater percentage of DNA in the comet tail (>15%) at the last PD 
analysed in 7 out of 11 clones. Values represent mean standard error for each 
assay counting 50 cells per slide (Hyland et al., 2001). 
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Table 1.10. Scale representation shows an age related decline in DNA repair 
capacity with age in T cell clones (400 series- 26 year old donor and 385 series- 45 
year old donor)  following induction of different types of DNA damage (Oxidation 
damage induced by H2O2, Alkylation damage induced by N-methyl- N-nitro- N-
nitrosoguanidine (MNNG), ultraviolet irradiation (UV-C)) 
 
Type of DNA damage induced 
Oxidation Alkylation UV-C Clone 
Young Middle Old Young Middle Old Young Middle Old 
400-23 + + + + + + + + + + + + + + + + + + + - - 
400-60 + + + + + + + + + + + + + + + + + 
385-2 + + + + + + + + + + + + + + + nd nd nd 
385-7 + + + + + + + + + + + + + + + + + + + nd nd nd 
 
 
 
Table 1.11. Scale representation shows maintenance in DNA repair capacity of T 
cell clones (399 series- 80 year old donor) following induction of different types of 
DNA damage (Oxidation damage induced by H2O2, Alkylation damage induced by 
MNNG, UV-C) 
 
Type of DNA damage induced 
Oxidation Alkylation UV-C Clone 
Young Middle Old Young Middle Old Young Middle Old 
399-35 + + + - + + + + + + + + + + + + + + 
399-37 + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + 
399-40 + + + + + + + + + + + + + + + + + nd nd nd 
 
 
+ + + + Excellent repair, + + + Good repair, + + Average repair, + Poor repair, - No 
repair, nd not determined (Adapted from Annett et al., 2004). 
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Table 1.12. Age related decrease in mismatch repair capacity was observed in T 
cell clones derived from a 26 year old donor (400 series) and a 45 year old donor 
(385 series). There was no decline in mismatch repair capacity in T cell clones 
derived from an 80 year old donor (399 series) (Annett et al., 2004) 
 
Clone 
Starting 
lifespan PD 
End of 
lifespan PD 
Repair rate 
at start of 
lifespan 
Repair rate 
at end of 
lifespan 
400-60 33.1 69.2 0.2% 0.05% 
385-2 34.5 64.4 0.27% 0.10% 
399-35 35.2 67.5 0.16% 0.21% 
 
1.1.4.4. Oxidative DNA damage to T cells 
ROS are considered as a major factor responsible for oxidative DNA damage in T cells. 
Free radicals, such as hydroxyl radicals and super-oxide radicals, are generated in vivo 
during normal cellular oxygen metabolism in the mitochondria (Ames et al., 1993; 
Cardozo-Pelaez et al., 2000). A variety of in vivo and in vitro experiments have 
revealed that ROS can induce various DNA lesions, such as DNA strand breaks [single-
strand breaks and double-strand breaks] and base modifications (Dizdaroglu, 1998; 
Cadet et al., 2003). DNA double stranded breaks etc, if un-repaired, can result in 
carcinogenesis, mutagenesis and other degenerative ageing diseases (Su et al., 2006). 
Hydroxyl radicals have also been shown to be responsible for the attack on the sugar 
moiety of DNA molecules responsible for inducing backbone breaks (Dizdaroglu, 1998). 
8-hydroxy-2-deoxyguanosine (oxo8dG) is a major mutagenic base lesion formed as a 
result of hydroxyl radical attack on DNA. Oxo8dG base pairs preferentially with 
adenosine, rather than cytosine, generating transversion mutations following replication.  
1.1.4.5. Mitochondrial DNA damage and mutations in T cells 
Human ageing has a peculiar effect on mitochondria. Ageing in various human tissues 
has been attributed to the occurrence and accumulation of different types of mutations 
(deletions, base substitutions and frame-shifts) in the mtDNA resulting in an established 
decline in mitochondrial bioenergetic function (Brierley et al., 1998; Liu et al., 1998; 
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Graff et al., 1999; Michikawa et al., 1999; Fernandez-Moreno et al., 2000; Kopsidas et 
al., 2000; Wang et al., 2001). Deletions of mtDNA were found to be the most common 
mutation associated with human diseases and ageing process (Kovalenko et al., 1997; 
Cormio et al., 2000; Cottrell et al., 2000; Raha and Robinson, 2000). 4977bp mtDNA 
deletion is the most commonly occurring deletion. It occurs between two 13bp direct 
repeats at nucleotide position nt8470-13447. mtDNA4977deletions have been shown to 
accumulate with age in various human tissues including heart, brain and lung (Kao et al., 
1997; Liu et al., 1998). Increased concentrations of mtDNA4977 have been consistently 
reported in the blood of patients suffering from Kearns-Sayre syndrome, Pearson’s 
pancreas syndrome and mitochondrial myopathies (Biagini et al., 1998; von Wurmb et 
al., 1998). The general hypothesis is that, point mutations accumulate with age 
(Michikawa et al., 1999; Wang et al., 2001). However, previous studies from the group 
of Barnett did not find any age related accumulation of mutations in the mitochondria 
from T cell clones or ex vivo lymphocytes from elderly subjects compared to young 
controls (Ross et al., 2002). This absence of an age related increase in mtDNA damage 
might be partly due to high turnover rate of blood cells which acts against the 
accumulation of mtDNA in any significant number (Meissner et al., 2000). 
1.1.5. Cellular defense systems in the body 
Cellular defense mechanisms involve several systems, namely enzymatic antioxidants, 
non-enzymatic antioxidants, activation of nuclear proteins such as poly adenosine 
diphosphate (ADP) ribose polymerase (PARP) (protein involved in DNA repair 
processes and programmed cell death), stress proteins and DNA repair pathways. 
1.1.5.1. Enzymatic antioxidant defense 
Superoxide dismutase (SOD), GPx, catalase (CAT) and caeruloplasmin (CPL) are 
important enzymatic antioxidants capable of counteracting biomolecular damage by 
converting highly reactive ROS into less reactive moieties. SOD is a group of 
metalloenzymes that enables the conversion of superoxide anion (O2.) into O2 and H2O2. 
CAT enzymes convert H2O2 into H2O and O2 and GPx enzymes are credited with the 
removal of H2O2 from the body. Biomolecular damage can still occur irrespective of the 
presence of these enzymes and repair enzymes (for example: Proteasome, 
phospholipase-A2) may be needed to minimise the extent of damage. Those repair 
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systems are actually incapable of repairing the damage instead they remove or 
breakdown the damage proteins, lipids respectively. 
1.1.5.2. Non-enzymatic antioxidant defense 
Uric acid (UA), vitamin E (α-tocopherol), vitamin C (ascorbic acid) and stress proteins 
are some of the non-enzymatic antioxidants present in vivo. Hydrophilic vitamin C 
counteracts ROS induced DNA damage in cells. The lipophilic nature of vitamin E 
enables it to act in membranes and lipoproteins (Beckman and Ames, 1998). 
 
Heat shock proteins (HSPs) are highly conserved nuclear proteins activated in response 
to oxidative stress or variable temperatures. Stress proteins have been credited with 
maintaining cellular homeostasis due to their ability to bind to and stabilise an unstable 
protein (molecular chaperones). Stress proteins also participate in the folding and 
correct assembly of unfolded or misfolded proteins, their transport to respective sub-
cellular compartments and/or disposal by proteolytic degradation (Hartl, 1996). But the 
exact molecular targets of HSP protection still remain a mystery. HSP 70 is an 
important molecular chaperone and can act against cytoplasmic oxidative damage (Papp 
et al., 2003). HSP 70 activity has been demonstrated to decline in response to increasing 
heat shock with age making the body more susceptible to stress induced damage 
(Favatier et al., 1997). 
1.1.5.3. Antioxidant status in vivo 
The antioxidant system in vivo is a pre-requisite for maintaining genomic stability and 
thereby contributing to longevity. Centenarians (individuals who have successfully 
reached > 100 years of age) were shown to maintain their levels of non-enzymatic 
antioxidants, in particular vitamin E and vitamin C with age (Mecocci et al., 2000). An 
age related decline in its efficiency has been well documented. King and Barnett (1997) 
showed an age related elevation in the levels of in vivo antioxidants (Gpx, CAT, CPL) 
in human lymphocytes from healthy 75 to 80 year old donors (Figure 1.10). 
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Figure 1.10. Shows an age related elevation in the levels of in vivo antioxidants 
(Gpx-(b), CAT-(c), CPL-(d)) in human lymphocytes from healthy 75 to 80 year old 
donors. There was no significant age related increase in the levels of in vivo 
antioxidants such as SOD, UA and Bilirubin (BR) (Barnett and King, 1997). 
1.1.5.4. Cellular responses to DNA damage 
A cell can respond to DNA damage in a number of ways; cell cycle arrest, repair of 
DNA damage, tolerate the DNA damage and continue to replicate or undergo apoptosis 
in response to critical levels of DNA damage (Hartwell and Kastan, 1994, Kaufmann 
and Paules, 1996). All these factors may lead to an effect on T cell mediated immune 
responses. 
 
Cell cycle is a term for the period of time between one cell division and the next. G1, S, 
G2 and M are the four key phases of the cell cycle. For resting cells, the phase is G0 in 
place of G1. The progression from one phase to another of the cell cycle is under strict 
control by cell cycle check points. There can be several cell cycle check points in a cell 
cycle. The cell cycle check points are recognised as positions of control in a cell that 
ensures the order of events in the cell cycle and that integrate DNA repair with cell 
cycle progression (Hartwell and Kastan, 1994). The cell cycle check points respond in 
different ways to DNA damage. The DNA damage in cells within G1 phase may cause 
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G1 arrest; in S phase, DNA damage may result in replicon initiation inhibition and in G2 
phase, DNA damage may result in G2 delay. These different types of responses by the 
cell to DNA damage are to facilitate time for the repair of DNA damage before it would 
result in DNA replication errors or mitotic errors (Kaufmann and Paules, 1996). DNA 
damage in T cells may hinder their ability to undergo rapid clonal expansion in response 
to the presence of an appropriate antigen, because of cell cycle arrest or delay. In this 
instance, the immune response may be sub-optimal due to inadequate number of T cells. 
Cell cycle arrest mechanisms are thought to be important in the process of replicative 
senescence. 
 
Key regulators of the cell cycle are CDKs and CKIs, which regulate the progression of 
cells through the cell cycle. CDKs and CKIs detect DNA damage and initiate a series of 
molecular events resulting in cell cycle delay or arrest to allow sufficient time for the 
processing and repair before the next round of replication. CDKs and CKIs also enable 
the deletion of affected cells by apoptosis (Hyland et al., 2001). T cells undergoing cell 
cycle arrest or delay will not be able to undergo rapid clonal expansion upon antigenic 
stimulation to produce an effective immune response in vivo and in vitro. In this case, 
the immune response may be sub-optimal due to inadequate production of T cells 
(Barnett and Barnett, 1998).  
 
Cell cycle delay/arrest, DNA repair, replicative senescence and apoptosis are some of 
the complex responses to DNA damage in eukaryotic cells. The three important CKIs 
are p16, p21 and p27. p21 expression is associated with the cell senescence phenotype. 
p21 mediated cell cycle arrest is induced by DNA damage via the p53 pathway (Cox, 
1997). In CD4+ T cell clones in vitro, the age related increase in DNA damage is not 
associated with proportionate increase in levels of p21 mRNA. This indicates that 
increased levels of oxidative DNA damage in T cell clones in vitro is probably not the 
major trigger of apoptosis via the p53/p21 pathway (Hyland et al., 2001). p16 
expression has been found to increase gradually during lifespan and persists at high 
levels during senescence (Li et al., 1994; Rogan et al., 1995; Alcorta et al., 1996; Hara 
et al., 1996; Reznikoff et al., 1996; Zindy et al., 1997). Short term induction of p16 
expression has also been shown to induce reversible cell cycle arrest (Mitra et al., 1999). 
But in most CD4+ T cell clones in vitro, mRNA levels of p16 were shown to decrease as 
a function of age suggesting, that they were not moving towards senescence (Hyland et 
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al., 2001). p27 expression functions as a mediator of extracellular antimitogenic signals 
and normally increases with lifespan, but there were no consistent pattern in the changes 
in levels of expression of p27 with age in CD4+ T cell clones in vitro (Hyland et al., 
2001). 
 
Oxidative stress also results in detrimental effects on T cell replicative capacity in vivo. 
Peripheral blood mononuclear cell derived T cells may have less replicative capacity as 
they may have already undergone enough divisions or proliferation in vivo as part of an 
immune response. This means that, on transfer to an in vitro system, they are or may be 
nearer to their Hayflick Limit (irreversible state of growth arrest). The stability and the 
reproducibility of the loss of replicative potential have led to the belief that loss of 
replicative capacity and replicative senescence is controlled by an intrinsic cell division 
counting mechanism called the replicometer. Replicative senescence can be described 
as a permanent loss in replicative potential independent of the culture time. T cells more 
or less undergo a fixed number of cell divisions in vitro under constant culture 
conditions before they reach an irreversible state of growth arrest (Hayflick and 
Moorehead, 1965). T cell clones are associated with an age associated decrease in CD28 
and IL-2 receptor expression and decreased IL-2 production (Watford et al., 1981; 
Grubeck- Loebenstein et al., 1994; Adibzadeh et al., 1995). Individual T cell clones 
exhibit different in vitro lifespans and differences in the quality of other biomarker 
changes. These differences might be contributed to by some simple manipulations of 
tissue culture conditions that may be enough for certain T cells to successfully adapt to 
particular culture conditions, as well as the molecular and biochemical properties of 
individual T cell clones. Oxidative stress, leading to mortality due to complete loss of 
replicative potential, was detected in lymphocytes from elderly humans compared to 
young controls (Garcia Arumi et al., 1998). 
1.1.5.5. DNA repair process 
The integrity of cellular DNA is under constant threat from a range of exogenous and 
endogenous DNA damaging agents (Toussaint et al., 2002). The human body is 
equipped with a complex range of defense systems having the ability to counteract these 
agents and maintain genomic stability in the body, they include facilitation of cell cycle 
delay/arrest, DNA repair pathways and antioxidants in vivo that might reduce, remove 
or repair the DNA damage (Smith and Fornace, 1996). DNA damages, if not 
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counteracted, might lead to accumulation with age and may result in fixation of the 
damage leading to mutations. Previous studies from the group of Barnett focused 
mainly on two different DNA repair systems (Section 1.1.5.5.1 & Section 1.1.5.5.2). 
1.1.5.5.1. Mismatch repair system 
The mismatch repair system (MMR) is another DNA repair system that has been 
extensively investigated. It is a very effective system capable of identifying and 
subsequently rectifying errors in DNA replication (accurate process with <1 error per 
1010 nucleotides synthesised) that escape DNA polymerase proofreading during the 
replication process (Kolodner, 1996). MMR enables the maintenance of genomic 
stability and helps in preventing spontaneous mutation that in turn prevents 
microsatellite instability (MSI). Microsatellites are short repetitive DNA sequences that 
are often copied incorrectly by DNA polymerases because their template daughter 
strands are particularly prone to misalignment during replication. An age related 
decrease in MMR capacity has been revealed in human CD4+ T cell clones in vitro 
(Annett et al., 2005) (Table 1.12). Earlier studies have shown a compromise in the 
activity of DNA polymerase contributing to increase in MSI with age (Srivastava and 
Busbee, 2003). In this case the MMR system was not able to counteract against DNA 
mismatch accumulation. 
1.1.5.5.2. Excision repair pathways 
The two different excision repair pathways identified are base excision repair (BER) 
and nucleotide excision repair (NER). BER is involved in repairing the damage that 
arises spontaneously. Instability, alkylation or oxidation of DNA is the major factors 
responsible for spontaneous DNA damage. NER is responsible for the removal of a 
variety of bulky DNA lesions such as Ultra violet (UV) rays induced cyclobutane 
pyrimidine dimers (CPD) and pyrimidine 6-4 pyrimidone photoproducts (6-4 PP) 
(Annett et al., 2004). An age related decrease in DNA excision repair capacity has been 
demonstrated in human CD4+ T cell clones in vitro (Annett et al., 2004) (Table 1.10).  
1.1.6. Exogenously applied antioxidants 
Accumulation of genetic damage within T cells may contribute to an age related decline 
in T cell replicative capacity through cell cycle arrest, apoptosis or selection against T 
cells containing mutations (Barnett and Barnett, 1998). In case of accumulation of 
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genetic damage, T cells may not be able to undergo rapid clonal expansion upon 
antigenic stimulation resulting in a sub-optimal immune response. This phenomenon 
suggests a relationship between genomic stability and immunosenescence. This theory 
was further supported by the findings of high levels of genomic stability for the 
maintenance of healthy immune function in extremely old human subjects (Steinmann 
and Hartwig, 1995). Previous findings from our research group suggested maintenance 
of low levels of oxidative DNA damage and significantly higher plasma antioxidant 
capacity in Swedish nonagenarian (people between 90 and 100 years of age) subjects 
compared to controls (Hyland et al., 2002), further emphasising the importance of a 
relationship between intact immune function and longevity. If oxidative damage to 
DNA in T cells results in decline in function with age, it is important to find a solution 
in which age related increase in oxidative damage to DNA in vivo can be counteracted. 
One way may be through the use of nutritional interventions and/or with antioxidant 
administration.  
 
Vitamin E, ascorbic acid, carnosine and N-tert-butyl-α-phenylnitrone (PBN) are some 
of the exogenous antioxidants successfully tested in humans. Several studies have 
pointed out the possibility that vitamin E may be protective against cancer (Duthie et al., 
1996; Yamashita et al., 1998). Previously, our research group has successfully used 
Carnosine (β-alanyl-L-histidine) and PBN, a spin-trap agent, as antioxidants in human T 
cell clones. Carnosine has raised considerable attention due to its ability at physiological 
concentrations of 20mM to significantly increase the lifespan and lower levels of 
oxidative DNA damage in T cell clones derived from a healthy young subject (Hyland 
et al., 2000). 250µM PBN increased the longevity and significantly lowered the levels 
of DNA damage in T cell clones compared to controls. The replicative capacity of T cell 
clone remained unchanged on supplementation with PBN. 
 
In this investigation, the impact of long term exposure (beyond 24 hours of 
supplementation) of a range of concentrations of ebselen or NAC in human peripheral 
blood derived CD4+ T cell clones and human peripheral blood mononuclear cells was 
investigated. 
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1.1.6.1. Ebselen 
Ebselen (2-phenyl-1,2-benzisoselazol-3(2H)-one; Figure 1.11) is an organoselenium 
compound mimicking glutathione peroxidise, an antioxidant selenoenzyme, in reducing 
H2O2 (Griffiths et al., 1992; Yang et al., 1999). This ability enables ebselen to minimise 
the deleterious effect of ROS (Muller et al., 1984; Wendel et al., 1984). The 
catalytically active selenium has the ability to reduce H2O2. Selenium in ebselen can 
reduce H2O2 to H2O and O2 (Coffey et al., 1995). The presence of the selenol group has 
been mainly attributed for the antioxidant properties in ebselen. Its protective effects 
against lipid peroxidation have been demonstrated in vitro and in vivo (Ozaki et al., 
1997). It has also been shown to be an efficient scavenger of free radicals such as 
peroxyl radical and peroxynitrite (Sies and Masumoto, 1997; Arteel et al., 1999) and to 
inhibit the release of apoptotic factor cytochrome c (Boireau et al., 2000). A recent 
study has shown the ability of ebselen to reduce the levels of peroxides enabling it to 
inhibit radiation induced apoptosis (Ramakrishnan et al., 1996).  
 
Ebselen has been successfully used in several cell types namely human hepatocellular 
liver carcinoma cell line (HepG2) (Yang et al., 1999), human promyelocytic leukemia 
cell line (HL-60) (Ji et al., 2000) and pheochromocytoma cells (PC12) (Yoshizumi et 
al., 2002). In HepG2 cells, ebselen has the ability to decrease intracellular ROS, thereby 
reducing hydroxyl radical formation which may explain the decrease in DNA damage 
on supplementation. The ability of ebselen to decrease hydroxyl radical formation may 
explain the increase in cell growth and reduction of lactate dehydrogenase (LDH) 
leakage, facilitating a block in lipid peroxidation in HepG2 cells (Yang et al., 1999). 
Apart from all the advantages, ebselen has some disadvantages such as its H2O 
insolubility. Prior to this investigation, the effects of ebselen in human T cells in vitro 
and ex vivo had yet to be explored.   
 
 
Figure 1.11. Schematic representation of ebselen 
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1.1.6.2. N-Acetyl L-Cysteine 
N-Acetyl L-Cysteine (NAC; C5H9NO3S; Figure 1.12), a precursor of GSH is an 
antioxidant involved in cellular detoxification (Meister and Anderson, 1983). It is an 
acetylated form of the aminoacid L-cysteine and has a thiol group that functions as a 
pre-cursor of glutathione synthesis. The presence of cysteine in NAC serves as a source 
to synthesise glutathione (Su et al., 2006) and sulfhydryl groups. NAC also acts as a 
stimulator of cytosolic enzymes involved in glutathione regeneration (Banaclocha, 
2001). It is H2O soluble and its intake is the most cost-effective way of boosting 
glutathione levels in the body. NAC is a low molecular weight compound that can 
readily pass through the blood brain barrier. NAC has also been shown to protect 
against oxidative damage with ROS (Aruoma et al., 1989). Initially it was used as a 
mucolytic agent (Cotgrave, 1997). It has been found to have a protective effect against 
cigarette smoke (Ozaras et al., 2003) and has a beneficial role in prostrate and 
respiratory conditions. Under normal conditions GSH peroxidases decomposes organic 
and inorganic peroxides in the cell using GSH as a substrate (Flohe, 1989). But 
peroxide accumulation may result in depletion of GSH thereby impairing the function 
of GSH peroxidase. The mechanism behind the antioxidant effect of NAC may be the 
presence of a free sulfhydryl group that enables scavenging of ROS and NO thereby 
blocking lipid peroxidation by peroxinitrate (Han et al., 1997). Glutamate and cysteine 
share the same transporter in the body and elevation in levels of extracellular glutamate 
competitively inhibit cysteine transport resulting in depletion of intracellular GSH 
synthesis. The ability of NAC to raise GSH levels due to its capacity to donate cysteine 
amino acid may also supplement its antioxidant potential (Han et al., 1997; Wagner et 
al., 1998).  
 
It would be interesting to investigate the effect of NAC in human T cells ex vivo using 
human peripheral blood mononuclear cells and human peripheral blood derived CD4+ T 
cell clones in vitro at 20% O2 tension. If ebselen or NAC could reveal an antioxidant 
capacity under physiological O2 tension, they may have potential anti-immunosenescent 
effects in vivo. 
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Figure 1.12. Schematic representation of NAC (Toussaint et al., 2000). 
1.1.6.3. MitoQ- a mitochondria targeted antioxidant 
Mitochondria have a pre-dominant role in the life and death of a cell. Damage to 
mitochondria has been widely implicated as a major reason behind a wide range of 
diseases such as Diabetes, Huntingdon, Parkinson’s, disorders associated with 
mitochondrial DNA mutations, apoptosis in cancer, pathophysiology of ageing to name 
a few (Nishikawa et al., 2000; Tabrizi et al., 2000; Smith et al., 2003). One of the main 
problems encountered in treating diseases caused by mitochondrial dysfunction is the 
inability to target bioactive molecules to mitochondria in vivo. This problem was 
rectified by the development of a strategy to target bioactive molecules specifically to 
mitochondria by their attachment to lipophilic triphenyl phosphonium cation through an 
alkyl linker (Murphy, 1997; Murphy and Smith, 2000; Kelso et al., 2001). The 
lipophilic triphenylphosphonium cation can rapidly permeate lipid bilayers due to a 
delocalised positive charge and the large mitochondrial membrane potential enables the 
cation to accumulate several hundred-fold inside isolated mitochondria and within 
mitochondria in cultured cells (Figure 1.15) (Sanjuan-Pla et al., 2005). This led to the 
development of mitoubiquinone (MitoQ), a mitochondria targeted antioxidant.  
 
MitoQ is a mixture of two redox forms of mitochondrially targeted ubiquinone 
derivatives 1) Mitoquinol (reduced form) (Figure 1.13) and 2) Mitoquinone (oxidised 
form) (Figure 1.14). The former, is the active antioxidant form of mitoQ that can 
detoxify ROS thereby enabling blockage of mitochondrial oxidative damage (Echtay et 
al., 2002; Jauslin et al., 2003; Schafer et al., 2003; Saretzki et al., 2003). This theory 
was further enhanced by the ability of mitoquinol to block lipid peroxidation compared 
to mitoquinones inability in human osteosarcoma 143B cells (Kelso et al., 2001). The 
ability of mitoQ to selectively accumulate within mitochondria enables the study of its 
effect on mitochondrial derived ROS and their signalling properties (Sanjuan-Pla et al., 
2005). The selective uptake of mitoQ by mitochondria increases the efficacy and 
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specificity of this bioactive molecule, designed to interact with mitochondria. The large 
mitochondrial membrane potential enables mitoQ to accumulate within mitochondria 
inside cells due to the attached cation. The ubiquinone moiety present in the lipid 
bilayer is reduced to an ubiquinol derivative by the respiratory chain. Ubiquinone buried 
within the lipid core of the inner membrane accepts two electrons from II resulting in 
reduction to ubiquinol. The ubiquinol derivative acts as an effective antioxidant by 
inhibiting lipid peroxidation and thereby preventing the leakage of superoxide from 
mitochondrial respiratory chain which has been mentioned as an important source of 
oxidative stress (Raha and Robinson, 2000). Ubiquinol donates a hydrogen atom from 
its hydroxyl groups to a lipid peroxyl radical enabling a decrease in lipid peroxidation 
within mitochondrial inner membrane (Takada et al., 1984; Ernster et al., 1992; Ingold 
et al., 1993). This results in either ubisemiquinone radicals disproportionating to 
ubiquinone and ubiquinol (Land and Swallow, 1970) or reacting with O2 to form 
superoxide and ubiquinone, which will be transferred to aqueous phase and will be 
detoxified by superoxide dismutase and peroxides (Maguire et al., 1989; Ingold et al., 
1993). The respiratory chain can regenerate the ubiquinol derivative enabling the 
recycling of its antioxidant activity (Kelso et al., 2001). The above mechanism enables 
mitoQ to protect mitochondria from oxidative damage (Kagan et al., 1994; Lass and 
Sohal, 1998). There is also evidence of mitoQ decreasing the release of ROS from 
mitochondria (Hwang et al., 2001).  
 
The effects of mitoQ has previously been investigated in human 143B osteosarcoma 
cells and concentrations upto 10µM mitoQ had little effect on the membrane potential 
of isolated mitochondria. Higher concentrations (25µM) decreased mitochondrial 
membrane potential and concentrations of 25-50µM were found to inhibit the 
respiration of the cells resulting in cell death. Cell viability remained unaffected at 
concentrations of 10µM (Kelso et al., 2001). Lower concentrations of mitoQ prevented 
oxidation of cisparinic acid by H2O2 and Ferrous ions (Fe2+) on co-incubation. Lower 
concentrations of mitoQ also blocked lipid peroxidation, evidenced by low levels of 
malonyldialdehyde (MDA) accumulation, and prevented disruption to mitochondrial 
function. Accumulation of caspases (cysteine dependent aspartate proteases known to 
be involved as a key executor of cell death) by H2O2 induced cytochrome c release from 
mitochondria into cytoplasm has been found to be a stimulus for apoptosis (Hampton 
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and Orenius, 1997). Pre-incubation with low concentrations of mitoQ completely 
blocked H2O2 induced caspase activation and apoptotic cell death in jurkat cells (Kelso 
et al., 2001). MitoQ, at concentrations of 50-100nm inhibited the growth of human 
foetal lung (MRC-5) fibroblasts in long term culture. But lower concentrations of -20nm 
needed an adaptation period of 1 week under normoxic (normal O2) conditions. At 40% 
hyperoxic (increase in O2) conditions, 10-20nm mitoQ completely prevented the rise in 
telomere shortening rate (Saretzki et al., 2003). 
 
Although the previous findings suggested low levels of point mutation (mtDNA4977) in 
mitochondrial DNA with age (Ross et al., 2002), the effect of mitoQ, on endogenous or 
exogenously applied ROS in human T cell samples had still to be investigated.  
 
 
 
Figure 1.13. MitoQ (reduced) (Smith et al., 2003). 
 
 
 
 
Figure 1.14. MitoQ (oxidised) (Smith et al., 2003). 
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Figure 1.15. The uptake of alkyltriphenylphosphoniumcation containing 
biologically active molecule by the lipid bilayer in mitochondria. The cation 
containing the biologically active molecule is accumulated 100 to 500 fold into the 
mitochondrial matrix due to high mitochondrial membrane potential (Adapted 
from Smith et al., 2003). 
1.1.6.4. Effect of reduced O2 tension as defense system 
A number of investigations have reported on the impact of O2 tension, cellular 
senescence and lifespan. Previous investigations have revealed a 25% increase in 
lifespan under 10% O2 tension in human diploid fibroblasts (HDF) (Packer and Feuheur, 
1977). A number of investigations have been carried out in HDF in reduced O2 tension 
culture conditions. Lately, long term culture of HDF at a physiological concentration of 
3% O2 in vitro significantly extended the lifespan of fibroblasts as well as increased the 
rates of proliferation in the cells, when compared to those cultured at 20% O2 tension 
(Chen et al., 1995). However, T cell clones cultured at low O2 tension (6%) had shorter 
lifespan (Table 1.13) and reduced replicative (proliferative) capacities (Table 1.14) 
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compared to the clones cultured at 20% O2 tension. The oxidative damage to DNA 
remained low throughout their lifespan (Figure 1.16). This phenomenon was observed 
for clones derived from young and old donors (Duggan et al., 2004). The shorter 
lifespan and low oxidative damage may be due to low levels of ROS in a low O2 tension 
environment in the culture system. Even though ROS is pre-dominantly known for its 
detrimental effect on cellular biomolecules, they also act as intracellular signaling 
molecules within T cells (Schreck et al., 1992; Kamata and Hirata, 1999). They are 
believed to act as signals/mediators to changes in cellular processes including cell 
function, proliferation, differentiation, cell damage and death. ROS are known to use 
several signaling molecules such as calcium, protein tyrosine kinases (PTKs), protein 
tyrosine phosphatases (PTPs), serine/threonine kinases, phospholipases in signalling 
pathways. Mitogen activated protein (MAP) kinases; a prominent family of protein 
kinases has several pathways identified such as extracellular signal regulated kinases 
(ERK), c-Jun N-terminal kinase (JNK), P38 kinase. These pathways are involved in 
proliferation, differentiation and apoptosis. Preliminary work from our group suggested 
an up-regulation of stress activated protein kinases (SAPK) also known as JNK and P38 
kinases at low O2 tension culture conditions in in vitro T cell clones. It was not clear 
whether the up-regulation was age dependent (Figure 1.17). T cell signalling events 
such as protein tyrosine phosphorylation and activation of JNK, cellular proliferation 
induced by lectin are some of the few instances that require the presence of ROS (Pani 
et al., 2000). This reduced ROS levels might interfere with the signalling pathways 
involved in T cell activation and proliferation, example: redox sensitive activation of 
transcription factors such as nuclear factor kappa light chain enhancer of activated B 
cells (NFkB) or activator protein-1 (AP-1) involved in T cell activation and 
proliferation (Tatla et al., 1998). The results of the above studies warrant further 
investigation and it will be interesting to see the effect of reduced O2 tension in T cell 
clones and ex vivo human peripheral blood mononuclear cells under varying culture 
conditions. 
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Table 1.13. Cumulative PD and the average lifespan of different T cell clones 
achieved overall under each culture conditions. Cumulative PD of T cell clones 
cultured under standard O2 tension are clearly higher in comparison to T cell 
clones maintained at reduced O2 tension (Adapted from Duggan et al., 2004) 
 
Clone Standard O2 tension Reduced O2 tension 
385-2 69.9 61.6 
385-7 73.5 71.5 
399-35 72.1 45.0 
399-37 78.1 51.9 
400-23 80.7 51.7 
Mean lifespan (PD) 74.9 ± 4.4 56.3 ± 10.3* 
* Significantly lower, p<0.05            
 
Table 1.14. Mean proliferative capacity per week of different T cell clones achieved 
overall under each culture conditions. Mean proliferative capacity of T cell clones 
cultured under standard O2 tension are clearly higher in comparison to T cell 
clones maintained at reduced O2 tension (Adapted from Duggan et al., 2004) 
 
Clone Standard O2 tension Reduced O2 tension 
385-2 1.9 ± 0.6 1.1 ± 0.6 
385-7 2.1 ± 0.7 1.2 ± 0.6 
399-35 2.1 ± 0.9 0.8 ± 0.5 
399-37 2.2 ± 0.8 0.9 ± 0.6 
400-23 2.1 ± 1.0 0.9 ± 0.6 
Mean PD/week 2.1 ± 0.1 1.0 ± 0.2* 
                                                                                   * Significantly lower, p<0.05           
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Figure 1.16. Oxidative DNA damage levels of T cell clones maintained under 
standard and reduced O2 tension conditions. a) DNA strand breaks and alkali 
labile sites b) oxidatively damaged pyrimidine bases plus DNA strand breaks and 
alkali labile sites c) oxidatively damaged purine bases plus DNA strand breaks and 
alkali labile sites (Adapted from Duggan et al., 2004). 
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Phospho JNK                                       Phospho P38 
 
Figure 1.17. Up-regulation of MAP kinases (phospho JNK and                         
phospho P38) at low O2 tension conditions in T cell clones independent of age. 
 
y- human peripheral blood derived CD4+ T cell clone derived from a healthy 26 year 
old donor, o- human peripheral blood derived CD4+ T cell clone derived from a healthy 
80 year old donor. 
                       Adapted from work carried out by Duggan et al., (2004). 
 
1.1.7. Aim of this investigation  
The aim of this PhD programme was to investigate the effects of antioxidants or low O2 
tension on T cell integrity and function using T cell clones and human peripheral blood 
mononuclear cells from donors of different age groups.  
 
The antioxidants used in this study were those which have potential applicability in vivo: 
1) Ebselen 2) NAC and 3) MitoQ. The effect of low O2 tension (2%) as a defense 
system on various aspects of T cells ex vivo was also investigated in this study.  
 
A number of bioassays were set up to analyse the impact of altered culture conditions 
on T cell integrity and function: 
20% low low20%
y o oy 
20% low low20%
y o o y 
Clone 1 Clone 2 
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1) Levels and types of oxidative damage to DNA were determined using a range of 
comet assay techniques. 
 
2) Intracellular redox tone (GSH:GSSG ratio) was measured using GSH:GSSG ratio 
assay kit. 
 
3) Total glutathione level were determined using GSH:GSSG ratio assay kit. 
 
4) Mitochondrial membrane permeability was determined using JC-1 dye. 
 
The specific biological markers of T cell function examined were:  
1) Proliferative capacity. In T cell clones in vitro, the proliferative capacity was 
determined by calculating the PDs per week of the clones during their span in the 
culture. PDs were calculated by counting the number of live cells using the Trypan Blue 
Exclusion Test. For human peripheral blood mononuclear cells ex vivo, the capacity to 
proliferate was evaluated using thymidine incorporatation. 
2) Lifespan of T cell clones in vitro determined by calculating cumulative PDs during 
their span in the culture. 
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CHAPTER-2 
 
Materials and Methods 
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2.1. Materials and Methods 
2.1.1. Human peripheral blood derived CD4+ T cell clones 
Human peripheral blood derived CD4+ T cell clones are accepted as a relevant system to 
allow the study of factors contributing to T cell senescence (Pawelec et al., 2002). The 
T cell clones used in this study were established using a limited dilution protocol 
(Pawelec, 1993) and were kindly supplied by Professor Graham Pawelec, University of 
Tubingen, Germany. Twelve independently derived T cell clones were examined in this 
investigation. The 400-series clones were obtained from a 26 year old overtly healthy 
laboratory worker and the 385-series clones were obtained from a 45 year old overtly 
healthy laboratory worker (Chapter-1, Section 1.1.3.8). 
2.1.1.1. Culture of T cell clones 
Human peripheral blood derived CD4+ T cell clones (expressing T cell receptors for 
antigen; TCR, CD3+, CD4+) were maintained in culture in a serum-free medium, X-
Vivo 10 (BioWhittaker), in 24 well plates (5 wells, 2 ml medium per well) at 
concentrations of 2-4 x 105 cells per well, along with 2 x 105 gamma-irradiated (80Gy) 
RJK853 cells per well (EBV-transformed B-lymphoblastoid cell line with complete hprt 
deletion, a gift from Dr. Jane Cole, MRC Cell Mutation Unit, University of Sussex, UK) 
as feeder cells. Clones were maintained in a 7-day cycle at 37oC under conditions of 5% 
CO2 and 95% air atmosphere. They were supplemented with 400U/ml recombinant IL-2 
(Chiron, UK) on days 1 and 4 of the cycle. On day 7, a viable cell count was performed 
on harvested cells using a Neubauer Counting Chamber, and a new culture cycle was set 
up with fresh medium and RJK853 feeder cells (Hyland et al., 2000, 2001). 
2.1.1.2. Determination of T cell clone proliferative capacity and 
lifespan 
The number of population doublings (PD) that a clone underwent in a week in culture is 
referred to as the proliferative capacity of the clone. The cumulative and total number of 
population doublings the clones underwent during culture is defined as lifespan.  
 
A peripheral blood derived T cell clone has to expand up to 26 PD to have sufficient 
number of clones for analysis or sufficient T cells for stock reserves, due to constraints 
  
 63
imposed by the cloning process. The earliest stage in the lifespan of T cell clones used 
in this analysis was 26-28 PD. Figure 2.1 demonstrates an example of growth of a T cell 
clone. 
 
Figure 2.1 Proliferative capacity of 385-7b clone throughout its lifespan. The points 
represent the PD achieved during successive seven day growth cycles and a spline 
curve has been used to illustrate growth rhythms. 
 
The viable count of T cell clones was determined on day four and at the end of every 7 
day cycle, with the trypan blue exclusion dye test used to assess viability. This count 
was used to calculate the number of PD the clones had undergone using the following 
formula: 
PD= Log2(cell count at the end of the cycle) - Log2(number of cells at the start of the 
cycle).  
 
The samples were then cryopreserved in a medium made up of 10% DMSO (Sigma), 
20% FBS (Invitrogen) and 70% X-Vivo 10 and stored in liquid nitrogen for further 
analysis at the end of a 7 day growth cycle (Hyland et al., 2000).  
 
The clones used in this investigation, mean PD achieved by them in a seven day cycle 
and the cumulative PD of each of the clones is illustrated in chapter 3 (Table 3.1). 
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Previous work carried out using T cell clones determined the relationship between 
PD/week and the cumulative population doublings or the in vitro age of the clones using 
linear regression analysis. The results of the growth of the T cell clones revealed 
considerably higher levels of growth at the start of the culture compared to the later 
stages of their life span in culture. The data of the previous studies suggested a 
decreased PD capacity with age. After an initial exponential phase of growth, the 
remainder of the lifespan of the clones transitioned into a steady state indicating the 
maintenance of PD capacity throughout the lifespan of the clones (Hyland et al., 2000; 
Pawelec et al., 2002). 
2.1.2. Ebselen or NAC supplementation 
Initial studies were carried out by supplementing T cell clones from the midpoint of 
their in vitro lifespan with a range of doses of ebselen (0-100µM) (Table 2.1) (Sigma) 
and NAC (0-10mM) (Table 2.1) (Sigma) in X-Vivo 10. The results of the impact of 
ebselen or NAC on T cell clones from the midpoint of their in vitro lifespan were taken 
into consideration before choosing the dose range of 0-30µM for ebselen and 0-7.5mM 
for NAC for the studies investigating the impact of these antioxidants when 
supplemented from a young in vitro age. Clones were supplemented with ebselen or 
NAC on days one and four of the growth cycle. The protocol for the supplementation of 
the antioxidants were done similar to that previously used by the group of Barnett with 
studies on the antioxidant carnosine (Hyland et al., 2000). Previously, no studies have 
been carried out to investigate the impact of long term exposure (beyond 24 hours) to 
ebselen or NAC in human T cell clones or in any other cell lines. The ability of ebselen 
to protect HepG2 cells (Yang et al., 1999), human HL-60 (Li et al., 2000) and PC-12 
cells (Yoshizumi et al., 2002) against H2O2 induced cell death and DNA damage and 
the proven ability of NAC to act as an efficient antioxidant in HeLa cells (Hansen et al., 
2004) and HepG2 cells (Yang et al., 1999) were taken into consideration before 
choosing the dose range of the antioxidants in this investigation (Chapter-4, Section 
4.1.2.4). 
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Table 2.1 denotes the different concentrations of ebselen or NAC used in this 
investigation 
 
Ebselen 
(µM) 
0 5 10 15 20 30 40 60 80 100 
NAC 
(mM) 
0 0.312 0.625 1.25 2.5 5 7.5 10   
 
2.1.3. Human peripheral blood mononuclear cells 
The antioxidant potential of ebselen or NAC in a polyclonal population of human 
peripheral blood mononuclear cells was assessed. These results were compared with the 
data obtained for the T cell clone model, a monoclonal population.  
2.1.3.1. Subject selection 
Ethical approval was granted by NTU based on the consent obtained from all the study 
subjects prior to this study. The human blood samples for the present study were drawn 
from ten healthy, non-smoking males fasted overnight, five each from the age group of 
25-30 years (n=5) and 55-60 years (n=5). Total number of donors from the age group of 
25-30 years and 55-60 years = 10. The subjects were not on any form of medication or 
had not suffered any recent illness. Other lifestyle factors such as alcohol consumption 
and exercise regime were also taken into consideration. Previous studies in human 
peripheral blood mononuclear cells isolated from the donors of different age groups 
carried out by the group of Barnett revealed that human peripheral blood mononuclear 
cells derived from older aged donors (age group of 65-69 years) had higher levels of 
mutations and DNA damage and had lower DNA repair capacity and altered in vivo 
antioxidant status compared to donors derived from the younger age groups (35-39 
years). The decrease in DNA repair capacity or alterations in in vivo antioxidant status 
may have contributed to the inrease in mutation load with age in mononuclear cells 
derived from donors in the age group of 65-69 years (Barnett and King, 1995). The 
result of this study was taken into consideration before choosing the two age groups of 
donors (25-30 years & 55-60 years) in this investigation. 
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2.1.3.2. Sample collection  
Human blood samples were drawn in the morning between 8.00 and 9.00 am by a 
licensed individual and collected in a tube containing heparin to prevent coagulation. 
The samples were kept on ice and taken to the laboratory within 5 minutes for 
separation of peripheral blood mononuclear cells. 
2.1.3.3. Preparation, maintenance of culture and storage of peripheral 
blood mononuclear cells  
Peripheral blood mononuclear cells were isolated from fresh heparinised venous blood 
by density gradient centrifugation on Ficoll-Isopaque (PAA Laboratories) in LeucoSep 
(Lymphocyte separation tubes). The ex vivo T cell samples were maintained in culture 
separately using a well established method optimised previously (Warnock et al., 1999; 
Barnett and Barnett, 2000). The peripheral blood mononuclear cells were washed twice 
in phosphate buffered saline or X-Vivo 10 media and then maintained in culture in a 
serum-free medium, X-Vivo 10, in 24 well plates (5 wells, 2 ml medium per well) at 
concentrations of 2-4 x 105 cells per well, along with 2 x 105 gamma-irradiated (80Gy) 
RJK853 cells per well (EBV-transformed B-lymphoblastoid cell line with complete hprt 
deletion) as feeder cells. Peripheral blood mononuclear cells were maintained in a 7-day 
cycle at 37oC under conditions of 5% CO2 and 95% air atmosphere. They were 
supplemented with 400U/ml recombinant IL-2 on days 1 and 4 of the cycle. On day 7 a 
new culture cycle was set up with fresh medium and RJK853 feeder cells. The samples 
required for further analysis were then cryopreserved in a medium made up of 10% 
DMSO (Sigma), 20% FBS (Invitrogen) and 70% X-Vivo 10 and stored in liquid 
nitrogen for further analysis at the end of a 7 day growth cycle (Hyland et al., 2000). 
2.1.4. Ebselen or NAC supplementation 
The impact of a range of doses of ebselen or NAC in human peripheral blood derived 
CD4+ T cell clones supplemented from a young in vitro age or the midpoint of their in 
vitro lifespan (monoclonal population) (Chapter-4) were taken into consideration before 
investigating the biological effect of the antioxidants on human peripheral blood 
mononuclear cells (a polyclonal population) (Chapter-5, Section 5.1.2.5). The human 
peripheral blood mononuclear cells from ten healthy, non-smoking males fasted 
overnight, five each from the age groups of 25-30 years and 55-60 years were 
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supplemented separately with 30µM ebselen or 5mM / 7.5mM NAC in X-Vivo 10. The 
ex vivo T cells (peripheral blood mononuclear cells) were supplemented with ebselen or 
NAC on days one and four of the growth cycle (Hyland et al., 2000). 
2.1.5. Negative selection of CD4+ T cells from peripheral blood 
mononuclear cells 
The biological effects of a broad range of doses of ebselen or NAC on human peripheral 
blood derived CD4+ T cell clones, a monoclonal population were investigated (Chapter-
4). The results from that investigation led to the analysis of the impact of the two 
antioxidants on human peripheral blood mononuclear cells, a polyclonal population 
(Chapter-5).  
 
Investigating the impact of these two antioxidants on CD4+ T cells ex vivo isolated from 
human peripheral blood mononuclear cells, allowed for a comparison of their effects on 
a polyclonal population CD4+ T cell population versus a monoclonal CD4+ T cell 
population. In this investigation a CD4+ T Cell Isolation Kit (Miltenyi Biotec) was used 
for the separation of CD4+ T cells from human peripheral blood mononuclear cells.  
2.1.5.1. Principle of the kit 
The CD4+ T Cell Isolation Kit (Miltenyi Biotech) is a magnetic labelling system for the 
isolation of CD4+ T helper cells from human peripheral blood mononuclear cells. Non-
CD4+ T cells are magnetically labelled by using a cocktail of biotin-conjugated 
antibodies against non-CD4+ T cells and these cells can subsequently be depleted by 
labelling with anti-biotin microbeads. The cell suspension is passed through the column 
in a MACS separator and CD4+ T cells are collected in the bottom tube. 
2.1.5.2. Isolation procedure and culture of CD4+ T cells 
10 x 106 human peripheral blood mononuclear cells from each of the donor samples 
were separately treated with a cocktail of biotin conjugated antibodies against non-
CD4+ T cells and were subsequently depleted by labelling with anti-biotin microbeads. 
The different cell suspensions were then allowed to pass separately through a PBS 
(Oxoid Ltd) pre-rinsed column placed in the magnetic field of a suitable MACS 
separator. CD4+ T cell elutes were collected in the bottom tube. The CD4+ T cell elutes 
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was then washed in phosphate buffered saline or X-Vivo 10 media and then maintained 
in culture separately, as described in section 2.1.5.2.  
2.1.6. Ebselen or NAC supplementation 
CD4+ T cells ex vivo from ten healthy, non-smoking males fasted overnight, five each 
from the age groups of 25-30 years and 55-60 years were supplemented separately with 
30µM ebselen or 5mM / 7.5mM NAC in X-Vivo 10. The ex vivo T cells (CD4+) were 
supplemented with ebselen or NAC on days one and four of the growth cycle, in line 
with the previous work carried out by the group of Barnett using other anioxidants in 
CD4+ T cell clones (Hyland et al., 2000). There is no information on the length of 
stability of ebselen or NAC in any cell lines in the existing scientific literature. Previous 
work has demonstrated the impact of ebselen or NAC upto 24 hours of supplementation 
(Yoshizumi et al., 2002; Hansen et al., 2004). 
2.1.7. Impact of mitoQ on human peripheral blood 
mononuclear cells ex vivo 
It has been shown that mitochondria accumulate oxidative damage more rapidly than 
the rest of the cell. Such damage is thought to contribute to mitochondrial dysfunction 
and cell death and lead to the development of degenerative diseases and ageing. The 
main reason behind this accumulation of oxidative damage in mitochondria is due to the 
presence of the mitochondrial respiratory chain which is a major source of reactive 
oxygen species (Kelso et al., 2002). A challenge to treating diseases resulting from 
mitochondrial dysfunction has been the inability to target bioactive molecules to 
mitochondria in vivo. This has been overcome by the use of mitoQ (Chapter-1, Section 
1.1.6.3).  
 
Previous work, carried out in Jurkat cells, revealed the ability of 1µM mitoQ to 
completely block 150µM H2O2 induced caspase activation and substantially decreased 
apoptotic induced cell death after 4 to 6 hours (Kelso et al., 2001). The accumulation of 
caspases following H2O2 exposure has been found to be a stimulus for apoptosis 
(Hampton and Orenius, 1997). Other studies have indicated that mitochondrial 
oxidative stress may play a significant role in H2O2 induced apoptosis via its effects on 
mitochondrial membrane transition pores resulting in a decrease in mitochondrial 
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transmembrane potential in Jurkat cells at 100µM H2O2 (Dumont et al., 1999). MitoQ 
concentrations of up to 10µM did not have an effect on mitochondrial membrane 
potential or cell viability in isolated mitochondria from human 143B cells. But higher 
concentrations, 25-50µM, decreased the mitochondrial membrane potential and resulted 
in cell death as revealed by the release of LDH into the culture medium. In this 
investigation, decyl triphenyl phosphonium cation (DTPP, a non-antioxidant 
mitochondria-targeted compound) and vitamin E (a lipophilic, non-mitochondria-
targeted antioxidant) were used as controls. The dose range of DTPP used in this 
investigation was the same as for mitoQ. Vitamin E at 37µM concentrations has been 
shown to reduce H2O2 induced toxicity in murine splenocytes (Horton et al., 2007). 
This study was taken into consideration before choosing the dose range for Vitamin E in 
this investigation.  
 
In terms of long term exposure to mitoQ, concentrations of 50-100nM inhibited the 
growth of human foetal lung (MRC-5) fibroblasts in long term culture. Concentrations 
of 10-20nM needed an adaptation period of 1 week under normoxic (normal O2) 
conditions before revealing its antioxidant potential. In MRC-5 cells, 10-20nM mitoQ 
completely prevented the rise in telomere shortening rate at 40% hyperoxic (increase in 
O2) conditions (Saretzki et al., 2003). The results of these studies were taken into 
consideration before finalising the dose range of mitoQ, DTPP, vitamin E and H2O2 in 
this investigation. 
2.1.7.1. Acute exposure of mitoQ in human peripheral blood 
mononuclear cells ex vivo 
Freshly isolated human peripheral blood mononuclear cells from ten healthy, non-
smoking males fasted overnight, five each from the age groups of 25-30 years and 55-
60 years were washed separately in phosphate buffered saline or X-Vivo 10 media and 
each of the samples were maintained separately in culture in a serum-free medium, X-
Vivo 10, in 24 well plates (5 wells, 2 ml medium per well) at concentrations of 2-4 x 
105 cells per well, along with 2 x 105 gamma-irradiated (80Gy) RJK853 cells per well 
(EBV-transformed B-lymphoblastoid cell line with complete hprt deletion) as feeder 
cells. The samples were then incubated in vitro with various doses of mitoQ (a gift from 
Dr. Mike Murphy, MRC- Dunn Human Nutrition Unit, Cambridge, UK) for 3 or 6 
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hours. Following mitoQ treatment, the cells were challenged with a range of doses of 
H2O2 (0-250µM) (Sigma) at two time intervals, after 3 or 6 hours. The samples were 
frozen down within 15 minutes of H2O2 treatment. The entire H2O2 treatment was 
performed at 4oC to minimise DNA repair. DTPP and vitamin E (Sigma) controls were 
similarly processed in parallel to the mitoQ samples. The samples required for further 
analysis were frozen down. 
2.1.7.2. Doses of mitoQ / DTPP / vitamin E supplementation 
Peripheral blood mononuclear cells from ten healthy, non-smoking males fasted 
overnight, five each from the age groups of 25-30 years and 55-60 years were incubated 
separately with 0-1µM mitoQ or DTPP or 37µM- 74µM Vitamin E for 3 or 6 hours. 0-
250µM H2O2 was exogenously applied after 3 or 6 hours. H2O2 (kept on ice) was 
maintained at 4oC prior to treatment and the samples treated with H2O2 were frozen 
down within 15 minutes of treatment, in order to maximise damage through reducing 
DNA repair (Annett et al., 2004).  
 
The impact of chronic exposure (upto three weeks after supplementation) of mitoQ was 
also investigated in this study. Freshly isolated human peripheral blood mononuclear 
cells from six healthy, non-smoking males fasted overnight, three each from the age 
groups of 25-30 years and 55-60 years were maintained in culture separately as 
described in section 2.1.3.3. The human peripheral blood mononuclear cells were 
supplemented with 0-30nM mitoQ or DTPP in X-Vivo 10. The ex vivo T cells 
(peripheral blood mononuclear cells) were supplemented with mitoQ or DTPP on days 
one and four of the growth cycle.  
2.1.8. JC-1 staining for analysing mitochondrial membrane 
permeability in ex vivo human peripheral blood mononuclear 
cells 
The JC-1 assay kit (Invitrogen) was used to measure the mitochondrial membrane 
potential, due to the potential dependent accumulation of the dye in the mitochondria. It 
is a well established method successfully used in human peripheral blood mononuclear 
cells (Ostan et al., 2006). In this investigation, JC-1 dye was used to investigate the 
impact of mitoQ on mitochondrial membrane potential + / - H2O2. 
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2.1.8.1. Principle of the assay and quantification of mitochondrial 
membrane potential in ex vivo human peripheral blood mononuclear 
cells using JC-1 staining assay kit 
The loss of mitochondrial membrane potential is a characteristic that normally precedes 
apoptosis. The loss of potential occurs through the formation of pores in the 
mitochondria by pro-apoptotic proteins such as Bax. These pores result in the collapse 
of the electrochemical gradient across the mitochondrial membrane and so resulting in 
loss of membrane potential. JC-1 assay kit measures the mitochondrial membrane 
potential in cells using the dye JC-1 (5, 5’, 6, 6’-tetrachloro-1, 1’, 3, 3’ 
tetraethylbenzimidazolylcarbocyanine iodide). The JC-1 exists as a monomer in the 
cytosol (green) and forms aggregates in the mitochondria, staining them red in healthy 
cells. The dye enters the mitochondria, due to their delocalised positive charge, and the 
negative charge established by the intact mitochondrial membrane potential. J-
aggregates form when the critical concentration of the dye increases in the mitochondria 
and stains them fluorescent red. In apoptotic cells, the loss of mitochondrial membrane 
potential results in the inability of the dye to accumulate in the mitochondria, and they 
stain the cytosol fluorescent green. The JC-1 stained cells are analysed using flow 
cytometer at absorption maxima of 488nm. 
 
Freshly isolated human peripheral blood mononuclear cells from six healthy, non-
smoking males fasted overnight, three each from the age groups of 25-30 years and 55-
60 years were washed twice in phosphate buffered saline or X-Vivo 10 media and 
maintained separately in culture in a serum-free medium, X-Vivo 10 as explained in 
section 2.1.7.1. The samples were then incubated in vitro with mitoQ (0.1µM or 0.5µM) 
for 6 hours. Following mitoQ treatment, the cells were challenged with H2O2 (0-250µM) 
maintained at 4oC (0-250µM). The H2O2 treated samples were then frozen down for 
further analysis within 15 minutes of treatment. 
 
The JC-1 staining kit assay was then optimised using a range of cells (0.5 x 106 to 2 x 
106 cells/ml). After optimisation, 1.5 x 106 human peripheral blood mononuclear cells 
ex vivo was used for analysis using JC-1 staining kit. Human peripheral blood 
mononuclear cells ex vivo were suspended in warm PBS and stained with JC-1 dye at 
final concentration of 2µM. The cells were maintained at 37oC at 5% CO2 for 30 
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minutes. The cells were then re-suspended in fresh warm PBS or X-Vivo media and the 
mean fluorescent intensity of green signal (percentage of apoptotic cells) was compared 
to the mean fluorescent intensity of red signal (percentage of live cells)  following 
analysis with flow cytometer at an absorption maxima of 488nm. The results were 
expressed as mean ratio values. Mean value represents the mean fluorescent intensity 
giving the highest number of counts in a flow cytometer. 
 
 
The mean ratio values are calculated using the following formula: 
 
 
 
Higher mean ratio represents lower mitochondrial membrane potential and a lower 
mean ratio or ratio closer to basal levels represents higher mitochondrial membrane 
potential. 
2.1.9. T cell proliferation assays  
The radioactive thymidine incorporation proliferation assay is a well established assay 
used for determining the proliferation capacity of human peripheral blood mononuclear 
cells (Pawelec et al., 2000). In this investigation the effects of the antioxidants ebselen 
or NAC on the proliferation capacity of human peripheral blood mononuclear cells / 
CD4+ T cells ex vivo were examined. 
 
The proliferation assay involved the incubation of cells with radioactive thymidine. The 
cells incorporate radioactive thymidine into their DNA with each cell division or 
proliferation during the incubation period. Higher proliferation rate is associated with 
higher amounts of thymidine incorporation (higher radioactivity). After incubation, the 
cells are washed with distilled water using force that sets the DNA free. The cell 
organelles and DNA is then filtered through a membrane of 1.5mm diameter. Intact 
DNA is collected on the filter membrane. The radioactivity is then measured using a 
scintillation counter. 
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Human peripheral blood mononuclear cells / CD4+ T cells ex vivo from ten healthy, 
non-smoking males fasted overnight, five each from the age groups of 25-30 years and 
55-60 years, with or without the antioxidants, were counted separately at 1 x 106 cells 
per well in a 24 well plate. Tritiated thymidine was added 18 hours prior to harvesting at 
a final concentration of 0.037MBq/ml. Cells were transferred onto a 96 well plate the 
next day and were harvested using a 96-well harvester onto a 96-well filter plate and 
40µl of scintillation fluid was added to each of the filter wells. Filters were counted for 
1 minute per well with a Top-Count scintillation counter and the amount of radioactivity 
incorporated (proliferation capacity of the cells) was expressed in thymidine 
incorporation (H3) counts per minute (cpm). All the samples were analysed in duplicate. 
2.1.10. Assessment of levels of oxidative damage to DNA  
In this study the alkaline comet assay was used to determine levels of oxidative damage 
to DNA. This method has been successfully used in the group of Barnett to measure 
DNA damage in T cells (Hyland et al., 2000; 2001; Duggan et al., 2004).  
 
The use of the Comet Assay was first introduced in NTU with this study. In this 
investigation, the alkaline comet assays were used to determine the effect of the 
antioxidants (ebselen, NAC, mitoQ & vitamin E) on the levels of oxidative damage to 
DNA in T cells in vitro and ex vivo.  
 
The comet assay, also known as single cell gel electrophoresis assay, is a method used 
to measure DNA strand breaks in eukaryotic cells. The alkaline comet assay involves 
analysing stained cells embedded in agarose in a microscopic slide using a fluorescent 
microscope. Prior to staining, the cells are lysed with detergent and high salt resulting in 
nucleoids containing super-coiled loops of DNA linked to the nuclear matrix. On 
electrophoresis, the loops containing a break lose their super-coiling and extend towards 
the anode. These loops give structures similar to comets. This technique involves 
electrophoresis at high pH that results in structures similar to comets viewed using a 
fluorescent microscope. The number of DNA breaks can be assessed by quantifying the 
intensity of comet tail compared to the head (Collins, 2004; Figure 2.2). The alkaline 
comet assay is performed to detect DNA single strand breaks and alkali-labile lesions. 
Modified comet assay involves the treatment of cells with enzymes endonuclease III 
(Endo III) (Asahara et al., 1989) or formamidopyrimidine glycosylase (FPG) (Boiteux 
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et al., 1992). Endo III or FPG (both from New England Biolabs) recognise oxidatively 
modified pyrimidines, or oxidatively modified purines, respectively. The enzymes 
create single-strand breaks by nicking DNA at the sites of oxidatively damaged 
nucleotides that can be detected with the comet assay. H2O2 treatment of T cells to 
induce DNA damage is used as positive control in the modified alkaline comet assay 
(150µM H2O2 for 5 minutes at 4oC). 
 
A) T cell without DNA        B) T cell with 30% DNA   C) T cell with 70% DNA  
    damage                                 damage                                damage 
 
  
 A                                           B                                          C 
 
Figure 2.2. Comet traces showing cells with different levels of damage. 
 
The levels and types of DNA damage in T cells ex vivo and in vitro at various time 
points throughout their lifespan in various supplemented culture conditions (Hyland et 
al., 2000, 2001). 
 
The comet assays were carried out at 4oC to reduce the amount of repair of 
basal/induced levels of DNA damage. 2 x 104 cells embedded in 1% low melting point 
agarose were overlaid on to an existing 1% high melting point agarose gel in each of the 
frosted slides. The slides were then maintained in a high salt alkaline lysis buffer (2.5 M 
Nacl, 0.1M EDTA, 0.01 M Tris, 1% (v/v) Triton X-100, pH 10) for an hour in ice. After 
the slides were lysed, they were equilibrated in enzyme buffer (0.04M HEPES, 0.1M 
KCl, 0.5mM EDTA, 0.2mg/ml BSA, pH 8.0) for three 5 minute washes prior to 
treatment with enzymes Endo III or FPG. The treated slides were then incubated in a 
dark humid chamber at 37oC for 45 minutes. Post incubation, the slides were maintained 
in electrophoresis buffer (0.3M NaOH, 1mM EDTA) for 40 minutes, enabling the 
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alkaline unwinding of the DNA. The slides were then electrophoresed in a pre-chilled 
tank at 25V, 300mA for 20 minutes. Then the slides were neutralised with three 5 
minutes washes in neutralising buffer (0.4M Tris pH 7.5). Finally, the gels were stained 
with 50µg/ml ethidium bromide (Sigma) and digitally analysed using a fluorescent 
microscope and the comet analysis was performed on the cells detected using computer 
image analysis software (Komet 5.5, Andor Technology, UK), counting 50 cells per 
slide. The percentage of DNA damage in the comet tail was used as the measure of 
DNA damage (Hyland et al., 2000, 2001). The reagents for the assay were purchased 
from Sigma. All the samples were performed in duplicate. 
2.1.11. Assessment of GSH:GSSG ratio and total glutathione 
level in human peripheral blood mononuclear cells / T cell 
clones 
The intracellular redox status (GSH:GSSG ratio) plays an important role as a mediator 
in apoptosis in many cell systems (Hall, 1999). Previous findings have demonstrated the 
depletion of intracellular reduced GSH, a major determinant of an altered intracellular 
redox status, prior to the onset of apoptosis (Ghibelli et al., 1998). The depletion of 
intracellular reduced GSH may be due to increased oxidation of GSH to GSSG. The 
oxidation of even a small amount of GSH may hinder the redox status of the cell 
resulting in a sub-optimal GSH:GSSG ratio. A low GSH:GSSG ratio in vivo has been 
associated with several human diseases (more in detail in chapter-1, Section 1.1.4.1). In 
this study, a GSH:GSSG ratio assay kit (Calbiochem) was used, after a period of time 
was spent unsuccessfully setting up an HPLC system. 
 
The GSH:GSSG ratio assay kit has been used previously in assessing the GSH:GSSG 
ratio in human peripheral blood mononuclear cells (Yamada et al., 2006). The assay 
was optimised for use in T cell clones in this investigation by trying a range of cells 
from 0.5 x 106 to 3 x 106 cells/ml for assessing the levels of total glutathione and 2 x 106 
to 7 x 106 cells/ml for assessing the levels of GSSG. Higher number of cells was used 
for GSSG measurement, since it is present in such low concentration in human tissue. 
The same procedure was carried out for human peripheral blood mononuclear cells ex 
vivo. In this investigation, GSH:GSSG ratio assay kit was used to determine the effect 
of antioxidants (ebselen, NAC, mitoQ & vitamin E)  on the redox status of T cells ex 
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vivo and in vitro. GSH is a tripeptide having a free thiol group and acts a major 
antioxidant in human tissues. GSH provides reducing equivalents for GPx catalysed 
reduction of H2O2 and lipid hydroperoxides to water and respective alcohol. This 
reduction results in the oxidation of GSH to form GSSG. GR and NADPH helps in the 
recycling of GSSG to GSH. An increase in oxidative stress is normally associated with 
the oxidation of GSH to GSSG, resulting in GSSG accumulation and an associated 
decrease in the GSH:GSSG ratio. The GSH:GSSG ratio is also used to analyse the 
effectiveness of antioxidant treatments. The accurate measurement of GSSG level in 
cells has proved to be very difficult due to a low concentration in human tissues 
(Griffith, 1980). The main reason for this is the absence of a method which can 
effectively prevent the oxidation of GSH to GSSG. The assay in this investigation relies 
on 1-methyl-2-vinylpyridine trifluoromethane sulfonate (M2VP), a thiol scavenging 
reagent that scavenges GSH, to prevent its oxidation to GSSG. M2VP does not interfere 
with the GR assay (Figure 2.3). 
 
 
Figure 2.3. M2VP scavenges GSH in the T cell sample resulting in GSSG. GR and 
NADPH recycle GSSG to 2 GSH. GSH then reacts with 5,51-Dithiobis-2-
nitrobenzoic acid (DTNB), a chromogen that oxidises 2GSH resulting in GSSG 
enabling its measurement. M2VP is not involved in the experiment involving the 
measurement of total glutathione (GSH + GSSG). 
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After assessing the levels of GSH + GSSG and GSSG in the T cell sample, the GSH in 
the sample can be calculated by subtracting GSSG from GSH + GSSG.  
The GSH:GSSG ratio is calculated using the formula: 
 
 
 
The cell extracts for analysis were prepared from harvested cells (2 x 106 cells/ml for 
GSH and 5 x 106 cells/ml for GSSG) according to the manufacturers instructions. The 
GSH:GSSG ratio and the total glutathione levels were calculated from the GSH and 
GSSG concentrations of the T cells ex vivo or in vitro were photometrically measured at 
412 nm in µM concentrations. The GSH:GSSG ratio was calculated using the formulae 
described in above. All the samples were analysed in duplicate. 
2.1.12. Statistical analysis of the samples 
The results were tested for significance using paired two-sample Student’s t-tests 
assuming equal variances; p values are presented as appropriate. The type 2 student’s t-
test was chosen because in one experiment there are two samples of the same cell 
population having similar variance or the variations between the values will be the same 
since they are of the same cell population. 
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3.1. The growth characteristics of human peripheral 
blood derived CD4+ T cell clones in vitro 
3.1.1. Introduction  
T cells are supposed to undergo rapid clonal expansion upon antigenic stimulation to 
produce an effective immune response. A successful stimulation, co-stimulation and an 
appropriate cytokine environment are a pre-requisite for T cell clonal expansion that in 
turn results in a successful T cell immune response. The clonal expansion is followed by 
contraction in the absence of antigen and almost all of the T cells die by apoptosis. 
Subsequent antigenic challenge can result in the repetition of the process. Any factor 
that interferes with the ability of the T cell clones to proliferate may deleteriously affect 
the immune response, thus limiting the clonal expansion. Replicative senescence and / 
or genetic damage can be an interfering factor (Effros and Pawelec, 1997; Barnett and 
Barnett, 1998). It is also worth mentioning the decreased proliferative potential of T 
cells that may have previously proliferated in vivo (Pawelec et al., 1999). 
 
The in vitro T cell clone model of immunosenescence is an invaluable model for 
determining age associated changes to T cell function and replicative senescence. The 
behaviour of a single cell type can be longitudinally followed using this model. The 
observed changes in a polyclonal model system may be due to the alterations in the 
proportions of different clones present. In terms of calculating longevities, polyclonal 
model systems have mixed populations and only the longevity of the remaining 
surviving clone can be calculated. For a proper clonal study in a mixed population, 
longevities of each of the clones have to be examined separately. This is technically 
very challenging. Cellular and molecular changes associated with T cell clone ageing in 
vitro have been found to be similar to the ageing T cells in vivo. The in vitro T cell 
clone model has important similarities to ageing of T cells in vivo (Chapter-1, Table 1.8; 
Pawelec et al., 2002). T cell clones are known to have a finite lifespan and can be 
maintained for extended periods in culture. The cloning efficiency of T cell clones from 
donors of varying ages, longevities of individually cultured T cell clones, their cytokine 
secretion and surface marker profiles have previously been examined (Pawelec et al., 
1999). This chapter reports on the growth characteristics of the T cell clones used in this 
investigation during in vitro culture and the impact of age on their ability to replicate. 
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3.1.2. Materials and Methods 
Twelve human peripheral blood derived CD4+ T cell clones were cultured as described 
previously by (Hyland et al., 2000, 2001; Chapter-2, Section 2.1.1.1). The 400-series 
clones were obtained from a 26 year old overtly healthy laboratory worker and the 385-
series clones were obtained from a 45 year old overtly healthy laboratory worker. 
Viable cell counts were determined at the end of each 7 day culture cycle. The viable 
cell counts were used to track the PDs each clone had undergone during their span in 
culture. Viability of the T cell clones was assessed by trypan blue exclusion test. The 
population doublings each clone had undergone per week or the proliferative capacity 
was calculated using the following formula; 
 
PD= Log2(Cell count at the end of cycle) – Log2(Cell count at the start of cycle).  
Cumulative PD or total PD of the clones at the end of their span in culture was used to 
track the in vitro age of the clones.  
3.1.3. Results and Discussion 
The range of PD per week of the T cell clones used in this investigation, during their 
lifespan was 0.7-1.1 (Table 3.1). The relationship between PD/week and the cumulative 
population doublings or the in vitro age of the clones was determined by linear 
regression analysis. The T cell clones used in this investigation revealed considerably 
higher levels of growth at the start of the culture compared to the later stages of their 
life span in culture (Appendix- I, Figures 1-12). The regression analysis data (as 
revealed in table 3.2) shows a significant downward slope reaching statistical 
significance for the complete lifespan data, suggesting decreased PD capacity with age. 
However, post the initial peak values, the remainder of the lifespan of the clones 
transitioned into a steady state. This result indicates the maintenance of PD capacity 
throughout the lifespan of the clones. The results of this investigation were in line with 
the previous findings of the group of Barnett using human peripheral blood derived 
CD4+ T cell clones (Hyland et al., 2000; Pawelec et al., 2002). 
 
 
 
 
  
 81
Table 3.1. Average PD/week and cumulative PDs of twelve human peripheral 
blood derived CD4+ T cell clones during their in vitro lifespan 
 
Clone Mean PD per seven day 
growth cycle 
Maximum PD achieved 
400-23a 0.7 44.9 
400-23b 0.9 49.1 
400-23c 1.1 83.6 
400-23d 0.8 77.6 
400-5a 0.9 57.0 
400-5b 0.8 53.2 
385-7a 0.9 44.4 
385-7b 1.0 47.2 
385-7c 1.1 78.2 
385-7d 0.9 74.4 
385-2a 0.8 50.5 
385-2b 0.7 48.1 
Mean 0.9 59.0 
 
 
 
 
Figure 3.1. Proliferative capacity of 385-7d clone throughout its lifespan. The 
points represent the PD achieved during successive seven day growth cycles and a 
spline curve has been used to illustrate growth rhythms.  
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The SPSS software was used for creating spline curves and the software is designed to 
interpolate (create new points) for a smooth transition between two points. The software 
uses a polynomial (finite length of expression constructed from variables) function to 
create spline curves. Figure 3.1 illustrates an example for how the T cell clones grew 
during their span in culture. All the twelve clones examined in this investigation, grew 
in waves of maximal and minimal rates of proliferation variable from one to several 
growth cycles in length during the early part of their lifespan (as indicated in figure 3.1 
and figures 1-12 in appendix-I). However, the size or length of the waves decreased and 
the wave frequency increased during the later stages of their lifespan. This finding was 
similar to the previous findings from the group of Barnett (Hyland et al., 2000). This 
phenomenon observed in T cell clones may be an indication of a frequency in cell cycle 
arrest due to age-related accumulation of oxidative DNA damage in T cell clones 
(Barnett and Barnett, 1998; Hyland et al., 2000; 2001; Chapter-4) in vitro during the 
later stages of the lifespan of T cell clones. This increase in DNA damage when critical 
would result in the failure of T cells to proliferate due to DNA damage mediated cell 
cycle arrest; decreased rates of proliferation as a consequence of selection in vivo 
against cells carrying mutations and finally may result in apoptosis (Barnett and Barnett, 
1998). The increase in frequency of the waves towards the later stages of a T cell clones 
lifespan data can be implied as their ability to retain their responsiveness to proliferative 
stimulation (Hyland et al., 2000; Pawelec et al., 2002). 
 
Table 3.2. Linear regression model statistics analysing the relationship between 
PD/growth cycle and the in vitro age in twelve human peripheral blood derived 
CD4+ T cell clones. Slope indicates the decrease in PD achieved per growth cycle. 
The data in this table is the average of twelve clones used in this investigation 
 
n=12 Slope r2 p value 
Full Lifespan data 
 
-.04701 0.1925 <0.01 
Lifespan data 
subsequent to initial 
crest 
 
-.0084 0.009 0.4486 
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The results of the analysis described in this chapter reveal that even though the T cell 
clones maintain their ability to proliferate with age, their ability to sustain proliferation 
during the late stages of their lifespan is reduced due to age related stresses. The relative 
proportion of the cells undergoing cell cycle arrest / senescence during the lifespan of 
the clone in culture was not investigated. 
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4.1. An investigation of effects of the antioxidants, 
ebselen or NAC, on cultured human peripheral blood 
derived CD4+ T cell clones 
4.1.1. Introduction 
T cell function has been shown to decline with age, resulting in an increase in 
susceptibility to infection, cancer and a variety of diseases. Naïve/memory T cells are 
supposed to undergo rapid clonal expansion on contact with the antigen, for which they 
carry unique antigen receptors, to produce an effective immune response. Any factor 
that interferes with the ability of T cells to clonally expand may impact on the 
effectiveness of an immune response with the potential to render it sub-optimal.  
 
Previous work from the group of Barnett has demonstrated an age associated increase of 
DNA damage in T cell clones in vitro under standard culture conditions of 20% O2 
tension (Barnett et al., 1999; Hyland et al., 2000, 2001). The major source of DNA 
damage in vivo has been attributed to ROS from a wide variety of intrinsic and extrinsic 
sources (Ames et al., 1993). ROS have been implicated in several human degenerative 
diseases of ageing (Naik et al., 2006). T cells are also exposed to high concentrations of 
ROS and reactive nitrogen intermediates, produced as a normal part of an immune 
response, at sites of inflammation. Such exposure may ultimately result in damage to 
the T cells. In vivo antioxidants and DNA repair systems are two types of T cell defense 
that can counteract the occurrence of damage (Hyland et al., 2000). An age related 
decline of DNA repair capacities in T cells has been previously reported in human 
peripheral blood derived CD4+ T cell clones cultured in vitro under standard O2 tension 
(Annett et al., 2004, 2005). The decline in DNA repair capacities may result in an 
accumulation of DNA damage to critical levels within T cells, resulting in cell cycle 
arrest or even apoptosis (Barnett and Barnett, 1998). The potential anti-ageing effect of 
antioxidants in T cells is yet to be thoroughly investigated. This chapter describes the 
results of such an investigation with the antioxidants ebselen and NAC. 
 
Ebselen is a synthetic, lipid soluble seleno-organic compound having potent antioxidant 
capacity. It is also a novel anti-inflammatory agent having glutathione peroxidase like 
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activity, first described in 1984 (Parnham et al., 1991; Sies, 1993; Yang et al., 1999). A 
neuroprotective effect of ebselen in a variety of in vitro and in vivo animal models and 
several pre-clinical studies has been well documented (Imai et al., 2003; Porciuncula et 
al., 2003; Moretto et al., 2005). Ebselen has also been reported to protect HepG2 cells 
(Yang et al., 1999), human HL-60 (Li et al., 2000) and PC-12 cells (Yoshizumi et al., 
2002) against H2O2 induced cell death and DNA damage.  
 
NAC is an important antioxidant containing an acetylated form of the aminoacid L-
cysteine that functions as a precursor of glutathione synthesis (Pivetta et al., 2005). 
Glutathione is an important thiol involved in cellular detoxification (Meister and 
Anderson, 1983). The presence of sulfhydryl groups in NAC also enables the 
neutralisation of free radicals. It is water soluble and its intake is the most cost-effective 
way of boosting glutathione levels in the body. NAC is a low molecular weight 
compound that can readily pass through the blood brain barrier (Martinez 2000). The 
aim of this chapter is to describe the results of an investigation on the impact of 
exposure to different concentrations of ebselen or NAC on cultured human peripheral 
blood derived in vitro CD4+ T cell clones. 
4.1.2. Materials and Methods 
4.1.2.1. Human peripheral blood derived CD4+ T cell clones 
Human peripheral blood derived CD4+ T cell clones (Chapter-1, Section 1.1.3.8) is a 
well established monoclonal in vitro model which has been used in many studies on 
immunosenescence (Pawelec et al., 2006). Twelve independently derived T cell clones 
were examined in this investigation. The 400-series clones were obtained from a 26 year 
old overtly healthy laboratory worker and the 385-series clones were obtained from a 45 
year old overtly healthy laboratory worker (Chapter-2, Section 2.1.1). 
4.1.2.2. Culture of T cell clones 
Human peripheral blood derived CD4+ T cell clones (expressing T cell receptors for 
antigen; TCR, CD3+, CD4+) were maintained in culture in a serum-free medium, X-
Vivo 10 (BioWhittaker), in 24 well plates as detailed in Hyland et al., (2000; 2001) and 
(Chapter-2, Section 2.1.1.1). 
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4.1.2.3. Determination of T cell clone proliferative capacity and 
lifespan 
Proliferative capacity was calculated as the number of PDs a clone underwent in a week 
in culture. PDs can be calculated using the following formula. 
PD= Log2(cell count at the end of the cycle) - Log2(number of cells at the start of the 
cycle). 
 
Lifespan was defined as the cumulative number of population doublings the clones 
underwent during their lifespan in culture. The required samples for analysis were 
cryopreserved using the protocol detailed previously in Hyland et al., (2000, 2001) and 
(Chapter-2, Section 2.1.1.2). 
4.1.2.4. Ebselen or NAC supplementation 
Initial studies were carried out by supplementing T cell clones from the midpoint of 
their in vitro lifespan with a range of doses of ebselen (0-100µM) (Table 2.1) (Sigma) 
and NAC (0-10mM) (Table 2.1) (Sigma) in X-Vivo 10. The results of the impact of 
ebselen or NAC on T cell clones from the midpoint of their in vitro lifespan were taken 
into consideration before choosing the dose range of 0-30µM for ebselen and 0-7.5mM 
for NAC for the studies investigating the impact of these antioxidants when 
supplemented from a young in vitro age. Clones were supplemented with ebselen or 
NAC on days one and four of the growth cycle (Chapter-2, Section 2.1.2).  
 
Previous studies with ebselen or NAC investigated their impact on acute exposure in 
different cell lines. The concentration range of ebselen used in this novel investigation 
was chosen on the basis of earlier studies of ebselen carried out in HepG2 and HL-60 
cell lines. HepG2 cells have been successfully used in several cancer and apoptotic 
studies mainly dealing with signalling pathways (Castaneda and Rosin-Steiner, 2006). 
Yang et al. (2000) demonstrated an increase in percentage of viability in HepG2 cells on 
treatment with 50µM ebselen for 24hrs. 25µM ebselen had no effect on cell viability 
and the percentage of viability significantly decreased at concentrations of 75µM or 
100µM of ebselen. A concentration dependent increase in apoptosis and decrease in 
intracellular GSH concentrations after 24hrs were demonstrated with ebselen (50-
100µM) supplementation in HepG2 cells (Yang et al., 2000) after 24 hrs. Previous work 
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in HepG2 cells demonstrated the ability of ebselen (1-25µM) to stimulate cell growth, 
inhibit H2O2 induced suppression, significantly reduce LDH leakage and lipid 
peroxidation, almost completely inhibit DNA damage and significantly reduced 
intracellular ROS levels in a concentration dependent manner. Concentrations above 
50µM proved cytotoxic to cells (Yang et al., 1999). Ebselen (1-20µM) has also been 
demonstrated to inhibit H2O2 induced suppression of cell growth, lipid peroxidation, 
reduction of DNA damage and intracellular ROS levels in a concentration dependent 
manner in HL-60 cells. Concentrations above 20µM were shown to be cytotoxic to cells 
(Ji et al., 2000). 
 
In terms of NAC, the following studies were taken into consideration before choosing 
the dose range in this investigation. Previous studies investigating the effect of a range 
of NAC concentrations (0.5-2mM) in HeLa cells have shown the ability of 2mM NAC 
to increase intracellular GSH by 15% compared to controls after 24hrs of incubation 
(Hansen et al., 2004). In HepG2 cells, the increase in intracellular GSH level was 
highest at 5mM NAC supplementation for 24hrs (Yang et al., 2000).  
4.1.2.5. Determination of levels of oxidative damage to DNA in 
human CD4+ peripheral blood derived T cell clones 
The levels of oxidative damage to DNA, plus DNA single strand breaks and alkali labile 
sites, in T cell clones were determined at four time points of their lifespan in culture, 
using the modified alkaline comet assay as previously described (Collins et al., 1993; 
Hyland et al., 2000, 2001; Duggan et al., 2004; Chapter-2, Section 2.1.10). This assay 
uses two different enzymes namely, FPG (New England Biolabs) that recognises 
oxidatively modified purines (Boiteux et al., 2002), and Endo III (New England Biolabs) 
which recognises oxidatively modified pyrimidines (Asahara et al., 1989). The enzymes 
nick DNA at the site of oxidatively damaged nucleotides, creating single strand breaks 
that can be detected by the assay. Computer image analysis software, Komet 5.5 (Andor 
Technology, UK) used to perform analysis of cells in the slides. Comet assays for the 
samples were performed in duplicate. 
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4.1.2.6. Quantitative determination of intracellular GSH:GSSG and 
total glutathione levels 
The ratio of the reduced and oxidised form of glutathione and total glutathione levels 
were assessed using a GSH:GSSG ratio assay kit (Calbiochem, UK) (Chapter-2, Section 
2.1.11). This technique incorporates a thiol-scavenging reagent, 1-methyl-2-
vinylpyridinium trifluoromethane-sulfonate1 (M2VP) at a level that rapidly scavenges 
GSH, but does not interfere with the glutathione reductase in recycling GSSG into GSH. 
Whole cell extracts were prepared from harvested cells (2 x 106 cells/ml for GSH and 5 
x 106 cells/ml for GSSG), according to the manufacturers instructions. The total 
glutathione levels and the GSH:GSSG ratio were calculated from the GSH and GSSG 
concentrations of the clones, photometrically measured at 412 nm in µM concentrations. 
The samples were analysed in duplicate. 
4.1.2.7. Statistical analysis  
The results were tested for significance using paired two-sample Student’s t-tests 
assuming equal variances; p values are presented as appropriate. 
4.1.3. Results 
4.1.3.1. The impact of ebselen or NAC on in vitro proliferative capacity 
and lifespan of human CD4+ T cell clones 
The human CD4+ T cell clones used in this study underwent apoptosis through deletion 
at the end of their lifespan after undergoing a number of PDs. This was in line with 
previous reports (Grubeck-Leobenstein et al., 1994; Hyland et al., 2000). 
 
The effect of different concentrations of ebselen (Tables 4.1A & 4.1B) or NAC (Tables 
4.2A & 4.2B) on the proliferative capacity and in vitro lifespan of CD4+ T cell clones 
was investigated by supplementing them from a young in vitro age (34.5 and 41.0 PD) 
until the end of their lifespan. The effect of different concentrations of ebselen (Tables 
4.3A & 4.3B) or NAC (Tables 4.4A & 4.4B) on the proliferative capacity and in vitro 
lifespan of CD4+ T cell clones supplemented from the midpoint of their in vitro lifespan 
(58.7 and 63.4 PD) until the end of their lifespan was also investigated. Control clones 
were grown in parallel to the ebselen or NAC supplemented clones and proliferative 
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capacity and lifespan were determined in both supplemented and non-supplemented 
clones.  
 
Table 4.1. The effect of ebselen on the proliferative capacity and lifespan of human 
peripheral blood derived CD4+ T cell clones derived from a healthy 26 year old 
donor (4.1A) and a healthy 45 year old donor (4.1B) supplemented from a young in 
vitro age 
* Significantly higher, p < 0.05 
 
4.1A 
Clone x 400-23 26-year old donor 
Initial PD- 34.5 
Concentration Average PD per week 
Cumulative PD achieved 
at the end of lifespan in 
culture 
Control 0.7 44.9 
10µM ebselen 0.8 46.9 
30µM ebselen 1.2   56.2*  
 
 
 
 
4.1B 
Clone x 385-7 45-year old donor 
Initial PD- 31.0 
Concentration Average PD per week 
Cumulative PD achieved 
at the end of lifespan in 
culture 
Control 0.9 44.4 
10µM ebselen 0.9 44.9 
30µM ebselen 1.4   50.8* 
 
 
Tables 4.1A and 4.1B indicates a significant increase in lifespan of CD4+ T cell clones 
derived from a young donor and a middle aged donor on supplementation with 30µM 
ebselen from a young in vitro age, compared to non-supplemented clones. 10µM 
ebselen did not significantly alter the lifespan of CD4+ T cell clones derived from 
donors of either age group, compared to non supplemented clones. 
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Table 4.2. The effect of NAC on the proliferative capacity and lifespan of human 
peripheral blood derived CD4+ T cell clones derived from a healthy 26 year old 
donor (4.2A) and a healthy 45 year old donor (4.2B) supplemented from a young in 
vitro age 
* Significantly higher, p < 0.05 
 
4.2A 
Clone x 400-23 26-year old donor 
Initial PD- 34.5 
Concentration Average PD per week 
Cumulative PD achieved 
at the end of lifespan in 
culture 
Control 0.9 49.1 
1.25mM NAC 0.8 48.4 
5mM NAC 1.1 53.5 
7.5mM NAC 1.2   56.1* 
 
 
4.2B 
Clone x 385-7 45-year old donor 
Initial PD- 31.0 
Concentration Average PD per week 
Cumulative PD achieved 
at the end of lifespan in 
culture 
Control 1.0 47.2 
1.25mM NAC 1.0 48.7 
5mM NAC 1.3 52.8 
7.5mM NAC 1.4   55.8* 
 
Tables 4.2A and 4.2B summarises a significant increase in lifespan of CD4+ T cell 
clones derived from a young donor and a middle aged donor on supplementation with 
7.5mM NAC from a young in vitro age, compared to non-supplemented clones. 5mM 
NAC supplementation resulted in a marginal increase in proliferation capacity and 
lifespan, compared to controls in both clones. There were no significant differences in 
proliferative capacity and lifespan of CD4+ T cell clones derived from a healthy 26 year 
old donor compared to the T cell clones derived from a healthy 45 year old donor on 
supplementation with 1.25mM NAC. 
 
 
 
  
 92
Table 4.3. The effect of ebselen on the proliferative capacity and lifespan of human 
peripheral blood derived CD4+ T cell clones derived from a healthy 26 year old 
donor (4.3A) and a healthy 45 year old donor (4.3B) supplemented from the 
midpoint of their in vitro lifespan 
 
4.3A 
Clone x 400-23 26-year old donor 
Initial PD- 63.4 
Concentration Average PD per week 
Cumulative PD achieved 
at the end of lifespan in 
culture 
Control 1.2 83.6 
5µM ebselen 0.8 80.8 
15µM ebselen 0.7 79.5 
30µM ebselen 0.9 82.8 
 
 
 
4.3B 
Clone x 385-7 45-year old donor 
Initial PD- 58.7 
Concentration Average PD per week 
Cumulative PD achieved 
at the end of lifespan in 
culture 
Control 1.1 78.2 
5µM ebselen 0.8 77.1 
15µM ebselen 0.8 77.8 
30µM ebselen 0.7 74.0 
 
 
Tables 4.3A and 4.3B shows that there were marginal reductions in proliferative 
capacity and lifespan CD4+ T cell clones derived from a young donor and a middle aged 
donor, supplemented wih different concentrations of ebselen from the midpoint of their 
in vitro lifespan, compared to control clones. The reductions in proliferative capacity 
and lifespan in supplemented clones were not statistically different compared to controls. 
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Table 4.4. The effect of NAC on the proliferative capacity and lifespan of human 
peripheral blood derived CD4+ T cell clones derived from a healthy 26 year old 
donor (4.4A) and a healthy 45 year old donor (4.4B) supplemented from the 
midpoint of their in vitro lifespan 
 
 
4.4A 
Clone x 400-23 26-year old donor 
Initial PD- 63.4 
Concentration Average PD per week 
Cumulative PD achieved 
at the end of lifespan in 
culture 
Control 1.0 77.6 
0.312mM NAC 0.8 76.4 
1.25mM NAC 0.7 75.8 
5mM NAC 0.9 77.2 
 
 
 
4.4B 
Clone x 385-7 45-year old donor 
Initial PD- 58.7 
Concentration Average PD per week 
Cumulative PD achieved 
at the end of lifespan in 
culture 
Control 1.0 74.4 
0.312mM NAC 0.7 72.8 
1.25mM NAC 0.7 71.6 
5mM NAC 0.8 73.5 
 
 
Tables 4.4A and 4.4B shows that there were marginal reductions in proliferative 
capacity and lifespan CD4+ T cell clones derived from a young donor and a middle aged 
donor, supplemented wih different concentrations of NAC from the midpoint of their in 
vitro lifespan, compared to control clones. The reductions in proliferative capacity and 
lifespan in supplemented clones were not statistically different compared to controls. 
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4.1.3.2. The impact of ebselen or NAC on levels of oxidative DNA 
damage in human CD4+ T cell clones as a function of in vitro age 
Aliquots of T cell clone samples were taken from culture at various time points and the 
effect of different concentrations of ebselen or NAC on the levels of oxidative DNA 
damage within the T cells was determined. In control samples, levels of oxidative 
damage to DNA increased as a function of age, as measured by the modified Endo III 
and FPG comet assays, in line with previously published findings (Barnett et al., 1999; 
Hyland et al., 2000).  
 
Figure 4.1 shows the results of the effect of 30µM ebselen on oxidative DNA damage 
levels at various time points during the lifespan of human peripheral blood derived 
CD4+ T cell clones derived from a healthy 26 year old donor (4.1A) and a healthy 45 
year old donor (4.1B) supplemented from a young in vitro age, compared to the non-
supplemented clones. Figure 4.2 shows the results of the effect of 7.5mM NAC on 
oxidative DNA damage levels at various time points during the lifespan of human 
peripheral blood derived CD4+ T cell clones derived from a healthy 26 year old donor 
(4.2A) and a healthy 45 year old donor (4.2B) supplemented from a young in vitro age, 
compared to the non-supplemented clones. Figure 4.3 shows the results of the effect of 
30µM ebselen on oxidative DNA damage levels at various time points during the 
lifespan of human peripheral blood derived CD4+ T cell clones derived from a healthy 
26 year old donor (4.3A) and a healthy 45 year old donor (4.3B) supplemented from the 
midpoint of their in vitro lifespan, compared to the non-supplemented clones. Figure 4.4 
shows the results of the effect of 5mM NAC on oxidative DNA damage levels at 
various time points during the lifespan of human peripheral blood derived CD4+ T cell 
clones derived from a healthy 26 year old donor (4.4A) and a healthy 45 year old donor 
(4.4B) supplemented from the midpoint of their in vitro lifespan, compared to the non-
supplemented clones.    
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Figure 4.1 The impact of 30µM ebselen on oxidative DNA damage levels at various 
time points during the lifespan of human peripheral blood derived CD4+ T cell 
clones derived from a healthy 26 year old donor (4.1A) and a healthy 45 year old 
donor (4.1B) supplemented from a young in vitro age. The bars indicate the mean ± 
S.D. Values statistically different from their controls (Student’s t-test, 95% 
confidence level) are indicated with an asterix. 
* p<0.05, ** p<0.01 - Significantly lower than control levels 
 
  
 96
4.2A 
Clone x 400-23 - 26 year old donor 
7.5mM NAC
0
5
10
15
20
25
30
35
40
45
50
35.1
Control
36.5 NAC 42.7
Control
44.1 NAC 46.3
Control
51.1 NAC 48.8
Control
53.5 NAC
Population Doublings
Pe
rc
en
ta
ge
 
o
f D
N
A
 
in
 
co
m
et
 
ta
il
Alkaline Comet
Endo III Comet
Fpg Comet
*
*
*
Week-1                   Week-5                   Week-9                         Week-14
 
 
4.2B 
Clone x 385-7 - 45 year old donor 
7.5mM NAC
0
5
10
15
20
25
30
35
40
32.5
Control
33.0 NAC 38.8
Control
40.3 NAC 41.2
Control
46.8 NAC 47.2
Control
52.3 NAC
Population Doublings
Pe
rc
en
ta
ge
 
o
f D
N
A
 
in
 
co
m
et
 
ta
il
Alkaline Comet
Endo III Comet
Fpg Comet
*
*
Week-1                   Week-5                   Week-9                        Week-14
 
Figure 4.2 The impact of 7.5mM NAC on oxidative DNA damage levels at various 
time points during the lifespan of human peripheral blood derived CD4+ T cell 
clones derived from a healthy 26 year old donor (4.2A) and a healthy 45 year old 
donor (4.2B) supplemented from a young in vitro age. The bars indicate the mean ± 
S.D. Values statistically different from their controls (Student’s t-test, 95% 
confidence level) are indicated with an asterix. 
* p<0.05 - Significantly lower than control levels 
  
 97
Figures 4.1A, 4.1B, 4.2A & 4.2B reveal an increase in levels of oxidative DNA damage 
with increase of time in culture in both supplemented and non-supplemented clones. 
Supplemented clones underwent more PDs after 14 weeks in culture, compared to non-
supplemented clones. When compared to non-supplemented clones, supplementation 
from a young in vitro age with 30µM ebselen (Figure 4.1) or 7.5mM NAC (Figure 4.2) 
resulted in no significant differences in the levels of oxidative DNA damage after one, 
five and nine weeks culture, in the T cell clones derived from both donors. At the nine 
week point the reduction in levels of oxidative damage to DNA in supplemented clones 
reached statistical significance at the fourth time point (after fourteen weeks) (Student’s 
t-test, 95% confidence levels).  
 
Furthermore, the impact of other doses of ebselen or NAC on the levels of oxidative 
DNA damage was investigated. 10µM ebselen or 5mM NAC did not significantly alter 
the levels of oxidative DNA damage in CD4+ T cell clones derived from a healthy 26 
year old donor and a healthy 45 year old donor, compared to non supplemented clones 
in any of the four time points investigated. There were no significant differences in 
levels of oxidative damage to DNA in T cell clones derived from a young donor when 
compared with levels in cells from a middle aged donor. 
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Figure 4.3 The impact of 30µM ebselen on oxidative DNA damage levels at various 
time points during the lifespan of human peripheral blood derived CD4+ T cell 
clones derived from a healthy 26 year old donor (4.3A) and a healthy 45 year old 
donor (4.3B) supplemented from the midpoint of their in vitro lifespan. The bars 
indicate the mean ± S.D. Values statistically different from their controls 
(Student’s t-test, 95% confidence level) are indicated with an asterix. 
*** Significantly higher than control levels, p < 0.001 
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Figure 4.4 The impact of 5mM NAC on oxidative DNA damage levels at various 
time points during the lifespan of human peripheral blood derived CD4+ T cell 
clones derived from a healthy 26 year old donor (4.4A) and a healthy 45 year old 
donor (4.4B) supplemented from the midpoint of their in vitro lifespan. The bars 
indicate the mean ± S.D.  
 
  
 100
Supplementation from the midpoint of their in vitro lifespan with 30µM ebselen 
(Figures 4.3A & 4.3B) or 5mM NAC (Figures 4.4A & 4.4B) resulted in no reductions in 
the levels of oxidative damage to DNA at the any of the time points examined in the T 
cell clones derived from a young donor (Figures 4.3A & 4.4A) as well as clones derived 
from a middle aged donor (Figures 4.3B & 4.4B). The levels of oxidative damage to 
DNA were marginally higher on supplementation with 30µM ebselen (Figures 4.3A & 
4.3B) or 5mM NAC (Figures 4.4A & 4.4B), compared to non-supplemented clones. The 
levels of oxidative damage to DNA on supplementation with 30µM ebselen (Figure 
4.3A) were significantly higher than the non-supplemented clones at the fourth time 
point (Student’s t-test, 95% confidence levels). In all the above cases, levels of 
oxidative DNA damage increased with increase of time in culture in both supplemented 
and non-supplemented clones. The non-supplemented clones underwent more PDs 
compared to supplemented clones after 14 weeks in culture as revealed in figures 4.3A, 
4.3B, 4.4A & 4.4B. There were no significant differences in levels of oxidative damage 
to DNA in T cell clones derived from a young donor when compared to those measured 
in T cells derived from a middle aged donor. 
4.1.3.3. The impact of ebselen or NAC on  intracellular redox status 
(GSH:GSSG ratio) and total glutathione levels in human peripheral 
blood derived CD4+ T cell clones in vitro 
T cell clone samples were taken from the culture at various time points of their lifespans 
and the effect of different concentrations of ebselen or NAC on intracellular redox 
status (GSH:GSSG ratio) and total glutathione levels within the T cells were determined. 
Figure 4.5 shows the results of the effect of 30µM ebselen on GSH:GSSG ratio at 
various time points during the lifespan of human peripheral blood derived CD4+ T cell 
clones derived from a healthy 26 year old donor (Figure 4.5A) and a healthy 45 year old 
donor (Figure 4.5B) supplemented from a young in vitro age, compared to non-
supplemented clones. Figure 4.6 shows the results of the effect of 7.5mM NAC on 
GSH:GSSG ratio at various time points during the lifespan of human peripheral blood 
derived CD4+ T cell clones derived from a healthy 26 year old donor (Figure 4.6A) and 
a healthy 45 year old donor (Figure 4.6B) supplemented from a young in vitro age, 
compared to non-supplemented clones. Figure 4.7 shows the results of the effect of 
30µM ebselen on GSH:GSSG ratio at various time points during the lifespan of human 
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peripheral blood derived CD4+ T cell clones derived from a healthy 26 year old donor 
(Figure 4.7A) and a healthy 45 year old donor (Figure 4.7B) supplemented from the 
midpoint of their in vitro lifespan, compared to non-supplemented clones. Figure 4.8 
shows the results of the effect of 5mM NAC on GSH:GSSG ratio at various time points 
during the lifespan of human peripheral blood derived CD4+ T cell clones derived from 
a healthy 26 year old donor (Figure 4.8A) and a healthy 45 year old donor (Figure 4.8B) 
supplemented from the midpoint of their in vitro lifespan, compared to non-
supplemented clones. Figure 4.9 shows the results of the effect of 30µM ebselen (Figure 
4.9A) or 7.5mM NAC (Figure 4.9B) on total glutathione levels at various time points 
during the lifespan of human peripheral blood derived CD4+ T cell clones derived from 
a healthy 26 year old donor supplemented from a young in vitro age, compared to non-
supplemented clones.  
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Figure 4.5 The impact of 30µM ebselen on GSH:GSSG ratio at various time points 
during the lifespan of human peripheral blood derived CD4+ T cell clones derived 
from a healthy 26 year old donor (4.5A) and a healthy 45 year old donor (4.5B) 
supplemented from a young in vitro age. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
* Significantly higher than the ratio of non-supplemented clones, p < 0.05 
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Figure 4.6 The impact of 7.5mM NAC on GSH:GSSG ratio at various time points 
during the lifespan of human peripheral blood derived CD4+ T cell clones derived 
from a healthy 26 year old donor (4.6A) and a healthy 45 year old donor (4.6B) 
supplemented from a young in vitro age. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
* Significantly higher than the ratio of non-supplemented clones, p < 0.05 
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The supplementation from a young in vitro age with 30µM ebselen (Figures 4.5A & 
4.5B) or 7.5mM NAC (Figures 4.6A & 4.6B) resulted in reduction of radical levels 
evidenced by a significantly higher GSH:GSSG ratio that reached statistical 
significance at the fourth time point (after 14 weeks of supplementation) (Student’s t-
test, 95% confidence levels) in T cell clones derived from a young donor (Figures 4.5A 
& 4.6A) as well as in the clones derived from a middle aged donor (Figures 4.5B & 
4.6B), compared to non-supplemented clones. The changes in GSH:GSSG ratio of 
30µM ebselen or 7.5mM NAC supplemented clones at one, five and nine weeks in 
culture were marginal, compared to non-supplemented clones (Figures 4.5A, 4.5B, 4.6A 
& 4.6B).  
 
Investigation of the impact of other doses of ebselen or NAC on GSH:GSSG ratio in T 
cell clones revealed the following. 10µM ebselen did not significantly alter the 
GSH:GSSG ratio of CD4+ T cell clones derived from a healthy 26 year old donor and a 
healthy 45 year old donor compared to non supplemented clones. Following NAC 
supplementation, there were no significant differences in the GSH:GSSG ratio in CD4+ 
T cell clones derived from a healthy 26 year old donor compared to a T cell clone 
derived from a healthy 45 year old donor on supplementation with 1.25mM NAC or 
5mM NAC. There were no significant differences in the GSH:GSSG ratio in T cell 
clones derived from a young donor compared to the ratio in T cells derived from a 
middle aged donor. 
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Figure 4.7 The impact of 30µM ebselen on GSH:GSSG ratio at various time points 
during the lifespan of human peripheral blood derived CD4+ T cell clones derived 
from a healthy 26 year old donor (4.7A) and a healthy 45 year old donor (4.7B) 
supplemented from the midpoint of their in vitro lifespan. The bars indicate the 
mean ± S.D.  
 
 
  
 106
4.8A 
Clone x 400-23 - 26 year old donor 
5mM NAC
0
10
20
30
40
50
63.4
Control
64.0 NAC 70.3
Control
67.4 NAC 72.8
Control
69.0 NAC 76.2
Control
73.1 NAC
Population Doublings
G
SH
:G
SS
G
 
ra
tio
Week-1                           Week-5                           Week-9                           Week-14                                                
 
4.8B 
 
Clone x 385-7 - 45 year old donor 
5mM NAC
0
10
20
30
40
50
58.9
Control
60.0 NAC 65.1
Control
61.2 NAC 68.7
Control
66.6 NAC 74.3
Control
72.8 NAC
Population Doublings
G
SH
:G
SS
G
 
ra
tio
Week-1                           Week-5                           Week-9                           Week-14                                                
 
 
Figure 4.8 The impact of 5mM NAC on GSH:GSSG ratio at various time points 
during the lifespan of human peripheral blood derived CD4+ T cell clones derived 
from a healthy 26 year old donor (4.8A) and a healthy 45 year old donor (4.8B) 
supplemented from the midpoint of their in vitro lifespan. The bars indicate the 
mean ± S.D.  
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The supplementation of CD4+ T cell clones from the midpoint of their in vitro lifespan 
with 30µM ebselen (Figures 4.7A & 4.7B) or 5mM NAC (Figures 4.8A & 4.8B) did not 
result in any significant changes in GSH:GSSG ratio, compared to non-supplemented 
clones at any of the four time points investigated. There were no significant differences 
in GSH:GSSG ratio in T cell clones derived from a young donor on comparison to the T 
cell clones derived from a middle aged donor.  
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Figure 4.9 The impact of 30µM ebselen (4.9A) or 7.5mM NAC (4.9B) on total 
glutathione levels at various time points during the lifespan of human peripheral 
blood derived CD4+ T cell clones derived from a healthy 26 year old donor 
supplemented from a young in vitro age. The bars indicate the mean ± S.D.  
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The supplementation from a young in vitro age with 30µM ebselen (Figure 4.9A) or 
7.5mM NAC (Figure 4.9B) resulted in no significant changes in total glutathione levels 
at any of the four time points in CD4+ T cell clones derived from a healthy 26 year old 
donor (Figures 4.9A & 4.9B) and a healthy 45 year old donor compared to non-
supplemented clones. Furthermore, supplementation with other concentrations of 
ebselen (10µM) or NAC (1.25mM, 5mM) also resulted in no significant impact on total 
glutathione levels in human CD4+ T cell clones derived from both donors compared to 
the non-supplemented clones.  
 
Studies investigating the supplementation of CD4+ T cell clones derived from a healthy 
26 year old donor and a healthy 45 year old donor with 30µM ebselen or 5mM NAC 
from the midpoint of their in vitro lifespan did not result in any significant changes in 
total glutathione levels, compared to non-supplemented clones. Similar set of results 
were derived for human CD4+ T cell clones derived from a healthy 26 year old donor 
and a healthy 45 year old donor supplemented with other concentrations of ebselen 
(5µM, 15µM) or NAC (0.312mM, 1.25mM). The results did not show any significant 
changes in total glutathione levels, when supplemented from the mid point of their in 
vitro lifespan. There were no significant differences in total glutathione levels in T cell 
clones derived from a young donor compared to the ratio in T cell clones derived from a 
middle aged donor. 
4.1.4. Discussion 
Recent studies have suggested that ebselen, an organoselenium compound, has the 
ability to minimise the deleterious effects of ROS (Muller et al., 1984; Wendel et al., 
1984) by reducing H2O2 in human plasma (Griffiths et al., 1992) and HepG2 cells (Yang 
et al., 1999). The catalytically active selenium in ebselen has the ability to reduce H2O2 
to H2O and O2 (Coffey et al., 1995; Sarma and Mugesh, 2005). The presence of the 
selenol group has been mainly attributed for the antioxidant properties in ebselen. Its 
protective effects against lipid peroxidation have also been demonstrated in vitro and in 
vivo (Ozaki et al., 1997). Earlier studies have revealed the ability of ebselen to scavenge 
hydroxyl radicals and ROS which are primarily responsible for lipid peroxidation 
ultimately resulting in DNA damage. This scavenging ability of ebselen results in 
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blockage of lipid peroxidation and decrease in levels of oxidative damage to DNA 
(Yang et al., 1999). 
 
NAC has also been shown to protect against oxidative damage with ROS in mice 
(Aruoma et al., 1989). NAC has also been shown to decrease H2O2 induced damage in 
calf thymus DNA in a concentration dependent manner (Izzotti et al., 1997). The 
presence of sulfhydryl group and cysteine amino acid residue contributes to the 
antioxidant potential of NAC. The free sulfhydryl group enables scavenging of ROS 
and NO thereby blocking lipid peroxidation by peroxinitrate (Han et al., 1997). NAC  
has the ability to donate cysteine aminoacid thereby raising GSH levels ultimately 
resulting in glutathione synthesis (Han et al., 1997; Wagner et al., 1998; Su et al., 2006). 
NAC also acts as a stimulator of the cytosolic enzymes involved in glutathione 
regeneration (Banaclocha, 2001). It was of interest in this current investigation to 
analyse whether ebselen or NAC supplementation would exhibit antioxidant potential in 
a monoclonal T cell population.  
 
The use of human peripheral blood derived in vitro T cell clones enables the study of 
age associated changes over their lifespan (Pawelec et al., 2002) and the identification 
of factors contributing to T cell senescence. In this investigation, supplementation of 
CD4+ T cell clones derived from a healthy 26 year old donor (400-23) and a healthy 45 
year old donor (385-7) with 30µM ebselen (Tables 4.1A & 4.1B) or 7.5mM NAC 
(Tables 4.2A & 4.2B) from a young in vitro (34.5 – 31.0 Initial PD) age significantly 
extended their lifespan (cumulative PD at the end of their lifespan in culture). T cell 
clones derived from a healthy 26 year old donor and a healthy 45 year old donor 
supplemented with 30µM ebselen survived for an additional three and two weeks 
respectively before apoptosis, compared to non-supplemented clones. 7.5mM NAC 
supplementation enabled the T cell clones from a healthy 26 year old donor and a 
healthy 45 year old donor to extend their lifespan evidenced by their additional 2 weeks 
in culture before apoptosis, compared to the non-supplemented clones.  
 
Further, to investigate the extent of the antioxidant / free radical scavenging properties 
of ebselen or NAC, modified alkaline comet assays were used to determine the levels of 
oxidative DNA damage in CD4+ T cell clones derived from a healthy 26 year old donor 
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(400-23) and a healthy 45 year old donor (385-7). 30µM ebselen (Figures 4.1A & 4.1B) 
or 7.5mM NAC (Figures 4.2A & 4.2B) significantly decreased the levels of oxidative 
damage to DNA after 14 weeks of supplementation in both CD4+ T cell clones when 
supplemented from their young in vitro age, compared to non-supplemented clones. The 
impact of supplementation on intracellular redox status (GSH:GSSG ratio) and total 
glutathione levels was also determined. Intracellular redox status is an important 
mechanism having an invaluable role as a mediator in apoptosis in many cell systems 
(Slater et al., 1996; Cotgreave and Gerdes, 1998; Hall, 1999). Recent findings reveal 
that intracellular reduced glutathione (GSH), a main determinant of intracellular redox 
status, is depleted before the onset of apoptosis (Beaver and Waring, 1995; Macho et al., 
1997; Ghibelli et al., 1998). The GSH:GSSG redox couple maintains the redox 
environment of the cell and GSH is abundant in the cell (Schafer and Buettner, 2001) 
serving as an indicator of the cellular redox environment. Redox status of the cell is 
hindered on oxidation of even a small amount of GSH. This oxidation results in the 
formation of GSSG and mixed disulfides between protein sulfhydryl groups in 
biological systems. It will also decrease the levels of GSH resulting in an increase in 
levels of GSSG and so lowering the GSH:GSSG ratio, which has been suggested to be 
responsible for several human diseases (Bonnefont Rousselot et al., 2000; Kharb, 2000; 
Lang et al., 2000; Mills et al., 2000; Pastore et al., 2001). 30µM ebselen (Figures 4.5A 
& 4.5B) or 7.5mM NAC (Figures 4.6A & 4.6B) reduced radical levels evidenced by 
significantly higher GSH:GSSG ratio after 14 weeks of supplementation in CD4+ T cell 
clones derived from a healthy 26 year old donor as well as a healthy 45 year old donor 
when supplemented from their young in vitro age, compared to non-supplemented 
clones. The reduction of radical levels evidenced by significantly higher GSH:GSSG 
ratio on supplementation with 30µM ebselen or 7.5mM NAC were in parallel to the 
significant decreases in oxidative DNA damage after 14 weeks of supplementation in 
CD4+ T cell clones from donors of both age groups, compared to the non-supplemented 
clones proving that the increased antioxidant status of the supplemented clones resulted 
in a significant reduction in the accumulation of oxidative DNA damage. The 
antioxidant potential of ebselen evident by their effect on markers of T cell integrity and 
function investigated above is a sign of fewer radicals present in culture or the radical 
scavenging capacity of ebselen. In terms of NAC, cysteine amino acid present is a 
derivative of GSH formation explaining the higher GSH:GSSG ratio on 
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supplementation. The significantly higher GSH:GSSG ratio on supplementation with 
ebselen or NAC, represents an increased antioxidant state. The increase in antioxidant 
status further explains the decrease in levels of oxidative DNA damage that in turn 
explains a lower apoptotic state explained by the extended lifespan of the clones on 
antioxidant supplementation. In terms of total glutathione levels, neither of the 
antioxidants (Figures 4.9A & 4.9B) significantly altered the total glutathione levels in 
either of the CD4+ T cell clones. This result reveals that none of the antioxidant 
supplements in any way had an impact on glutathione pathways, and therefore failed to 
initiate a significant change in glutathione levels, in the T cell clones examined. 
 
There were no significant changes in proliferative capacity and lifespan of T cell clones 
derived from a healthy 26 year old donor and a healthy 45 year old donor on 
supplementation from the midpoint of their in vitro age (58.7 & 63.4 Initial PD) with 
any of the concentrations of ebselen (Tables 4.3A & 4.3B) or NAC (Tables 4.4A & 
4.4B). In terms of the levels of oxidative damage to DNA, antioxidant supplementation 
did not significantly alter the levels of DNA damage in clones (Figures 4.3B, 4.4A & 
4.4C), compared to non-supplemented clones at any of the four time points. An 
exception being for 30µM ebselen (Figure 4.3A) supplemented clones derived from a 
healthy 26 year old donor where there were significantly higher levels of oxidative 
damage to DNA, compared to controls after 14 weeks of supplementation from the 
midpoint of their in vitro lifespan. The results of the analysis of GSH:GSSG ratios 
revealed that 30µM ebselen (Figures 4.7A & 4.7B) supplementation did not 
significantly alter the GSH:GSSG ratio at any of the time points investigated in CD4+ T 
cell clones derived from a healthy young donor and a healthy middle aged donor when 
supplemented from the midpoint of their in vitro lifespan. In terms of NAC, at 
concentrations of 5mM (Figures 4.8A & 4.8B), the GSH:GSSG ratio in CD4+ T cell 
clones derived from a healthy young donor and a healthy middle aged donor when 
supplemented from the midpoint of their in vitro lifespan were similar to the non-
supplemented clones.  
 
The results of proliferation capacity, lifespan and oxidative damage to DNA on 
supplementation with either of the antioxidants from the midpoint of their in vitro 
lifespan were in line with the previous findings from the group of Barnett that revealed 
no significant changes in longevity in CD4+ T cell clones on long term culture with 
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20mM Carnosine from the midpoint of their in vitro lifespan (Hyland et al., 2000).  The 
suggested reason for the failure of carnosine to reveal its antioxidant potential may have 
been the high background of biomolecule damage that already existed in these T cells 
accumulated during earlier stages of their lifespan under conditions of 20% O2 that may 
have decreased the antioxidant or free radical scavenging potential of carnosine. There 
may be more radicals in older T cell clones that may affect the function of defense 
systems in the body. So the antioxidants at specific concentrations, able to reveal an 
antioxidant potential in T cell clones supplemented from a young in vitro age may not 
be enough to reveal an antioxidant potential when supplemented from the midpoint of 
their lifespan. This could be the reason for the failure of ebselen or NAC at specific 
concentrations to reveal an antioxidant potential in aged T cell clones. It would also be 
worth noting the decrease in other markers of T cell integrity with age revealed in the 
existing scientific literature for example: DNA repair capacity and HSPs. The DNA 
repair capacity in T cells in vitro has been shown to decline with age, revealed in 
previous studies by the group (Annett et al., 2004; 2005; Chapter-1, Section 1.1.5.5.1 & 
1.1.5.5.2). Furthermore, HSPs activity has been demonstrated to decline in response to 
age making the body more susceptible to stress induced damage (Favatier et al., 1997; 
Chapter-1, Section 1.1.5.2). 
 
Analysis of the percentage or levels of oxidative DNA damage in clones supplemented 
from the midpoint of their in vitro lifespan independent of the donor age compared to 
the clones supplemented from a young in vitro age were not significantly different. In 
terms of GSH:GSSG ratio and total glutathione levels, there were only marginal 
differences in their levels between the clones supplemented from a young in vitro age, 
compared to clones supplemented from the midpoint of their in vitro lifespan.  
 
Previous findings from the group of Barnett have demonstrated an age related increase 
in levels of oxidised purine and pyrimidine bases within T cells (Barnett et al., 1999) 
which is in line with our findings. The introduction of new culture conditions by the 
supplementation of antioxidants from the midpoint of the in vitro lifespan of the clones 
may have altered their redox status resulting in the failure of the antioxidants to reveal 
their antioxidant potential. Long term supplementation from a young in vitro age of 
CD4+ T cell clones derived from a healthy young donor or a healthy middle aged donor 
with 30µM ebselen or 7.5mM NAC at 20% O2 tension used in this investigation 
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revealed mild antioxidant / free radical scavenging potential that may be more 
significant under physiological O2 tension.  
 
Interestingly, the impact of long term supplementation of ebselen or NAC has not yet 
been revealed in other cell lines. The previous studies investigating the impact of 
ebselen in HepG2 (Yang et al., 2000), HL-60 (Ji et al., 2000) and glioblastoma cell lines 
(Sharma et al., 2008) or the impact of NAC in HepG2 (Yang et al., 2000) and HeLa 
(Hansen et al., 2004) cell lines to name a few, revealed their potential impact upto 24 
hours after the antioxidant supplementation. In this investigation, T cell clones were 
supplemented with ebselen or NAC on day one and day four of every seven day cycle 
till the end of their lifespan. The viability of the clones when investigated on day four 
using trypan blue exclusion test revealed no significant difference in the number of live 
cells compared to the live cell number at the start of the cycle.  
 
Furthermore, on investigation of the effect of higher concentrations of ebselen (60-
100µM) or NAC (10mM) on human peripheral blood derived CD4+ T cell clones from a 
healthy young or middle aged donor revealed complete inhibition of the growth of T 
cell clones. It may be that higher concentrations of ebselen or NAC may have 
completely scavenged intracellular oxygen free radicals contributing to the inhibition of 
the growth of the CD4+ T cell clones. Although ROS are generally thought as harmful 
molecules, they play an important role in T cell signalling events such as protein 
tyrosine phosphorylation and activation of JNK (Pani et al., 2000). One of the 
prominent families of protein kinases is the MAP kinases. ERK, JNK (SAPK) and P38 
kinase are some of the important pathways in MAP kinases that have been identified. 
These pathways are involved in proliferation, differentiation and apoptosis in cells. 
Previous work from the group of Barnett suggested an increase in JNK phosphorylation 
and P38 phosphorylation at 6% O2 tension (Duggan et al., 2004). It would be interesting 
to examine the impact of ebselen or NAC on these pathways. Previous studies have 
demonstrated a significant increase in intracellular GSH depletion with an increase in 
ebselen concentration in HepG2 cells (Yang et al., 2000). Ebselen has the ability to bind 
with GSH to form ebselen selenyl sulphide (Haenen et al., 1990). Ebselen selenyl 
sulphide reacts with excess of GSH to form ebselen selenol intermediate that in turn 
reacts with peroxides (Morgenstern et al., 1992). Ebselen selenol intermediate can 
further react with ebselen selenyl sulphide to form ebselen diselenide. Ebselen 
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diselenide can further react with peroxides resulting in intracellular GSH depletion that 
leads to induction of apoptosis (Yang et al., 2000) or cells succumbing to stress (Maher, 
2005). This may also be the reason for the complete inhibition of growth of T cell 
clones on supplementation with higher concentrations of ebselen. In terms of NAC, 
supplementation with high concentrations of 10mM, may have completely scavenged 
the ROS which are important in less critical levels, for cell proliferation, differentiation 
and apoptosis.  
 
In summary, the overall data of the current study revealed that for an optimal set of 
conditions, 30µM ebselen or 7.5mM NAC supplementation among a range of 
concentrations of ebselen or NAC investigated showed antioxidant potential, evidenced 
by the significant increase in lifespan; significantly higher GSH:GSSG ratio and a 
significant decrease in levels of oxidative damage to DNA in CD4+ T cell clones, when 
supplemented from a young in vitro age.  
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5.1. Impact of ebselen or NAC in human peripheral 
blood mononuclear cells 
5.1.1. Introduction 
The general decline in T cell function with age has been associated with the 
susceptibility of the human body to a wide range of infection and diseases (Remarque 
and Pawelec, 1998). The ability of very small clonal populations of naïve / memory T 
cells to multiply rapidly on contact with the antigen for which they carry unique 
receptors determines the immune response. The ability of T cells to clonally expand 
may be threatened by several factors, including DNA damage (Barnett and Barnett, 
1998).  
 
The levels of DNA damage and mutation have been shown to increase with age in 
humans (Vijg, 1995). Previous work from the group of Barnett has established an age-
related increase of DNA damage and mutation in human lymphocytes (King et al., 1994; 
Barnett and King, 1995; King et al., 1997; Hyland et al., 2000). ROS, intrinsically and 
extrinsically derived, have been implicated as a major source of DNA damage in vivo 
(Ames et al., 1993). As part of the normal immune system, T cells are additionally 
exposed to high concentrations of ROS and reactive nitrogen intermediates produced 
from activated neutrophils and macrophages. An ineffective in vivo defense system (in 
vivo antioxidants and DNA repair pathways) could result in DNA damage. Previous 
work from Barnett et al. has demonstrated an age-related decline in DNA repair 
capacity against DNA damage induced by ROS in lymphocytes derived from healthy 
male subjects between the age group of 35-69 years (Barnett and King, 1995; King et 
al., 1997). The increase in levels of genetic damage over a period of time may result in 
cell cycle arrest and/or T cell apoptosis (Barnett and Barnett, 1998), thus rendering the 
immune response sub-optimal. 
 
In this chapter the impact of long term exposure of ebselen (30µM) or NAC (5mM / 
7.5mM) on certain markers of T cell integrity and function in a polyclonal population of 
human peripheral blood mononuclear cells and CD4+ T cells ex vivo was examined.  
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Ebselen is a synthetic, seleno-organic compound scavenging ROS and having a 
glutathione peroxidase like activity. 30µM ebselen has been demonstrated to 
significantly decrease levels of oxidative damage to DNA and increase the proliferative 
capacity, lifespan and GSH:GSSG ratio in CD4+ T cell clones in vitro, when 
supplemented from a young in vitro age, as previously described in chapter-4. NAC is 
an important antioxidant that can act as a precursor for the synthesis of glutathione. It 
has also been demonstrated to stimulate cytosolic enzymes that enable glutathione 
regeneration in rats (Sleven et al., 2006). NAC contains an acetylated form of the 
aminoacid L-cysteine, a pre-cursor of glutathione synthesis (Pivetta et al., 2005; Su et 
al., 2006). The presence of sulfhydryl groups also serves to support its antioxidant 
potential. 7.5mM NAC demonstrated antioxidant potential in CD4+ T cell clones in 
vitro, when supplemented from a young in vitro age evidenced by the significantly 
decreased levels of oxidative damage to DNA, significantly increased lifespan and 
significantly higher GSH:GSSG ratio, compared to controls. In the previous study 
carried out in CD4+ T cell clones in vitro, 5mM NAC supplementation marginally 
increased the lifespan of the clones when supplemented from a young in vitro age. 
Furthermore, among the range of doses of NAC investigated in clones supplemented 
from the midpoint of their in vitro lifespan (Chapter-4), dosage of 5mM NAC had 
similar effects to controls, compared to other doses, on markers of T cell integrity and 
function investigated (Chapter-4).  
5.1.2. Materials and Methods 
5.1.2.1. Subject selection 
Ethical approval was granted by NTU based on the consent obtained from all study 
subjects prior to this study. The human blood samples for the present study were drawn 
from ten healthy, non-smoking males fasted overnight, five each in the age group of 25-
30 years and 55-60 years. The subjects were not on any form of medication or had not 
suffered any recent illness. Other lifestyle factors such as alcohol consumption and 
exercise regime were also taken into consideration. The results of the previous studies 
in human peripheral blood mononuclear cells carried out by the group of Barnett were 
taken into consideration before choosing the two age groups of donors in this study 
(Barnett and King, 1995; Chapter-2, Section 2.1.3.1). 
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5.1.2.2. Sample collection  
Human blood samples were drawn in the morning between 8.00 and 9.00 am by a 
licensed individual and collected in a tube containing heparin to prevent coagulation. 
The samples were kept on ice and taken to the laboratory within 5 minutes for 
separation of peripheral blood mononuclear cells. 
5.1.2.3. Preparation, maintenance of culture and storage of peripheral 
blood mononuclear cells  
Peripheral blood mononuclear cells were isolated from fresh heparinised venous blood 
by density gradient centrifugation on Ficoll-Isopaque (PAA Laboratories) in LeucoSep 
(Lymphocyte separation tubes). The peripheral blood mononuclear cells from the 
different donors were washed twice in phosphate buffered saline or X-Vivo 10 
(BioWhittaker) media and then maintained in culture separately in a serum-free medium, 
X-Vivo 10, in 24 well plates (5 wells, 2 ml medium per well) at concentrations of 2-4 x 
105 cells per well, along with 2 x 105 gamma-irradiated (80Gy) RJK853 cells per well 
(EBV-transformed B-lymphoblastoid cell line with complete hprt deletion, a gift from 
Dr. Jane Cole, MRC Cell Mutation Unit, University of Sussex, UK) as feeder cells. 
Peripheral blood mononuclear cells were maintained in a 7-day cycle at 37oC under 
conditions of 5% CO2 and 95% air atmosphere. They were supplemented with 400U/ml 
recombinant IL-2 (Chiron, UK) on days 1 and 4 of the cycle. On day 7, a viable cell 
count was performed on harvested cells using a Neubauer Counting Chamber, and a 
new culture cycle was set up with fresh medium and RJK853 feeder cells. The samples 
required for further analysis were then cryopreserved in a medium made up of 10% 
DMSO (Sigma), 20% FBS (Invitrogen) and 70% X-Vivo 10 and stored in liquid 
nitrogen for further analysis at the end of a 7 day growth cycle (Warnock et al., 1999; 
Barnett & Barnett, 2000; Hyland et al., 2000, 2001). 
5.1.2.4. Isolation of CD4+ T cells from peripheral blood mononuclear 
cells and maintenance in culture 
CD4+ T cells ex vivo were isolated separately from ten healthy, non-smoking males 
fasted overnight, five each in the age group of 25-30 years and 55-60 years, using the 
CD4+ T cell isolation kit II (Miltenyi Biotec) (Chapter-2, Section 2.1.5.2). The CD4+ T 
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cells ex vivo were then washed separately in phosphate buffered saline or X-Vivo 10 
media and maintained in culture separately as detailed above (Section 5.1.2.3).  
5.1.2.5. Ebselen or NAC supplementation 
The effect of a range of concentrations of ebselen or NAC on CD4+ T cell clones was 
taken into consideration before choosing the doses of ebselen or NAC. 30µM ebselen or 
7.5mM NAC revealed significant antioxidant potential in human peripheral blood 
derived CD4+ T cell clones supplemented from a young in vitro age (Chapter-4). 
Preliminary studies in human peripheral blood derived CD4+ T cell clones 
supplemented from the midpoint of their in vitro lifespan prior to the studies on 
supplementation of clones from a young in vitro age, revealed that T cell clones 
supplemented with 5mM NAC had a longer lifespan compared to clones supplemented 
with other concentrations of NAC (Chapter-4). These results from the previous studies 
lead to the investigation of the effect of 5mM / 7.5mM NAC in human peripheral blood 
mononuclear cells, which would enable the differentiation of antioxidant potential or 
pro-oxidant potential of NAC at different concentrations to be determined in this study. 
NAC at higher concentrations (10mM) completely inhibited the growth of T cell clones 
in the previous study (Chapter-4, Section 4.1.4). The peripheral blood mononuclear 
cells or CD4+ T cells from ten healthy, non-smoking males fasted overnight, five each 
in the age group of 25-30 years and 55-60 years were supplemented separately with 
30µM ebselen (Sigma) or 5mM / 7.5mM NAC (Sigma) in X-Vivo 10 media. The 
different ex vivo T cell samples (peripheral blood mononuclear cells / CD4+ T cells) 
were supplemented with ebselen or NAC on days one and four of the growth cycle. The 
supplementation of the antioxidants in this investigation was performed in the same way 
to the previous studies carried out by the group of Barnett (Hyland et al., 2000) and 
chapter-4 (Section 4.1.2.4). Existing scientific literature was consulted before the 
investigation. Previous studies have demonstrated the ability of ebselen (dose ranges 
detailed in chapter-4, Section 4.1.2.4) on acute exposure (up to 24 hours after 
supplementation) to protect HepG2 cells (Yang et al., 1999), human HL-60 (Li et al., 
2000) and PC-12 cells (Yoshizumi et al., 2002) from H2O2 induced cell death and DNA 
damage. NAC has also been proven to act as an efficient antioxidant on acute exposure 
in HeLa cells (Hansen et al., 2004) and HepG2 cells (Yang et al., 1999) (Chapter-4, 
Section 4.1.2.4). In this PhD, the effect of chronic exposure (beyond 24 hours of 
supplementation) to ebselen or NAC in human T cells ex vivo has been investigated. 
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5.1.2.6. Proliferation assays for peripheral blood mononuclear cells ex 
vivo / CD4+ T cells 
Human peripheral blood mononuclear cells / CD4+ T cells ex vivo were seeded 
separately at 1 x 106 cells per well in a 24 well plate. Tritiated thymidine at a final 
concentration of 0.037MBq/ml was added to each of the ex vivo T cell samples 18 hours 
prior to harvesting. Cells were transferred onto a 96 well plate the next day and were 
harvested using a 96-well harvester onto a 96-well filter plate and 40µl of scintillation 
fluid was added to each of the filter wells. Filters were counted for 1 minute per well 
with a Top-Count scintillation counter. Proliferation assays (Chapter-2, Section 2.1.9) 
were performed in duplicate for both human peripheral blood mononuclear cells and 
CD4+ T cells ex vivo. Control (untreated) human peripheral blood mononuclear cells 
were grown in parallel to the ebselen or NAC supplemented peripheral blood 
mononuclear cells and proliferation capacity was determined in both supplemented and 
non-supplemented cells. 
5.1.2.7. Assessment of levels of oxidative damage to DNA  
The levels of oxidative DNA damage within human peripheral blood mononuclear cells 
or CD4+ T cells ex vivo were determined separately using the modified alkaline comet 
assay (Collins et al., 1993; Chapter-2, Section 2.1.10). The modified alkaline comet 
assay involves the pre-treatment of cells with two enzymes namely FPG (New England 
Biolabs) and Endo III (New England Biolabs) which recognise oxidatively modified 
purines or oxidatively modified pyrimidines, respectively. The enzymes nick DNA at 
the site of oxidatively modified nucleotides, creating single stranded breaks which can 
be detected by the comet assay. Comet analysis was performed on the cells counting 50 
cells per slide using Komet 5.5 computer image analysis software (Andor Technology, 
UK). The comet assays were performed in duplicates for both human peripheral blood 
mononuclear cells and CD4+ T cells ex vivo derived. 
5.1.2.8. Quantitative determination of intracellular GSH:GSSG and 
total glutathione levels  
A GSH:GSSG ratio assay kit (Calbiochem, UK) (Chapter-2, Section 2.1.11) was used to 
assess the ratio of reduced to oxidised form of glutathione and total glutathione levels in 
peripheral blood mononuclear cells / CD4+ T cells ex vivo. This technique incorporates 
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a thiol-scavenging reagent, 1-methyl-2-vinylpyridinium trifluoromethane-sulfonate1 
(M2VP) at a level that rapidly scavenges GSH, but does not interfere with the 
glutathione reductase in recycling GSSG into GSH. The whole cell extract was prepared 
from harvested cells (2 x 106 cells/ml for GSH and 5 x 106 cells/ml for GSSG) 
according to the manufacturers instructions. The GSH:GSSG ratio and the total 
glutathione levels were calculated from the GSH and GSSG concentrations of the 
peripheral blood mononuclear cells photometrically measured at 412 nm in µM 
concentrations. The assays were performed in duplicate. 
5.1.2.9. Statistical analysis  
The results were tested for statistical significance using paired two-sample Student’s t-
tests assuming equal variances; p values are presented as appropriate. 
5.1.3. Results 
5.1.3.1. The impact of ebselen or NAC on proliferation capacity in 
human peripheral blood mononuclear cells and CD4+ T cells ex vivo  
The effect of 30µM ebselen (Figures 5.1A & 5.1B) or 7.5mM NAC (Figures 5.2A & 
5.2B) on the proliferation capacity of ten different human peripheral blood mononuclear 
cells, isolated from fresh human blood, was investigated. Figures 5.3A & 5.3B and 
figures 5.4A & 5.4B denote the effect of 30µM ebselen or 7.5mM NAC on the 
proliferation capacity in human CD4+ T cells isolated from fresh human blood.  
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Figure 5.1 The effect of 30µM ebselen on the proliferation capacity of human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (5.1A) and 
55-60 years (5.1B) supplemented ex vivo for 3 weeks. The bars indicate the mean ± 
S.D. Values statistically different from their controls (Student’s t-test, 95% 
confidence level) are indicated with an asterix. 
*** Significantly higher proliferation capacity compared to controls, p < 0.001 
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Figure 5.2 The effect of 7.5mM NAC on the proliferation capacity of human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (5.2A) and 
55-60 years (5.2B) supplemented ex vivo for three weeks. The bars indicate the 
mean ± S.D. Values statistically different from their controls (Student’s t-test, 95% 
confidence level) are indicated with an asterix.  
* p < 0.05, *** p < 0.001 - Significantly higher proliferation capacity compared to 
controls 
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Figure 5.1A shows a significant increase (Student’s t-test, 95% confidence levels) in the 
proliferation capacity of human peripheral blood mononuclear cells derived from donors 
from the 25-30 years age group after the second week of supplementation ex vivo with 
30µM ebselen, compared to non-supplemented peripheral blood mononuclear cells. 
Figure 5.1B denotes a significant increase of proliferation capacity in human peripheral 
blood mononuclear cells derived from donors from the 55-60 years age group from one 
week of supplementation ex vivo with 30µM ebselen, compared to non-supplemented 
peripheral blood mononuclear cells. In the case of 7.5mM supplementation, the increase 
in proliferation capacity reached statistical significance after 2 weeks of 
supplementation in samples from both age groups (Figures 5.2A & 5.2B). The results 
on supplementation of ex vivo T cells with 5mM NAC were not significantly different 
to the results on supplementation with 7.5mM NAC in human peripheral blood 
mononuclear cells derived from donors of both age groups. The number of live cells 
was too low after three weeks of supplementation to carry out any analysis (Warnock et 
al., 1999). Furthermore, the rate of proliferation capacity observed among human 
peripheral blood mononuclear cells derived from each of the five different donors in 
each of the above cases were not significantly different (Figures 5.1A, 5.1B, 5.2A & 
5.2B). 
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Figure 5.3 The effect of 30µM ebselen on the proliferation capacity of CD4+ T cells 
isolated from fresh human blood derived from ten different healthy donors, five 
each in the age groups of 25-30 years (5.3A) and 55-60 years (5.3B) supplemented 
ex vivo for three weeks. The bars indicate the mean ± S.D. Values statistically 
different from their controls (Student’s t-test, 95% confidence level) are indicated 
with an asterix. 
** p < 0.01, *** p < 0.001 - Significantly higher proliferation capacity compared to 
controls 
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Figure 5.4 The effect of 7.5mM NAC on the proliferation capacity of CD4+ T cells 
isolated from fresh human blood derived from ten different healthy donors, five 
each in the age groups of 25-30 years (5.4A) and 55-60 years (5.4B) supplemented 
ex vivo for three weeks. The bars indicate the mean ± S.D. Values statistically 
different from their controls (Student’s t-test, 95% confidence level) are indicated 
with an asterix. 
** p < 0.01, *** p < 0.001 - Significantly higher proliferation capacity compared to 
controls 
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Figures 5.3A and 5.3B show a significant increase (Student’s t-test, 95% confidence 
levels) in proliferative capacity of CD4+ T cells derived from donors from the two age 
groups studied after one and two weeks of supplementation ex vivo with 30µM ebselen, 
compared to non-supplemented CD4+ T cells. Figures 5.4A and 5.4B show a significant 
increase in proliferative capacity of CD4+ T cells derived from donors from the two age 
groups studied from one week of supplementation ex vivo with 7.5mM NAC, compared 
to non-supplemented CD4+ T cells. In terms of supplementation with 5mM NAC, an 
increase in proliferation capacity was observed which reached statistical significance 
from one week of supplementation in CD4+ T cells compared to non-supplemented 
CD4+ T cells ex vivo in donors from both age groups. The antioxidant potential of 5mM 
NAC from one week of supplementation was not significantly different from the 
antioxidant potential of 7.5mM NAC after one or two weeks of supplementation of 
human CD4+ T cells from donors of both age groups. The number of live cells was too 
low after three weeks of supplementation to carry out any analysis. Furthermore, the 
rate of proliferation capacity observed among CD4+ T cells ex vivo derived from each of 
the five different donors in each of the above cases were not significantly different 
(Figures 5.3A, 5.3B, 5.4A & 5.4B). 
5.1.3.2. The impact of ebselen or NAC on levels of oxidative DNA 
damage in human peripheral blood mononuclear cells / CD4+ T cells ex 
vivo 
Ex vivo T cell samples were taken from culture at various time points and the effect of 
30µM ebselen or 7.5mM NAC on the levels of oxidative DNA damage was determined. 
In all cases, levels of oxidative damage to DNA increased as a function of age, as 
measured by the modified Endo III and FPG comet assays. Figures 5.5 and 5.6 show the 
results of the effects of 30µM ebselen or 7.5mM NAC on levels of oxidative DNA 
damage in human peripheral blood mononuclear cells isolated from fresh human blood 
derived from donors from the 25-30 years age group (Figures 5.5A & 5.6A) and 55-60 
years age group (Figures 5.5B & 5.6B). Figures 5.7 and 5.8 illustrate the results of the 
effect of 30µM ebselen or 5mM NAC on oxidative DNA damage in CD4+ T cells 
isolated from fresh human blood derived from donors from 25-30 years (Figures 5.7A 
& 5.8A) age group and 55-60 years age group (Figures 5.7B & 5.8B).  
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Figure 5.5 The effect of 30µM ebselen on levels of oxidative damage to DNA in 
human peripheral blood mononuclear cells isolated from fresh human blood 
derived from ten different healthy donors, five each in the age groups of 25-30 
years (5.5A) and 55-60 years (5.5B) supplemented ex vivo for three weeks. The bars 
indicate the mean ± S.D. Values statistically different from their controls 
(Student’s t-test, 95% confidence level) are indicated with an asterix. 
*** Significantly lower than control levels, p < 0.001  
  
 130
5.6A 
Human PBMC- 
25-30 yr old donors
7.5mM NAC
0
5
10
15
20
25
30
35
40
Control NAC Control NAC Control    
Minimal
Growth
NAC        
Minimal
Growth
Pe
rc
e
n
ta
ge
 
o
f D
N
A
 
in
 
c
o
m
e
t t
a
il
Alkaline Comet
Endo III Comet
Fpg Comet
Week-1                                  Week-2                                 Week-3
**
**
***
n=5
 
 
5.6B 
Human PBMC- 
55-60 yr old donors
7.5mM NAC
0
5
10
15
20
25
30
35
40
Control NAC Control NAC Control    
Minimal
Growth
NAC        
Minimal
Growth
Pe
rc
e
n
ta
ge
 
o
f D
N
A
 
in
 
c
o
m
e
t t
a
il
Alkaline Comet
Endo III Comet
Fpg Comet
Week-1                                  Week-2                                 Week-3
**
**
**
n=5
 
 
Figure 5.6 The effect of 7.5mM NAC on levels of oxidative damage to DNA in 
human peripheral blood mononuclear cells isolated from fresh human blood 
derived from ten different healthy donors, five each in the age groups of 25-30 
years (5.6A) and 55-60 years (5.6B) supplemented ex vivo for three weeks. The bars 
indicate the mean ± S.D. Values statistically different from their controls 
(Student’s t-test, 95% confidence level) are indicated with an asterix. 
** p<0.01, *** p < 0.001- Significantly lower than control levels 
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Figures 5.5A and 5.5B show a significant decrease (Student’s t-test, 95% confidence 
levels) in levels of oxidative damage to DNA in human peripheral blood mononuclear 
cells derived from donors from both age groups (25-30 years; 5.5A and 55-60 years; 
5.5B) after two weeks of supplementation ex vivo with 30µM ebselen, compared to non-
supplemented cells. 7.5mM NAC supplementation led to a significant decrease in levels 
of oxidative damage to DNA in human peripheral blood mononuclear cells derived 
from donors from both age groups (25-30 years; 5.6A and 55-60 years; 5.6B) after two 
weeks of supplementation ex vivo, compared to non-supplemented cells. The 
supplementation of human peripheral blood mononuclear cells with 5mM NAC resulted 
in a significant decrease in levels of oxidative DNA damage after two weeks of 
supplementation, compared to non-supplemented peripheral blood mononuclear cells 
from donors of both age groups. The levels of oxidative DNA damage in 5mM 
supplemented human peripheral blood mononuclear cells were not significantly 
different from the levels of oxidative DNA damage in ex vivo T cells from either age 
group supplemented with 7.5mM NAC. All four figures (5.5A, 5.5B, 5.6A & 5.6B) 
show an increase in levels of oxidative DNA damage with age (in line with the findings 
in chapter-4 [Section 4.1.3.2] with T cell clones). There were no significant differences 
in the levels of oxidative damage to DNA in donors from the 25-30 years age group 
compared to donors from the 55-60 years age group. The number of live cells was too 
low after three weeks of supplementation to carry out any analysis. Furthermore, the 
levels of oxidative DNA damage observed among human peripheral blood mononuclear 
cells derived from each of the five different donors in each of the above cases were not 
significantly different (Figures 5.5A, 5.5B, 5.6A & 5.6B). 
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Figure 5.7 The effect of 30µM ebselen on levels of oxidative damage to DNA in 
CD4+ T cells isolated from fresh human blood derived from ten different healthy 
donors, five each in the age groups of 25-30 years (5.7A) and 55-60 years (5.7B) 
supplemented ex vivo for three weeks. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
** p<0.01, *** p < 0.001- Significantly lower than control levels 
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Figure 5.8 The effect of 7.5mM NAC on levels of oxidative damage to DNA in 
CD4+ T cells isolated from fresh human blood derived from ten different healthy 
donors, five each in the age groups of 25-30 years (5.8A) and 55-60 years (5.8B) 
supplemented ex vivo for three weeks. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
** p<0.01, *** p < 0.001- Significantly lower than control levels 
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Figures 5.7A and 5.7B show a significant decrease (Student’s t-test, 95% confidence 
levels) in levels of oxidative damage to DNA in CD4+ T cells derived from donors from 
the 25-30 years age group (Figure 5.7A) and 55-60 years age group (Figure 5.7B) after 
two weeks of supplementation ex vivo with 30µM ebselen compared to non-
supplemented CD4+ T cells. 7.5mM NAC supplementation also revealed a significant 
decrease in levels of oxidative damage to DNA in CD4+ T cells derived from donors of 
both age groups after two weeks of supplementation ex vivo, compared to non-
supplemented CD4+ T cells. The supplementation of CD4+ T cells with 5mM NAC 
resulted in a significant decrease in levels of oxidative DNA damage after two weeks of 
supplementation compared to non-supplemented CD4+ T cells in donors from both age 
groups. The levels of oxidative DNA damage in 5mM supplemented CD4+ T cells were 
not significantly different from the levels of oxidative DNA damage in CD4+ T cells ex 
vivo from either age group supplemented with 7.5mM NAC. All the four figures 
(Figures 5.7A, 5.7B, 5.8A & 5.8B) show an increase in levels of oxidative DNA 
damage with age (in line with the findings in chapter-4 (Section 4.1.3.2) with T cell 
clones). There were no significant differences in the levels of oxidative damage to DNA 
in donors from the 25-30 years age group compared to donors from the 55-60 years age 
group. The number of live cells was too low after three weeks of supplementation to 
carry out any analysis. It was also worth noting that the levels of oxidative DNA 
damage observed among CD4+ T cells ex vivo derived from each of the five different 
donors in each of the above cases were not significantly different (Figures 5.7A, 5.7B, 
5.8A & 5.8B). 
5.1.3.3. The impact of ebselen or NAC on intracellular redox status 
(GSH:GSSG ratio) in human peripheral blood mononuclear cells / 
CD4+ T cells ex vivo 
T cell samples were taken from culture at various time points and the effect of 30µM 
ebselen or 7.5mM NAC on intracellular redox status (GSH:GSSG ratio) was determined. 
Figures 5.9 and 5.10 illustrate these results. Figures 5.11 and 5.12 show the results of 
the effect of 30µM ebselen or 7.5mM NAC on GSH:GSSG ratio in CD4+ T cells 
derived from donors from 25-30 years age group (Figures 5.11A & 5.12A) and 55-60 
years age group (Figures 5.11B & 5.12B), when supplemented ex vivo compared to 
non-supplemented CD4+ T cells.  
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Figure 5.9 The effect of 30µM ebselen on intracellular GSH:GSSG ratio in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (5.9A) and 
55-60 years (5.9B) supplemented ex vivo for three weeks. The bars indicate the 
mean ± S.D. Values statistically different from their controls (Student’s t-test, 95% 
confidence level) are indicated with an asterix. 
** Significantly higher than the ratio of non-supplemented mononuclear cells,       
p < 0.01 
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Figure 5.10 The effect of 7.5mM NAC on intracellular GSH:GSSG ratio in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (5.10A) and 
55-60 years (5.10B) supplemented ex vivo for three weeks. The bars indicate the 
mean ± S.D. Values statistically different from their controls (Student’s t-test, 95% 
confidence level) are indicated with an asterix. 
** Significantly higher than the ratio of non-supplemented mononuclear cells,       
p < 0.01 
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Figure 5.9A shows a significantly higher (Student’s t-test, 95% confidence levels) 
GSH:GSSG ratio in human peripheral blood mononuclear cells derived from donors 
from the 25-30 years age group after two weeks of supplementation ex vivo with 30µM 
ebselen, compared to non-supplemented peripheral blood mononuclear cells. Figure 
5.9B denotes a significantly higher GSH:GSSG ratio of human peripheral blood 
mononuclear cells derived from donors from the 55-60 years age group after one week 
as well as two weeks of supplementation ex vivo with 30µM ebselen, compared to non-
supplemented peripheral blood mononuclear cells. Figure 5.10A denotes a significantly 
higher GSH:GSSG ratio in human peripheral blood mononuclear cells derived from 
donors from the 25-30 years age group after one week as well as two weeks of 
supplementation ex vivo with 7.5mM NAC, compared to non-supplemented peripheral 
blood mononuclear cells. Figure 5.10B indicates a significantly higher GSH:GSSG ratio 
of human peripheral blood mononuclear cells derived from donors from the 55-60 years 
age group after two weeks of supplementation ex vivo with 7.5mM NAC, compared to 
non-supplemented peripheral blood mononuclear cells. Following supplementation with 
5mM NAC, there was a significantly higher GSH:GSSG ratio after both one week and 
two weeks of supplementation in cells derived from both age groups compared to non-
supplemented peripheral blood mononuclear cells. There were no significant differences 
in GSH:GSSG ratio in human peripheral blood mononuclear cells supplemented with 
5mM NAC or 7.5mM NAC and derived from either age group. There were no 
significant differences in GSH:GSSG ratio in donors from the 25-30 years age group 
compared to donors from the 55-60 years age group. The number of live cells was too 
low after three weeks of supplementation to carry out any analysis. Furthermore, the 
GSH:GSSG ratios observed among human peripheral blood mononuclear cells derived 
from each of the five different donors in each of the above cases were not significantly 
different (Figures 5.9A, 5.9B, 5.10A & 5.10B). 
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Figure 5.11 The effect of 30µM ebselen on intracellular GSH:GSSG ratio in CD4+ 
T cells isolated from fresh human blood derived from ten different healthy donors, 
five each in the age groups of 25-30 years (5.11A) and 55-60 years (5.11B) 
supplemented ex vivo for three weeks. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
** p<0.01, *** p < 0.001- Significantly higher than the ratio of non-supplemented 
CD4+ T cells 
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Figure 5.12 The effect of 7.5mM NAC on intracellular GSH:GSSG ratio in CD4+ T 
cells isolated from fresh human blood derived from ten different healthy donors, 
five each in the age groups of 25-30 years (5.12A) and 55-60 years (5.12B) 
supplemented ex vivo for three weeks. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
** p<0.01, *** p < 0.001- Significantly higher than the ratio of non-supplemented 
CD4+ T cells 
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Figures 5.11A and 5.11B show a significantly higher (Student’s t-test, 95% confidence 
levels) GSH:GSSG ratio of CD4+ T cells derived from donors from the 25-30 years age 
group and 55-60 years age group, after one week and two weeks of supplementation ex 
vivo with 30µM ebselen compared to non-supplemented CD4+ T cells. Figures 12A and 
12B denote a significantly higher GSH:GSSG ratio of CD4+ T cells derived from 
donors of 25-30 years age group and 55-60 years age group, after two weeks of 
supplementation ex vivo with 7.5mM NAC compared to non-supplemented CD4+ T 
cells. The results of CD4+ T cells supplemented with 5mM NAC were not significantly 
different from the results of CD4+ T cells supplemented with 7.5mM NAC in donors 
from both age groups. The supplementation of 5mM NAC resulted in a significantly 
higher GSH:GSSG ratio after two weeks of supplementation in donors from both age 
groups. There was no significant increase in GSH:GSSG ratio in CD4+ T cells after one 
week of supplementation with 5mM / 7.5mM NAC in donors from either age groups 
compared to non-supplemented CD4+ T cells ex vivo. The number of live cells was too 
low after three weeks of supplementation to carry out any analysis. The results of the 
analysis also revealed that the GSH:GSSG ratios observed among CD4+ T cells ex vivo 
derived from each of the five different donors in each of the above cases were not 
significantly different (Figures 5.11A, 5.11B, 5.12A & 5.12B). 
5.1.3.4. The impact of ebselen or NAC on total glutathione levels in 
human peripheral blood mononuclear cells / CD4+ T cells ex vivo 
T cell samples were taken from the culture at various time points of their lifespan and 
the effects of 30µM ebselen or 7.5mM NAC on total glutathione levels within the T 
cells ex vivo were examined. Figures 5.13 & 5.14 show the results of the effect of 30µM 
ebselen or 7.5mM NAC on total glutathione levels in human peripheral blood 
mononuclear cells derived from donors from the 25-30 years age group and 55-60 years 
age group supplemented ex vivo, compared to non-supplemented peripheral blood 
mononuclear cells. Figures 5.15 & 5.16 show the results of the effect of 30µM ebselen 
or 7.5mM NAC on total glutathione levels in CD4+ T cells derived from donors from 
the 25-30 years age group and 55-60 years age group supplemented ex vivo, compared 
to non-supplemented CD4+ T cells.  
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Figure 5.13 The effect of 30µM ebselen on total glutathione levels in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (5.13A) and 
55-60 years (5.13B) supplemented ex vivo for three weeks. The bars indicate the 
mean ± S.D. Values statistically different from their controls (Student’s t-test, 95% 
confidence level) are indicated with an asterix. 
** p<0.01 - Significantly higher than the non-supplemented controls 
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Figure 5.14 The effect of 7.5 mM NAC on total glutathione levels in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (5.14A) and 
55-60 years (5.14B) supplemented ex vivo for three weeks. The bars indicate the 
mean ± S.D. Values statistically different from their controls (Student’s t-test, 95% 
confidence level) are indicated with an asterix. 
** p<0.01, ***p<0.001 - Significantly higher than the non-supplemented controls 
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Figures 5.13A, 5.13B, 5.14A & 5.14B indicate a significant increase (Student’s t-test, 
95% confidence levels) in total glutathione levels in human peripheral blood 
mononuclear cells derived from donors from the 25-30 years age group and 55-60 years 
age group, after two weeks of supplementation ex vivo with 30µM ebselen (Figures 
5.13A & 5.13B) or 7.5mM NAC (Figures 5.14A & 5.14B), compared to non-
supplemented peripheral blood mononuclear cells. The impact on total glutathione 
levels in human peripheral blood mononuclear cells supplemented with 5mM NAC was 
not significantly different from the impact of 7.5mM NAC supplementation in 
peripheral blood mononuclear cells. 5mM NAC supplementation resulted in a 
significant increase in total glutathione levels after two weeks of supplementation 
compared to non-supplemented peripheral blood mononuclear cells in donors from both 
age groups. There were no significant differences in total glutathione levels in donors 
from the 25-30 years age group compared to donors from the 55-60 years age group. 
The number of live cells was too low after three weeks of supplementation to carry out 
any analysis. Furthermore, the results of the analysis also revealed that the total 
glutathione levels observed among human peripheral blood mononuclear cells derived 
from each of the five different donors in each of the above cases were not significantly 
different (Figures 5.13A, 5.13B, 5.14A & 5.14B). 
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Figure 5.15 The effect of 30µM ebselen on total glutathione levels in CD4+ T cells 
isolated from fresh human blood derived from ten different healthy donors, five 
each in the age groups of 25-30 years (5.15A) and 55-60 years (5.15B) 
supplemented ex vivo for three weeks. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
** p<0.01, ***p<0.001 - Significantly higher than the non-supplemented controls 
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Figure 5.16 The effect of 7.5mM NAC on total glutathione levels in CD4+ T cells 
isolated from fresh human blood derived from ten different healthy donors, five 
each in the age groups of 25-30 years (5.16A) and 55-60 years (5.16B) 
supplemented ex vivo for three weeks. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
** p<0.01, ***p<0.001 - Significantly higher than the non-supplemented CD4+ 
controls 
  
 146
Figure 5.15A indicates a significant increase (Student’s t-test, 95% confidence levels) in 
total glutathione levels after two weeks of supplementation ex vivo with 30µM ebselen 
in CD4+ T cells derived from donors from the 25-30 years age group and the increase in 
total glutathione levels reached statistical significance in donors from the 55-60 years 
age group (Figure 5.15B) after both weeks of supplementation compared to non-
supplemented CD4+ T cells. In the case of supplementation with 7.5mM NAC, the 
increase in total glutathione levels reached statistical significance after the first and 
second week of supplementation in donors from the 25-30 years age group (Figure 
5.16A) and the increase in total glutathione levels significantly increased after the 
second week of supplementation in donors from the 55-60 years age group. 5mM NAC 
supplementation resulted in a significant increase in total glutathione levels after both 
one week and two weeks of supplementation in CD4+ T cells compared to non-
supplemented CD4+ T cells in donors from both age groups. The number of live cells 
was too low after three weeks of supplementation to carry out any analysis. The results 
also revealed that the total glutathione levels observed among CD4+ T cells ex vivo 
derived from each of the five different donors in each of the above cases were not 
significantly different (Figures 5.15A, 5.15B, 5.16A & 5.16B). 
5.1.4. Discussion 
In this study the impact of ebselen or NAC as antioxidants on ex vivo human peripheral 
blood mononuclear cells and ex vivo CD4+ T cells (both polyclonal populations) has 
been investigated. The study has also allowed a comparative analysis of the impact of 
these antioxidants in human CD4+ T cells ex vivo compared to their impact in human 
peripheral blood derived CD4+ T cell clones in vitro, a monoclonal population (Chapter-
4). The impact of age on markers of T cell integrity and function was also determined 
by comparing the proliferative capacity, the levels of oxidative DNA damage, 
GSH:GSSG ratio and total glutathione levels in peripheral blood mononuclear cells 
derived from donors of the 25-30 years age group compared to the cells derived from 
donors of the 55-60 years age group. 
 
The ability of ebselen or NAC to minimise or scavenge ROS is well documented 
(Chapter-1, Section 1.1.6.1 & 1.1.6.2). The ability of ebselen to scavenge hydroxyl 
radicals and peroxyl radicals, responsible for lipid peroxidation and leading to DNA 
damage, contributes to its antioxidant potential (Yang et al., 1999). The free sulfhydryl 
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group scavenging ROS and NO and the ability to raise GSH levels by cysteine donation 
supplements the antioxidant potential of NAC (Han et al., 1997; Wagner et al., 1998). 
Supplementation of human peripheral blood mononuclear cells and CD4+ T cells ex vivo 
derived from donors from either age groups, with 30µM ebselen or 7.5mM NAC 
resulted in a significantly higher GSH:GSSG ratio (Figures 5.9A, 5.9B, 5.10A, 5.10B, 
5.11A, 5.11B, 5.12A & 5.12B), total glutathione levels (Figures 5.13A, 5.13B, 5.14A, 
5.14B, 5.15A, 5.15B, 5.16A & 5.16B) and proliferative capacity (Figures 5.1A, 5.1B, 
5.2A, 5.2B, 5.3A, 5.3B, 5.4A & 5.4B) at various time points during their span in culture 
compared to non-supplemented human peripheral blood mononuclear cells. Previous 
studies have demonstrated the ability of ebselen at concentrations of 1-25µM to 
stimulate cell growth, inhibit H2O2 induced suppression, and significantly reduce LDH 
leakage and lipid peroxidation and significantly reduced intracellular ROS levels in 
HepG2 cells in a concentration dependent manner due to its ability to scavenge hydroxyl 
radicals and other ROS (Yang et al., 1999). The free radical scavenging ability of 
ebselen has also been successfully demonstrated in HL-60 cells (Ji et al., 2000). In 
terms of NAC, other studies investigating the effect of a range of NAC concentrations 
(0.5-2mM) in HeLa cells have shown that 2mM NAC increased intracellular GSH by 
15% compared to controls after 24hrs of incubation (Hansen et al., 2004). In HepG2 
cells, the increase in intracellular GSH level was highest after 5mM NAC 
supplementation for 24hrs (Yang et al., 2000). 
 
The ability of ebselen or NAC to scavenge radicals and thereby elevate the GSH:GSSG 
ratio is of significance considering the important role of intracellular redox status 
(GSH:GSSG ratio) as a mediator of apoptosis in many cell systems (Slater et al., 1996; 
Cotgreave and Gerdes, 1998; Hall, 1999). Intracellular reduced glutathione (GSH), a 
main determinant of intracellular redox status, is known to become depleted before the 
onset of apoptosis (Beaver and Waring, 1995; Macho et al., 1997; Ghibelli et al., 1998). 
The GSH:GSSG redox couple maintains the redox environment of the cell and GSH is 
abundant in the cell (Schafer and Buettner, 2001), serving as an indicator of the cellular 
redox environment. Oxidation of even a small amount of GSH may hinder the redox 
status of the cell. This oxidation results in the formation of GSSG and mixed disulfides 
between protein sulfhydryl groups in biological systems. It will also result in a decrease 
in the levels of GSH and so lead to a lowering of the GSH:GSSG ratio, which has been 
suggested to be responsible for several human diseases (Chapter-1, Section 1.1.4.1.1). 
  
 148
Thus the higher GSH:GSSG ratio represents an improved antioxidant state for the 
ebselen or NAC treated cells. 
 
The results of this investigation also revealed a significant decrease in the levels of 
oxidative DNA damage (Figures 5.5A, 5.5B, 5.6A, 5.6B, 5.7A, 5.7B, 5.8A & 5.8B) at 
various time points in human peripheral blood mononuclear cells and CD4+ T cells ex 
vivo during their span in culture, when compared to non-supplemented peripheral blood 
mononuclear cells. The ability of ebselen to almost completely inhibit oxidative DNA 
damage has been previously demonstrated in HepG2 cells (Yang et al., 1999) and HL-
60 cells (Ji et al., 2000), attributed to their ability to scavenge hydroxyl and peroxide 
radicals. In terms of NAC, concentrations of 100-300µM NAC, significantly lower than 
the concentrations used in this investigation, reduced the DNA damage compared to 
controls in PC-12 cells (Yan and Greene, 1998).  
 
Further studies on the effect of ebselen or NAC supplementation on total glutathione 
levels revealed a significant increase, on supplementation with ebselen (30µM) or NAC 
(7.5mM) in human peripheral blood mononuclear cells and CD4+ T cells ex vivo.  
 
The significant increase in total glutathione levels on supplementation with 7.5mM 
NAC demonstrates the ability of NAC to contribute glutathione to the cell thereby 
supplementing the in vivo antioxidant status. A significant increase in total glutathione 
levels was also observed on supplementation with 30µM ebselen. Ebselen is a GPx 
mimetic. GPx has the ability to scavenge organic and inorganic peroxides using GSH as 
substrate. GSH is depleted during peroxide accumulation. Ebselen has a proven ability 
to scavenge hydroxyl radicals and ROS that initiates lipid peroxidation as a result of 
peroxide accumulation. In this study, ebselen may have scavenged the radicals present 
in the cell system. The fewer the radicals, the lesser will be the need for GSH to 
scavenge them. Since the GSH is not consumed to scavenge the radicals, levels of GSH 
may appear greater in the cell system on supplementation with ebselen.  
 
The results of this chapter clearly reveal the antioxidant potential of 30µM ebselen or 
7.5mM NAC, against endogenously generated oxidants and those associated with the 
95% air, 5% CO2 culture conditions in human peripheral blood mononuclear cells and 
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CD4+ T cells ex vivo at various time points during their span in culture. The higher 
GSH:GSSG ratio represents an increased antioxidant state on supplementation with 
ebselen or NAC. The increase in antioxidant status explains the decrease in levels of 
oxidative DNA damage that further explains a lower apoptotic state explained by the 
increase in proliferative capacity of the cells on antioxidant supplementation. 5mM 
NAC supplementation investigated in this study also revealed a significant antioxidant 
potential, similar to supplementation with 7.5mM NAC, in human peripheral blood 
mononuclear cells and CD4+ T cells ex vivo, considering their effect on the markers of T 
cell function and integrity investigated in this study. 
 
Apart from the potentially detrimental effects, ROS play an important role in T cell 
signalling events such as protein tyrosine phosphorylation and activation of JNK (Pani 
et al., 2000). ERK, JNK (SAPK) and P38 are some of the important pathways of 
mitogen activated protein (MAP) kinases, a prominent family of protein kinases, 
involved in proliferation, differentiation and apoptosis in cells. Previous work from the 
group of Barnett suggested an increase in JNK phosphorylation and P38 
phosphorylation at 6% O2 tension (Duggan et al., 2004). Other studies revealed 
inhibition of H2O2 induced P38 MAP kinase activation and cytochrome c release 
(cytochrome c plays an important role in apoptotic cell death and is released from the 
mitochondria in response to apoptotic signals) by 0.3µM ebselen supplementation in 
HUVECs and inhibition of the H2O2 induced activation of JNK signalling pathway by 
ebselen in PC-12 cells (Yoshizumi et al., 2002). This inhibition of P38 MAP kinase was 
later revealed as the major factor for endothelial cell death. This finding was implied as 
useful in prevention or treatment of endothelial dysfunction, suggested to be the first 
step in the development of atherosclerosis (Ali et al., 2004). The inhibition of H2O2 
induced activation JNK pathway by ebselen may be useful for the treatment of 
ischaemic cerebral diseases (Yoshizumi et al., 2002). JNK and P38 MAP kinase has 
been proven to be activated on cytotoxic insult and are often associated with apoptotis 
on activation (Ali et al., 2004). The inhibition of H2O2 induced activation of the MAP 
kinase pathways by ebselen has been attributed to its hydroxyl radical scavenging 
capacity. It will be interesting to examine the impact of ebselen or NAC on these 
pathways in human peripheral blood mononuclear cells and CD4+ T cells ex vivo. 
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Furthermore, when the effects of 30µM ebselen or 7.5mM NAC in human CD4+ T cells 
ex vivo was compared to the effects on human peripheral blood derived CD4+ T cell 
clones in vitro, there were no significant differences found across all markers of T cell 
integrity and function. Interestingly, 5mM NAC supplementation did not reveal any 
significant antioxidant potential in CD4+ T cell clones in vitro (Chapter-4), unlike the 
potential demonstrated in the ex vivo polyclonal peripheral blood mononuclear cell 
population and CD4+ T cells ex vivo. Human T cell clones are maintained in culture 
throughout their lifespan over several months. This is not the case in cells ex vivo. It 
may be that the longer span of culture in vitro may have altered certain aspects of the 
biochemical / molecular status of the cells. The in vitro T cell clones may have steadily 
accumulated biomolecule damage during their lifespan under conditions of 20% O2 that 
may have decreased the antioxidant or free radical scavenging potential of NAC at this 
specific concentration on long term supplementation. Under these extensive culture 
conditions, antioxidant or free radical scavenging effects of NAC at 5mM 
concentrations may be insufficient to reveal any significant antioxidant potential in T 
cell clones in vitro.  
 
Previous findings from the group of Barnett revealed that human peripheral blood 
mononuclear cells derived from donors of 65-69 years had higher levels of mutations 
and DNA damage and had lower DNA repair capacity and altered in vivo antioxidant 
status compared to cells derived from donors aged 35-39 years. The decrease in DNA 
repair capacity or alterations in in vivo antioxidant status may have contributed to the 
increase in mutation load in mononuclear cells derived from donors of 65-69 years 
(King et al., 1997). The accumulation of such damage and mutations in T cells ex vivo, 
when in critical levels, could result in failure of T cells to proliferate due to DNA 
damage induced cell cycle arrest; decreased rate of proliferation as a consequence of 
selection in vivo against cells carrying mutation and / or apoptosis (Barnett & Barnett, 
1998). In the study reported in this chapter, no significant differences between the levels 
of oxidative DNA damage in untreated human peripheral blood mononuclear cells or 
CD4+ T cells ex vivo derived from donors of 25-30 years age group, compared to T cells 
derived from donors of 55-60 years age group were found. Other markers of T cell 
function (proliferative capacity) and integrity (GSH:GSSG ratio and total glutathione 
levels) investigated in this study did not reveal any significant differences between the 
two age groups.  
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There could be several reasons for the difference in the results of this study compared to 
the previous studies of the group. One of the differences is due to the differences in age 
groups used in the two studies. Age group of donors used in this study were 55-60 year 
age group compared to the 65-69 year age group used in the previous study by the 
group. Another difference could be the differences in sensitivity of the assays used. The 
previous study carried out by the group of Barnett revealing an increase in basal levels 
of DNA damage and mutations in mononuclear cells ex vivo with age, used sandwich 
enzyme linked immunosorbent assay (ELISA) technique based on the action of a 
monoclonal antibody (Barnett and King, 1995). The combined comet assay used in this 
investigation detects single stranded breaks and oxidised bases. Other studies have 
shown the comparison between the output of ELISA and comet assays and both assays 
have shown comparable results in detecting DNA damage. But one of the important 
advantage of comet assay over ELISA is the detection of DNA damage in individual 
cells and its distribution is assessed giving a pattern of the DNA damage (Hughes et al., 
1999).  
 
In summary, the overall data of the current study revealed that 30µM ebselen or 5mM / 
7.5mM NAC supplementation demonstrated antioxidant potential evidenced by the 
significant increase in proliferation capacity, significantly higher GSH:GSSG ratio and 
total glutathione levels, and significant decreases in levels of oxidative damage to DNA 
in human peripheral blood mononuclear cells and CD4+ T cells ex vivo. From the results 
of this study, it is suggested that the possible in vivo antioxidant potential of ebselen or 
NAC should be investigated alongside their potential as anti-immunosenescent 
interventive strategies. 
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6.1. The effects of acute / chronic exposure to mitoQ on 
human peripheral blood mononuclear cells ex vivo 
6.1.1. Introduction 
Previous work from the group of Barnett has demonstrated an age related increase in 
DNA damage and mutations in human T lymphocytes ex vivo (King et al., 1994; 1997; 
Barnett and King, 1995). This increase in DNA damage may result in cell cycle arrest or 
apoptosis (Barnett & Barnett, 1998; Hyland et al., 2000). Recent studies have revealed 
that damage to mitochondria could contribute to an age related immunodeficiency and 
may also result in insufficient ATP production, through OXPHOS, for the function of 
lymphocytes (Ross et al., 2002).  
 
The important role of mitochondria in the life and death of a cell has been well 
established. Mitochondria are a major source of ROS, which can cause damage to 
cellular constituents such as DNA, RNA, proteins and lipids and contribute to cellular 
ageing and death. This is the basis of mitochondrial theory of ageing (Salvioli et al., 
2001; Ross et al., 2002). Mitochondria possess a genome which has been sequenced 
(Anderson et al., 1981; Chapter-1, Section 1.1.1.2.1). mtDNA lacks a protective histone 
protein and, an efficient DNA repair mechanism; this contributes to a 5-10 times faster 
mutation rate in mtDNA compared to the rate for nDNA (Richter, 1995).  
 
A decline in mitochondrial bioenergetic function with age in various human tissues has 
been widely implicated as a major factor contributing to the onset of a wide range of 
diseases (Smith et al., 2003; Chapter-1, Section 1.1.6.3). One of the main difficulties 
encountered in treating diseases caused by mitochondrial dysfunction is the inability to 
target bioactive molecules to mitochondria in vivo. This problem was solved by the 
development of mitoQ (Murphy, 1997; Kelso et al., 2001; Chapter-1, Section 1.1.6.3; 
Figure 1.13 & 1.14). The lipophilic cation attached to the mitoQ enables it to penetrate 
the lipid bilayers and the large mitochondrial membrane potential enables mitoQ to 
accumulate several hundred-fold within the mitochondria. The ubiquinone derivative, 
then buried within the lipid core of the mitochondrial inner membrane, accepts two 
electrons from complex II, resulting in reduction to ubiquinol. The ubiquinol donates a 
hydrogen atom from its hydroxyl group to a lipid peroxyl radical resulting in a decrease 
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in lipid peroxidation within the mitochondrial inner membrane (Takada et al., 1984; 
Ernster et al., 1992; Ingold et al., 1993).  The ability of the ubiquinol derivative to 
donate a hydrogen atom to a lipid peroxyl radical enables the inhibition of lipid 
peroxidation caused by the leakage of superoxide from the mitochondrial respiratory 
chain, an important source of oxidative stress (Raha and Robinson, 2000). This 
mechanism helps mitoQ to protect mitochondria from oxidative damage (Kagan et al., 
1994; Lass and Sohal, 1998; Chapter 1, Figure 1.15).  
 
Previous studies have demonstrated the ability of mitoQ to completely block H2O2 
induced caspase activation and apoptotic cell death in Jurkat cells on acute exposure 
(Kelso et al., 2001). The accumulation of caspases by H2O2 may result in mitochondrial 
oxidative stress resulting in mitochondrial membrane transition pores leading to loss of 
mitochondrial membrane potential that may play an important role in H2O2 induced 
apoptosis in Jurkat cells (Hampton and Orenius, 1997; Dumont et al., 1999). Other 
studies have revealed antioxidant potential on long term exposure to mitoQ, evidenced 
by prevention in rise of telomere shortening in human fibroblasts (Saretzki et al., 2003). 
In this chapter, the impact of a range of doses of mitoQ, following acute (after 3 or 6 
hours of mitoQ supplementation) or chronic (after 3 weeks of mitoQ supplementation) 
exposure, on endogenously produced ROS or H2O2 induced oxidative stress was 
examined in human peripheral blood mononuclear cells ex vivo. Decyl triphenyl 
phosphonium cation (DTPP, a non-antioxidant mitochondria-targeted compound) and 
vitamin E (a lipophilic, non-mitochondria-targeted antioxidant) were used as controls in 
this investigation. 
6.1.2. Materials and Methods  
6.1.2.1. Subject selection 
The human blood samples for this study were drawn from ten healthy, non-smoking 
males fasted overnight, five each in the age groups of 25-30 and 55-60 years. The 
subjects were not on any form of medication nor had they suffered any recent illness. 
The results of the previous studies in human peripheral blood mononuclear cells carried 
out by the group of Barnett were taken into consideration before choosing the two age 
groups of donors in this study (Barnett and King, 1995; Chapter-2, Section 2.1.3.1). 
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6.1.2.2. Sample collection  
Human blood samples were drawn in the morning between 8.00 and 9.00 am by a 
licensed individual and collected in a tube containing heparin to prevent coagulation. 
The samples were kept on ice and taken to the laboratory within 5 minutes for 
separation of peripheral blood mononuclear cells. 
6.1.2.3. Acute / chronic exposure to mitoQ in human peripheral blood 
mononuclear cells ex vivo 
Freshly isolated human peripheral blood mononuclear cells were washed separately in 
phosphate buffered saline or X-Vivo 10 media (Bio Whittaker) and each of the samples 
were maintained separately in culture as explained in chapter-2, section 2.1.7.1. The 
human peripheral blood mononuclear cells from ten healthy, non-smoking males fasted 
overnight, five each in the age group of 25-30 years and 55-60 years were incubated 
separately with mitoQ or DTPP (0µM, 0.1µM, 0.25µM, 0.5µM, 1.0µM) or Vitamin E 
(Sigma) (37µM or 74µM) for 3 or 6 hours. 0-250µM H2O2 (Sigma) was exogenously 
applied after 3 or 6 hours of mitoQ or DTPP or vitamin E supplementation. The samples 
were frozen down within 15 minutes of H2O2 treatment. The entire H2O2 treatment was 
performed at 4oC to minimise DNA repair. The existing scientific literature was 
consulted in order to confirm the dose range of the antioxidants and the oxidant 
(explained in detail in chapter-2, Section 2.1.7). DTPP and Vitamin E were used as 
controls for mitoQ, in this investigation.  
 
For chronic exposure to mitoQ, freshly isolated human peripheral blood mononuclear 
cells from six healthy, non-smoking males fasted overnight, three each from the age 
group of 25-30 years and 55-60 years were maintained in culture separately for three 
weeks as described in chapter-2, section 2.1.3.3. The human peripheral blood 
mononuclear cells were supplemented with 0-30nM mitoQ or DTPP in X-Vivo 10 and 
were maintained in culture for up to 3 weeks. The cells ex vivo were supplemented with 
mitoQ or DTPP on days one and four of the growth cycle. The mitoQ or DTPP 
supplementation were performed on both days (one and four), similar to the previous 
analysis investigating the impact of chronic exposure of other antioxidants in T cells in 
vitro and ex vivo (Hyland et al., 2000; Chapter-4, Section 4.1.2.4; Chapter-5, Section 
5.1.2.5). MitoQ supplementation was performed on day four in order to replenish the 
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culture system with the antioxidant. Previous studies were taken into consideration 
before choosing the dose range for chronic exposure to mitoQ and DTPP (Chapter-2, 
Section 2.1.7). Only DTPP was used as a control for mitoQ for this part of the 
investigation.    
6.1.2.4. Quantification of mitochondrial membrane potential in ex vivo 
human peripheral blood mononuclear cells exposed to mitoQ  
The JC-1 staining kit assay (Invitrogen) (Chapter-2, Section 2.1.8) was optimised by 
trying a range of cell numbers (0.5 x 106 to 2 x 106 cells/ml) for assessing the 
mitochondrial membrane potential in human peripheral blood mononuclear cells ex vivo. 
After optimisation of the technique, 1.5 x 106 human peripheral blood mononuclear 
cells were analysed using the kit. The cells were suspended in warm PBS (Oxoid Ltd) 
and stained with JC-1 dye at a final concentration of 2µM and were maintained at 37oC 
at 5% CO2 for 30 minutes. The cells were then re-suspended in fresh warm PBS or X-
Vivo 10 media and the mean fluorescent intensity of green signal (percentage of 
apoptotic cells) was compared to the mean fluorescent intensity of red signal 
(percentage of live cells). Intensity values were determined using a flow cytometer at 
absorption maxima of 488nm. The results were expressed as mean ratio values. Mean 
value represents the mean fluorescent intensity giving the highest number of counts in a 
flow cytometer. 
 
The mean ratio values were calculated using the following formula: 
 
 
 
 
 
A higher mean ratio represents lower mitochondrial membrane potential due to higher 
levels of oxidative stress and a lower mean ratio or ratio closer to basal levels represents 
higher mitochondrial membrane potential due to low levels of oxidative stress. 
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6.1.2.5. Determination of levels of oxidative damage to DNA in human 
peripheral blood mononuclear cells ex vivo pre-treated with mitoQ / 
DTPP / Vitamin E 
The levels of oxidative damage to DNA plus DNA single strand breaks and alkali labile 
sites in human peripheral blood mononuclear cells ex vivo were determined using the 
modified alkaline comet assay as previously described (Collins et al., 1993; Hyland et 
al., 2000, 2001; Duggan et al., 2004; Chapter-2, Section 2.1.10). Comet assays for the 
samples were analysed in duplicate. 
6.1.2.6. Intracellular GSH:GSSG ratio and total glutathione levels in 
human peripheral blood mononuclear cells ex vivo pre-treated with 
mitoQ / DTPP / Vitamin E 
 
The ratio of the reduced and oxidised form of glutathione and total glutathione levels 
were assessed using a GSH:GSSG ratio assay kit (Calbiochem, UK) (Chapter-2, Section 
2.1.11). The samples were analysed in duplicate. 
6.1.2.7. Statistical analysis  
The results were tested for significance using paired two-sample Student’s t-tests 
assuming equal variances; p values are presented as appropriate. 
6.1.3. Results 
6.1.3.1. Impact of mitoQ on levels of oxidative DNA damage in human 
peripheral blood mononuclear cells ex vivo 
The effect of 0.5µM mitoQ (Figures 6.1A & 6.1B) on the levels of endogenous 
oxidative DNA damage and on DNA damage levels following treatment with H2O2 in 
peripheral blood mononuclear cells is illustrated. Control (unsupplemented) human 
peripheral blood mononuclear cells were grown in parallel to the mitoQ supplemented 
cells. 
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6.1A 
6.1B 
Figure 6.1 The effect of 0.5µM mitoQ on levels of oxidative DNA damage in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (6.1A) and 
55-60 years (6.1B), supplemented ex vivo. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
* p<0.05, ** p<0.01, *** p < 0.001 - Significantly lower than control levels 
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Figures 6.1A and 6.1B show a significant (Student’s t-test, 95% confidence levels) 
decrease in endogenous levels of oxidative DNA damage following a 3 hour treatment 
with 0.5µM mitoQ. In addition, 0.5µM mitoQ treatment afforded significant protection 
against H2O2 (50µM-250µM) induced DNA damage. There was no significant 
difference in, the levels of oxidative DNA damage in cells derived from donors from the 
two age groups and in the effect of H2O2 treatment in cells from either age group of 
donors. In all cases, there was a consistent increase in levels of oxidative DNA damage 
with increase in concentration of H2O2 (0-250µM) treatment. The levels of oxidative 
DNA damage observed between human peripheral blood mononuclear cells derived 
from each of the five different donors in each of the above cases were not significantly 
different (Figures 6.1A & 6.1B). 
 
Further studies were carried out to investigate the effect of a higher dosage of mitoQ 
(1µM) on human peripheral blood mononuclear cells. The results of this investigation 
revealed that the antioxidant potential of 1µM mitoQ in peripheral blood mononuclear 
cells derived from donors from both age groups were not significantly different from the 
effect of 0.5µM mitoQ (Table 6.1). 
 
In the next part of the investigation, in order to confirm the antioxidant potential of 
ubiquinone in mitoQ, the impact of 0.5µM or 1µM DTPP (control for mitoQ) on human 
peripheral blood mononuclear cells was investigated. The effect of 1µM DTPP (Figures 
6.2A & 6.2B) on the levels of endogenous oxidative DNA damage and on DNA damage 
levels following treatment with H2O2 in peripheral blood mononuclear cells is 
illustrated. Control (unsupplemented) human peripheral blood mononuclear cells were 
grown in parallel to the DTPP supplemented peripheral blood mononuclear cells.  
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6.2A 
 
6.2B 
Figure 6.2 The effect of 1µM DTPP on levels of oxidative DNA damage in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (6.2A) and 
55-60 years (6.2B), supplemented ex vivo. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
* p<0.05, ** p<0.01, *** p < 0.001 - Significantly lower than control levels 
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Figures 6.2A and 6.2B do not show any significant changes in endogenous levels of 
oxidative DNA damage following treatment with 1µM DTPP. However, 1µM DTPP 
treatment resulted in significant (Student’s t-test, 95% confidence levels) protection 
against H2O2 induced DNA damage. There was no significant difference in, the levels 
of oxidative DNA damage in cells derived from donors from the two age groups and in 
the effect of H2O2 treatment in cells from either age group of donors. There was a 
consistent increase in levels of oxidative DNA damage with increase in concentration of 
H2O2 (0-250µM) treatment. Furthermore, the levels of oxidative DNA damage observed 
between human peripheral blood mononuclear cells derived from each of the five 
different donors in each of the above cases were not significantly different (Figures 
6.2A & 6.2B). 
 
Further studies conducted, to investigate the effect of 0.5µM DTPP on human 
peripheral blood mononuclear cells yielded results which were not significantly 
different from the effect of 1µM DTPP (Table 6.2), in case of peripheral blood 
mononuclear cells derived from donors from both age groups. 
 
The effect of 6 hours of supplementation with 0.5µM or 1µM mitoQ / DTPP on the 
levels of endogenous oxidative DNA damage and on DNA damage levels following 
H2O2 treatment were not significantly different from the antioxidant potential after 3 
hours of supplementation in cells derived from donors of both age groups (Tables 6.1 & 
6.2).  
 
The effect of 0.1µM mitoQ (Figures 6.3A & 6.3B) on the levels of endogenous 
oxidative DNA damage and on DNA damage levels following treatment with H2O2 in 
peripheral blood mononuclear cells was also investigated.  
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6.3A 
6.3B 
Figure 6.3 The effect of 0.1µM mitoQ on levels of oxidative DNA damage in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (6.3A) and 
55-60 years (6.3B), supplemented ex vivo. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
* p<0.05, ** p<0.01, *** p < 0.001 - Significantly lower than control levels 
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Figures 6.3A and 6.3B show no significant changes in endogenous levels of oxidative 
DNA damage in cells on treatment with 0.1µM mitoQ. However, 0.1µM mitoQ 
treatment resulted in significant (Student’s t-test, 95% confidence levels) protection 
against H2O2 induced DNA damage. There was no significant difference in, the levels 
of oxidative DNA damage in cells derived from donors from the two age groups and in 
the effect of H2O2 treatment in cells from either age group of donors. In all cases there 
was a consistent increase in levels of oxidative DNA damage with increase in 
concentration of H2O2 (0-250µM) treatment. The levels of oxidative DNA damage 
observed between human peripheral blood mononuclear cells derived from each of the 
five different donors in each of the above cases were not significantly different (Figures 
6.3A & 6.3B). 
 
Further studies conducted, to investigate the effect of 0.25µM mitoQ on human 
peripheral blood mononuclear cells yielded results which were not significantly 
different from the effect of 0.1µM mitoQ, in case of peripheral blood mononuclear cells 
derived from donors from both age groups (Table 6.1). 
 
In the next part of the investigation, the impact of 0.1µM or 0.25µM DTPP (control for 
mitoQ) on human peripheral blood mononuclear cells were investigated. The effect of 
0.1µM DTPP (Figures 6.4A & 6.4B) on the levels of endogenous oxidative DNA 
damage and on DNA damage levels following treatment with H2O2 in peripheral blood 
mononuclear cells is illustrated. Control (unsupplemented) human peripheral blood 
mononuclear cells were grown in parallel to the DTPP supplemented peripheral blood 
mononuclear cells.  
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6.4A 
6.4B 
 
 
Figure 6.4 The effect of 0.1µM DTPP on levels of oxidative DNA damage in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years (6.4A) and 
55-60 years (6.4B), supplemented ex vivo. The bars indicate the mean ± S.D. 
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Figures 6.4A and 6.4B did not reveal any significant changes in endogenous levels of 
oxidative DNA damage following 0.1µM DTPP treatment. In addition, 0.1µM DTPP 
did not result in any significant protection against H2O2 induced DNA damage. There 
was no significant difference in, the levels of oxidative DNA damage in cells derived 
from donors from the two age groups and in the effect of H2O2 treatment in cells from 
either age group of donors. There was a consistent increase in levels of oxidative DNA 
damage with increase in concentration of H2O2 (0-250µM) treatment. The levels of 
oxidative DNA damage observed between human peripheral blood mononuclear cells 
derived from each of the five different donors in each of the above cases were not 
significantly different (Figures 6.4A & 6.4B). 
 
The results of the investigation of the effect of 0.25µM DTPP on cells derived from 
donors of both group of ages were not significantly different from the effect of 0.1µM 
DTPP (Table 6.2). 
 
In summary, the results of acute exposure to mitoQ (0.1µM, 0.25µM, 0.5µM or 1µM) 
afforded protection against H2O2 induced oxidative damage to DNA. In addition, 0.5µM 
or 1µM of mitoQ reduced levels of endogenous DNA damage in the various peripheral 
blood mononuclear cell samples derived from donors of both age groups in this 
investigation. DTPP at concentrations of 0.1µM or 0.25µM did not significantly alter 
the levels of oxidative DNA damage (endogenous or exogenously applied) . 
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Table 6.1. Summary of the results of the effect of different concentrations of mitoQ 
supplementation, on the levels of oxidative DNA damage in human peripheral 
blood mononuclear cells isolated from fresh human blood derived from ten 
different healthy donors, five each in the age groups of 25-30 years and 55-60 years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of mitoQ 
supplementation 
Length of mitoQ 
supplementation 
Endogenous 
DNA damage 
levels in 
mitoQ treated 
cells 
compared to 
untreated 
cells 
(controls) 
DNA damage 
levels in 
mitoQ treated 
cells subjected 
to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 1µM mitoQ 3 hours Significantly 
reduced 
Significantly 
reduced 
25-30 1µM mitoQ 6 hours Significantly 
reduced 
Significantly 
reduced 
55-60 1µM mitoQ 3 hours Significantly 
reduced 
Significantly 
reduced 
55-60 1µM mitoQ 6 hours Significantly 
reduced 
Significantly 
reduced 
25-30 0.5µM mitoQ 6 hours Significantly 
reduced 
Significantly 
reduced 
55-60 0.5µM mitoQ 6 hours Significantly 
reduced 
Significantly 
reduced 
25-30 0.25µM mitoQ 6 hours No significant 
changes 
Significantly 
reduced 
55-60 0.25µM mitoQ 6 hours No significant 
changes 
Significantly 
reduced 
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Table 6.2. Summary of the results of the effect of different concentrations of DTPP 
supplementation, on the levels of oxidative DNA damage in human peripheral 
blood mononuclear cells isolated from fresh human blood derived from ten 
different healthy donors, five each in the age groups of 25-30 years and 55-60 years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of DTPP 
supplementation 
Length of DTPP 
supplementation 
Endogenous 
DNA damage 
levels in 
DTPP treated 
cells 
compared to 
untreated 
cells 
(controls) 
DNA damage 
levels in 
DTPP treated 
cells subjected 
to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 1µM DTPP 6 hours No significant 
changes 
Significantly 
reduced 
55-60 1µM DTPP 6 hours No significant 
changes 
Significantly 
reduced 
25-30 0.5µM DTPP 3 hours No significant 
changes 
Significantly 
reduced 
25-30 0.5µM DTPP 6 hours No significant 
changes 
Significantly 
reduced 
55-60 0.5µM DTPP 3 hours No significant 
changes 
Significantly 
reduced 
55-60 0.5µM DTPP 6 hours No significant 
changes 
Significantly 
reduced 
25-30 0.25µM DTPP 6 hours No significant 
changes 
No significant 
changes 
55-60 0.25µM DTPP 6 hours No significant 
changes 
No significant 
changes 
 
The results warranted the use of vitamin E, a lipophilic non-mitochondria targeted 
antioxidant as controls. The acute exposure of vitamin E at concentrations of 37µM or 
74µM, on the levels of oxidative DNA damage (caused by endogenously produced and 
exogenously applied ROS) after 3 or 6 hours of supplementation in human peripheral 
blood mononuclear cells, as investigated revealed no antioxidant potential (Table 6.3).  
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Table 6.3. Summary of the results of the effect of different concentrations of 
vitamin E supplementation, on the levels of oxidative DNA damage in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years and 55-60 
years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of vitamin E 
supplementation 
Length of 
vitamin E 
supplementation 
Endogenous 
DNA damage 
levels in 
vitamin E 
treated cells 
compared to 
untreated 
cells 
(controls) 
DNA damage 
levels in 
vitamin E 
treated cells 
subjected to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 37µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
25-30 37µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
55-60 37µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
55-60 37µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
25-30 74µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
25-30 74µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
55-60 74µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
55-60 74µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
 
 
The overall summary of the effect of different concentrations of mitoQ, DTPP and 
vitamin E on the levels of oxidative DNA damage (endogenously produced and 
exogenously applied) in human peripheral blood mononuclear cells derived from donors 
of both age groups are illustrated in appendix-II. 
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Further investigations were conducted to examine the impact of chronic (up to three 
weeks of supplementation) exposure to mitoQ / DTPP on the levels of oxidative DNA 
damage in human peripheral blood mononuclear cells derived from six healthy, non-
smoking males fasted overnight, three each in the age groups of 25-30 and 55-60 years. 
None of the concentrations of mitoQ or DTPP used (10nM, 20nM, 30nM) significantly 
altered the levels of oxidative DNA damage of human peripheral blood mononuclear 
cells ex vivo during their span in culture. These concentrations of mitoQ were chosen 
based on the existing scientific literature, showing antioxidant potential of mitoQ at 
these concentrations in human fibroblasts (Saretzki et al., 2003).  
6.1.3.2. The effect of mitoQ on intracellular GSH:GSSG ratio and total 
glutathione levels in human peripheral blood mononuclear cells 
The effect of 0.5µM mitoQ on the GSH:GSSG ratio + / - H2O2 treatment in peripheral 
blood mononuclear cells derived from ten healthy, non-smoking males fasted overnight, 
five each in the age group of 25-30 years and 55-60 years, is illustrated (Figures 6.5A & 
6.5B). Control (unsupplemented) human peripheral blood mononuclear cells were 
grown in parallel to the mitoQ supplemented peripheral blood mononuclear cells and 
the GSH:GSSG ratio was determined in both supplemented and non-supplemented cells.  
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6.5A 
6.5B 
Figure 6.5 The effect of 0.5µM mitoQ on intracellular GSH:GSSG ratio in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age group of 25-30 years (6.5A) and 
55-60 years (6.5B), supplemented ex vivo. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
* p<0.05, ** p<0.01 - Significantly higher than control levels 
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Figures 6.5A and 6.5B show that 0.5µM mitoQ treatment resulted in a significantly 
higher GSH:GSSG ratio in peripheral blood mononuclear cells + / - H2O2 treatment. 
There was no significant difference in the levels of GSH:GSSG ratio in cells derived 
from donors of the two age groups and in the effect of H2O2 treatment in cells from 
either age group of donors. In all cases, there was a consistent decrease in levels of 
GSH:GSSG ratio with increase in concentration of H2O2 (0-250µM) treatment. 
Furthermore, the GSH:GSSG ratios observed between human peripheral blood 
mononuclear cells derived from each of the five different donors in each of the above 
cases were not significantly different (Figures 6.5A & 6.5B). 
 
The effect of 1µM mitoQ in peripheral blood mononuclear cells derived from donors 
from both age groups was similar to the effect of 0.5µM mitoQ (Table 6.4). 
 
The effect of 1µM DTPP on the levels of GSH:GSSG ratio with and without treatment 
of H2O2 in peripheral blood mononuclear cells derived from donors of both age groups, 
is illustrated (Figures 6.6A & 6.6B). Control (unsupplemented) human peripheral blood 
mononuclear cells were grown in parallel to the DTPP supplemented peripheral blood 
mononuclear cells and the GSH:GSSG ratio was determined in both supplemented and 
non-supplemented cells.  
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6.6A 
6.6B 
Figure 6.6 The effect of 1µM DTPP on intracellular GSH:GSSG ratio in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age group of 25-30 years (6.6A) and 
55-60 years (6.6B), supplemented ex vivo. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
** p<0.01 - Significantly higher than control levels 
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Figures 6.6A and 6.6B show that there were no significant changes in GSH:GSSG ratio 
(without exogenously applied ROS) on treatment with 1µM DTPP. However, 1µM 
DTPP treatment resulted in a significantly higher GSH:GSSG ratio in peripheral blood 
mononuclear cells treated with a range of doses of H2O2. There was no significant 
difference in GSH:GSSG ratio in cells derived from donors of the two age groups and in 
the effect of H2O2 treatment in cells from either age group of donors. The results 
showed a consistent decrease in levels of GSH:GSSG ratio with increase in 
concentration of H2O2 (0-250µM) treatment. Furthermore, the GSH:GSSG ratios 
observed between human peripheral blood mononuclear cells derived from each of the 
five different donors in each of the above cases were not significantly different (Figures 
6.6A & 6.6B). 
 
The results of the investigation of the effect of a lower dosage of DTPP (0.5µM) on the 
GSH:GSSG ratio in human peripheral blood mononuclear cells revealed no significant 
differences from the results of the effect of 1µM DTPP in peripheral blood mononuclear 
cells derived from donors from both age groups (Table 6.5). 
 
The effect of 0.5µM or 1µM mitoQ / DTPP after 6 hours of supplementation were not 
significantly different from the results obtained after 3 hours of supplementation in cells 
derived from donors of both age groups (Tables 6.4 & 6.5).  
 
The effect of 0.1µM mitoQ (Figures 6.7A & 6.7B) on the levels of GSH:GSSG ratio 
with and without H2O2 in peripheral blood mononuclear cells was also investigated.  
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6.7A 
6.7B 
Figure 6.7 The effect of 0.1µM mitoQ on intracellular GSH:GSSG ratio in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age group of 25-30 years (6.7A) and 
55-60 years (6.7B), supplemented ex vivo. The bars indicate the mean ± S.D. Values 
statistically different from their controls (Student’s t-test, 95% confidence level) 
are indicated with an asterix. 
* p<0.05, ** p<0.01, *** p < 0.001 - Significantly higher than control levels 
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Figures 6.7A and 6.7B did not reveal any significant changes in GSH:GSSG ratio 
(without exogenously applied ROS) on treatment with 0.1µM mitoQ. However, 0.1µM 
mitoQ treatment resulted in significantly higher GSH:GSSG ratio in peripheral blood 
mononuclear cells treated with a range of doses of H2O2. There was no significant 
difference in the levels of GSH:GSSG ratio in cells derived from donors of the two age 
groups and in the effect of H2O2 treatment in cells from either age group of donors. 
Furthermore, the results revealed a consistent decrease in GSH:GSSG ratio with 
increase in concentration of H2O2 (0-250µM) treatment. Furthermore, the GSH:GSSG 
ratios observed between human peripheral blood mononuclear cells derived from each 
of the five different donors in each of the above cases were not significantly different 
(Figures 6.7A & 6.7B). 
 
Further studies investigating the effect of another dosage of mitoQ (0.25µM) on the 
GSH:GSSG ratio in human peripheral blood mononuclear cells revealed no significant 
differences from the results of the effect of 0.1µM mitoQ in peripheral blood 
mononuclear cells derived from donors from both age groups (Table 6.4). 
 
In the next part of the investigation, the impact of 0.1µM or 0.25µM DTPP (control for 
mitoQ) on human peripheral blood mononuclear cells was investigated. The effect of 
0.1µM DTPP (Figures 6.8A & 6.8B) on the GSH:GSSG ratio with and without H2O2 
treatment in peripheral blood mononuclear cells is illustrated. Control (unsupplemented) 
human peripheral blood mononuclear cells were grown in parallel to the DTPP 
supplemented peripheral blood mononuclear cells.  
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6.8A 
 
6.8B 
 
Figure 6.8 The effect of 0.1µM DTPP on intracellular GSH:GSSG ratio in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age group of 25-30 years (6.8A) and 
55-60 years (6.8B), supplemented ex vivo. The bars indicate the mean ± S.D. 
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Figures 6.8A and 6.8B did not reveal any significant changes in the GSH:GSSG ratio 
with and without H2O2 treatment following 0.1µM DTPP treatment. There was no 
significant difference in the levels of GSH:GSSG ratio in cells derived from donors 
from the two age groups and the effect of H2O2 treatment in cells from either age group 
of donors. There was a consistent decrease in GSH:GSSG ratio with increase in 
concentration of H2O2 (0-250µM) treatment. Furthermore, the GSH:GSSG ratios 
observed between human peripheral blood mononuclear cells derived from each of the 
five different donors in each of the above cases were not significantly different (Figures 
6.8A & 6.8B). 
 
The results of the investigation of the effect of 0.25µM DTPP on cells derived from 
donors of both age groups were not significantly different from the effect of 0.1µM 
DTPP (Table 6.5). 
 
In summary, the results of acute exposure to mitoQ (0.1µM, 0.25µM, 0.5µM or 1µM) 
revealed higher GSH:GSSG ratio in cells treated with exogenously applied ROS. In 
addition, 0.5µM or 1µM of mitoQ reduced the radical levels evidenced by significantly 
higher GSH:GSSG ratio in various peripheral blood mononuclear cell samples derived 
from donors of both age groups in this investigation. DTPP, at concentrations of 0.1µM 
or 0.25µM did not significantly alter the GSH:GSSG ratio in cells treated with and 
without H2O2.  
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Table 6.4. Summary of the results of the effect of different concentrations of mitoQ 
supplementation, on the GSH:GSSG ratio in human peripheral blood 
mononuclear cells isolated from fresh human blood derived from ten different 
healthy donors, five each in the age groups of 25-30 years and 55-60 years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of  mitoQ 
supplementation 
Length of mitoQ 
supplementation 
Basal 
GSH:GSSG 
ratio in mitoQ 
treated cells 
compared to 
untreated 
cells 
(controls) 
GSH:GSSG 
ratio in mitoQ 
treated cells 
subjected to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 1µM mitoQ 3 hours Significantly higher 
Significantly 
higher 
25-30 1µM mitoQ 6 hours Significantly higher 
Significantly 
higher 
55-60 1µM mitoQ 3 hours Significantly higher 
Significantly 
higher 
55-60 1µM mitoQ 6 hours Significantly higher 
Significantly 
higher 
25-30 0.5µM mitoQ 6 hours Significantly higher 
Significantly 
higher 
55-60 0.5µM mitoQ 6 hours Significantly higher 
Significantly 
higher 
25-30 0.25µM mitoQ 6 hours No significant 
changes 
Significantly 
higher 
55-60 0.25µM mitoQ 6 hours No significant 
changes 
Significantly 
higher 
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Table 6.5. Summary of the results of the effect of different concentrations of DTPP 
supplementation, on the GSH:GSSG ratio in human peripheral blood 
mononuclear cells isolated from fresh human blood derived from ten different 
healthy donors, five each in the age groups of 25-30 years and 55-60 years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of DTPP 
supplementation 
Length of DTPP 
supplementation 
Basal 
GSH:GSSG 
ratio in DTPP 
treated cells 
compared to 
untreated 
cells 
(controls) 
GSH:GSSG 
ratio in DTPP 
treated cells 
subjected to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 1µM DTPP 6 hours No significant 
changes 
Significantly 
higher 
55-60 1µM DTPP 6 hours No significant 
changes 
Significantly 
higher 
25-30 0.5µM DTPP 3 hours No significant 
changes 
Significantly 
higher 
25-30 0.5µM DTPP 6 hours No significant 
changes 
Significantly 
higher 
55-60 0.5µM DTPP 3 hours No significant 
changes 
Significantly 
higher 
55-60 0.5µM DTPP 6 hours No significant 
changes 
Significantly 
higher 
25-30 0.25µM DTPP 6 hours No significant 
changes 
No significant 
changes 
55-60 0.25µM DTPP 6 hours No significant 
changes 
No significant 
changes 
 
Furthermore, vitamin E was used as controls. The acute exposure of vitamin E at 
concentrations of 37µM or 74µM, on the levels of the GSH:GSSG ratio after 3 or 6 
hours of supplementation in human peripheral blood mononuclear cells treated with and 
without H2O2 is revealed in table 6.6. 
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Table 6.6 Summary of the results of the effect of different concentrations of 
vitamin E supplementation, on the GSH:GSSG ratio in human peripheral blood 
mononuclear cells isolated from fresh human blood derived from ten different 
healthy donors, five each in the age groups of 25-30 years and 55-60 years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of vitamin E 
supplementation 
Length of 
vitamin E 
supplementation 
Basal 
GSH:GSSG 
ratio in 
vitamin E 
treated cells 
compared to 
untreated 
cells 
(controls) 
GSH:GSSG 
ratio in 
vitamin E 
treated cells 
subjected to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 37µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
25-30 37µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
55-60 37µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
55-60 37µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
25-30 74µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
25-30 74µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
55-60 74µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
55-60 74µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
 
 
The results of the supplementation of vitamin E at concentrations of 37µM or 74µM, on 
the levels of the GSH:GSSG ratio after 3 or 6 hours of supplementation in human 
peripheral blood mononuclear cells treated with and without H2O2 revealed no 
significant changes compared to controls (Table 6.6).  
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The overall summary of the effect of different concentrations of mitoQ, DTPP and 
vitamin E on the GSH:GSSG ratio (basal levels and GSH:GSSG ratio after treatment of 
cells with exogenously applied ROS) in human peripheral blood mononuclear cells 
derived from donors of both age groups are illustrated in appendix-II. 
 
The results of the investigation of the impact of chronic (up to three weeks of 
supplementation) exposure to mitoQ / DTPP on the levels of GSH:GSSG ratio revealed 
that none of the concentrations of mitoQ or DTPP applied in this study (10nM, 20nM, 
30nM) significantly altered the levels of GSH:GSSG ratio in human peripheral blood 
mononuclear cells ex vivo derived from donors of both age groups.  
 
In terms of total glutathione levels, there were no consistent changes on 
supplementation with any of the concentrations of mitoQ (0.1µM, 0.25µM, 0.5µM, 
1µM) or DTPP (0.1µM, 0.25µM, 0.5µM, 1µM) or vitamin E (37µM or 74µM) in 
human peripheral blood mononuclear cells treated with and without a range of doses of 
H2O2 in peripheral blood mononuclear cells derived from donors from both age groups. 
6.1.3.3. The effect of mitoQ on mitochondrial membrane potential in 
human peripheral blood mononuclear cells 
The effect of 0.1µM mitoQ (Figures 6.9A & 6.9B) or 0.5µM mitoQ on mitochondrial 
membrane potential in human peripheral blood mononuclear cells derived from six 
healthy, non-smoking males fasted overnight, three each in the age group of 25-30 years 
and 55-60 years, is illustrated. The mitochondrial membrane potential was measured 
with and without H2O2 treatment after 6 hours of supplementation with mitoQ. The 
mitochondrial membrane potential was determined in both supplemented and non-
supplemented cells. 
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6.9A 
6.9B 
Figure 6.9 The effect of 0.1µM mitoQ on mitochondrial membrane potential in 
human peripheral blood mononuclear cells isolated from fresh human blood 
derived from ten different healthy donors, five each in the age groups of 25-30 
years (6.9A) and 55-60 years (6.9B), supplemented ex vivo. The bars indicate the 
mean ± S.D. Values statistically different from their controls (Student’s t-test, 95% 
confidence level) are indicated with an asterix. 
* p<0.05, ** p<0.01, *** p < 0.001 - Significantly lower than control levels 
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Figures 6.9A and 6.9B indicate no significant changes in mitochondrial membrane 
potential on treatment with 0.1µM mitoQ. However, 0.1µM mitoQ treatment resulted in 
a significant increase (Student’s t-test, 95% confidence levels) in mitochondrial 
membrane potential in peripheral blood mononuclear cells treated with a range of doses 
of H2O2. There was no significant difference in the levels of mitochondrial membrane 
potential in cells derived from donors of the two age groups and in the effect of H2O2 
treatment in cells from either age group of donors. In all cases there was a consistent 
decrease in levels of mitochondrial membrane potential with increase in concentration 
of H2O2 (0-250µM). The mitochondrial membrane potential observed between human 
peripheral blood mononuclear cells derived from each of the five different donors in 
each of the above cases were not significantly different (Figures 6.9A & 6.9B). 
 
Further studies carried out on the effect of 0.5µM mitoQ on the mitochondrial 
membrane potential in cells derived from donors of both age groups revealed similar set 
of results to those of 0.1µM mitoQ supplementation. 
6.1.4. Discussion 
Mitochondrial dysfunction contributes to a wide range of diseases in humans (Chapter-1, 
Section 1.1.6.3; Chapter-6, Section 6.1.1). The main problem in treating those diseases 
is the inability to target an antioxidant in vivo to the mitochondria. This problem was 
rectified by the development of mitoQ. The mechanism of action of mitoQ has been 
described elsewhere in this thesis (Chapter-1, Section 1.1.6.3; Chapter-6, Section 6.1.1). 
 
Overall, the results of this investigation revealed that 0.5µM or 1µM mitoQ 
supplementation decreased the levels of free radicals in human peripheral blood 
mononuclear cell samples, from the donors of both age groups (25-30 and 55-60 year 
olds) evidenced by the significantly higher GSH:GSSG ratios (Figures 6.5A & 6.5B), 
compared to controls. Furthermore, the mitoQ supplementation decreased the levels of 
endogenous oxidative DNA damage (Figures 6.1A & 6.1B) in cell samples derived 
from both age groups. Lower concentrations of mitoQ (0.1µM or 0.25µM) did not have 
any impact on the GSH:GSSG ratio (Figures 6.7A & 6.7B) or on the levels of 
endogenous oxidative DNA damage (Figures 6.3A & 6.3B), in human peripheral blood 
mononuclear cell samples from the donors of both age groups.  
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All concentrations of mitoQ used in this investigation (0.1µM, 0.25µM, 0.5µM  or 1µM) 
resulted in a significantly higher GSH:GSSG ratio and a significant decrease in 
oxidative DNA damage levels following treatment with H2O2 in mitoQ supplemented 
cell samples. The results were interesting because although mitoQ is a mitochondria 
targeted antioxidant, it demonstrated significant antioxidant potential in the cytosol. The 
antioxidant potential of 1µM concentration of mitoQ outside the mitochondria 
evidenced by their effect on exogenously applied ROS, in this investigation was in line 
with the results of previous findings revealing blockage of 150µM H2O2 induced 
caspase activation in Jurkat cells by 1µM mitoQ (Kelso et al., 2001). The reason for the 
antioxidant potential outside the mitochondria may be that the mitochondria took up as 
much mitoQ as possible and the excess mitoQ accumulated in the cytosol with 
consequent radical lowering effects. Even though mitochondria are the major site for the 
production of ROS in cells, the results suggest that there are other sources of 
contributors to genomic DNA damage since endogenous oxidative DNA damage 
remains even at saturating concentrations of mitoQ. It could also be that the lower 
concentrations of mitoQ (0.1µM or 0.25µM) may be taken up by the mitochondria, but 
they were not sufficient to reduce free radical release from the mitochondria explaining 
no significant differences in endogenous DNA damage levels and the lack of changes to 
GSH:GSSG ratio. 
 
The ability of mitoQ at specific concentrations to scavenge radicals, resulting in a 
significantly higher GSH:GSSG ratio compared to controls, is invaluable considering 
the role of intracellular redox status (GSH:GSSG ratio) as a mediator of apoptosis in 
several cell systems (Slater et al., 1996; Cotgreave and Gerdes, 1998; Hall, 1999). GSH 
is a main determinant of intracellular redox status, and is known to become depleted 
before the onset of apoptosis (Beaver and Waring, 1995; Macho et al., 1997; Ghibelli et 
al., 1998). GSH is abundant in the cell (Schafer and Buettner, 2001), serving as an 
indicator of the cellular redox environment. The redox status of the cell is altered on 
oxidation of even a small amount of GSH. Oxidation of GSH results in GSSG coupled 
with decrease in the levels of GSH leading to the lowering of the GSH:GSSG ratio, 
suggested to be responsible for several human diseases (Chapter-1, Section 1.1.4.1.1). 
The higher GSH:GSSG ratio on mitoQ supplementation represents an increased 
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antioxidant status in cells that further explains the decrease in levels of oxidative DNA 
damage in cells on mitoQ supplementation. 
 
DTPP is a lipophilic mitochondria targeted compound having a similar structure to 
mitoQ, except for the ubiquinone derivative in mitoQ. The ubiquinone derivative is 
responsible for the antioxidant capability of mitoQ. Rather surprisingly, DTPP (0.5µM 
or 1µM) significantly decreased the DNA damage levels and reduced the radical levels 
(evidenced by significantly higher GSH:GSSG ratio) following treatment with H2O2 
(treatment after 3 or 6 hours of supplementation with DTPP) in peripheral blood 
mononuclear cell samples from both age groups. It may be that DTPP stimulated or up-
regulated other cellular antioxidants although there is no scientific evidence to support 
this hypothesis. According to existing scientific literature, only one previous study has 
shown the ability of 1µM DTPP to reduce succinate (a complex I substrate) driven ROS 
in isolated bovine aortic endothelial mitochondria in rats (Malley et al., 2006). But the 
mechanism was not explained. Lower concentrations of DTPP (0.1µM or 0.25µM) did 
not have any significant impact on free radical levels (GSH:GSSG ratio unchanged) and 
on DNA damage levels with and without H2O2 treatment in peripheral blood 
mononuclear cell samples from both age groups examined. 
 
Recent studies revealed the ability of vitamin E at a concentration of 37µM to reduce 
toxicity in murine splenocytes (Horton et al., 2007). In this investigation, the impact of 
37µM or 74µM concentrations of vitamin E (a non-mitochondria targeted antioxidant) 
on the levels of free radicals (determining the GSH:GSSG ratio) and oxidative DNA 
damage, in human peripheral blood mononuclear cells, was investigated. None of the 
concentrations of vitamin E resulted in significant changes in the levels of oxidative 
DNA damage or GSH:GSSG ratio in human peripheral blood mononuclear cells treated 
+ / - H2O2. Even though vitaimin E at 37µM concentration was able to reduce toxicity 
in murine cells, the concentrations used in this study may not be enough to reveal an 
antioxidant potential or free radical scavenging potential in human peripheral blood 
mononuclear cells ex vivo. Vitamin E targets the cell membranes since it is lipophilic 
and is known to prevent their oxidation. The reason for the lack of effect of vitamin E 
supplementation in human peripheral blood mononuclear cells compared to the murine 
cells could be due to the differences in cell types. It could be that the concentrations of 
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vitamin E used in this study may have been too low to cause an effect on the markers 
investigated in this study and these low concentrations could have been taken up by the 
cell membranes. Further investigations could be carried out using a higher range of 
vitamin E concenrations and analyse their impact on the markers of T cell integrity used 
in this study. Of further interest would be to determine the ROS production for different 
concentrations of vitamin E supplementations using flowcytometric analysis of samples 
subjected to 5-(and-6)-carboxy-2’,7’-dichlorofluorescein diacetate (DCFDA) staining. 
 
Investigations on the impact of a range of concentrations of mitoQ / DTPP / vitamin E 
on total glutathione levels, a marker of T cell integrity, revealed a lack of consistent 
changes in levels of total glutathione on administration of any of the concentrations of 
mitoQ or DTPP (0.1µM, 0.25µM, 0.5µM, 1µM) or vitamin E (37µM or 74µM) in 
human peripheral blood mononuclear cells derived from donors of both age groups, in 
this investigation. This result reveals that none of these supplements in any way had an 
impact on glutathione pathways, and therefore the lack of significant changes in 
glutathione levels, in the mononuclear cells examined. 
 
Mitochondrial membrane potential is another marker of T cell integrity that plays an 
important role in apoptosis (Chapter-2, Section 2.1.8). The results of this investigation 
indicated no significant changes in mitochondrial membrane potential in human 
peripheral blood mononuclear cells on treatment with 0.1µM or 0.5µM mitoQ. However, 
0.1µM (Figures 6.9A & 6.9B) or 0.5µM mitoQ treatment resulted in a significant 
increase in mitochondrial membrane potential on treatment with a range of doses of 
H2O2 in cells derived from donors of both age groups. In the existing scientific literature 
only one previous study has revealed the maintenance of mitochondrial membrane 
potential on supplementation with 1µM mitoQ. This study was performed in vitro in 
isolated mitochondria in rat models where 1µM mitoQ treatment decreased ROS 
production, thereby, protecting the mitochondria from damage and resulted in 
maintenance of the mitochondrial membrane potential (Lowes et al., 2008). 
Furthermore, mitoQ suppressed the release of pro-inflammatory cytokines and increased 
the release of anti-inflammatory cytokines from the cells in the in vitro study conducted 
in rat models. 
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Previous studies have revealed antioxidant potential on chronic exposure to mitoQ at 
concentrations of 10-20nM in MRC-5 fibroblasts evident by telomere shortening 
(Saretzki et al., 2003). In this investigation the impact of chronic exposure of 10-30nM 
concentrations of mitoQ / DTPP in human peripheral blood mononuclear cells derived 
from donors of both age groups was investigated. None of the concentrations of mitoQ 
or DTPP (10nM, 20nM or 30nM) caused any significant alterations which was reflected 
in a lack of change to free radical levels (unchanged GSH:GSSG ratio), oxidative DNA 
damage levels and total glutathione levels. From the little information available in the 
existing scientific literature, on the effects of chronic exposure of mitoQ in cells in vitro 
and ex vivo, only one other recent study investigated the effects of chronic exposure of 
mitoQ. However, the study was performed in isolated mitochondria. The results 
revealed the potency of 1µM mitoQ after a week of supplementation to decrease 
oxidative stress, evidenced by a decrease in mitochondrial damage and maintenance of 
mitochondrial membrane potential in isolated mitochondria in human achilles tendon 
cells (Lowes et al., 2009). 
 
MitoQ has revealed significant antioxidant potential previously in other cell and animal 
models. The findings of this current investigation in human peripheral blood 
mononuclear cells are consistent with the earlier findings revealing the antioxidant 
potential of mitoQ. Although mitochondria are the major site for the production of ROS 
in cells, there may be other potential sources that are major contributors of genomic 
DNA damage. Well functioning mitochondria is a pre-requisite for human life. A 
decrease in the respiratory function of mitochondria in human tissues and an increase in 
mtDNA damage are some of the age related moleculer changes observed within 
mitochondria affecting mitochondrial integrity and function (Hayakawa et al., 1993). 
However, this study has shown that the use of carefully selected concentrations of 
mitoQ may be a viable strategy to decrease harmful levels of free radicals in human 
peripheral blood mononuclear cells ex vivo, to help manage oxidative stress levels and 
elements of the resultant age-related decline in T cell structure and function. 
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7.1. An investigation of the impact of low O2 tension on 
cultured human peripheral blood mononuclear cells 
7.1.1. Introduction 
An investigation into the effects of reduced O2 tension on T cells was carried out as part 
of collaboration with the Centre for Medical Research, Tuebingen Ageing and Tumor 
Immunology Group, University of Tuebingen, Germany. The work was done as part of 
the research project funded by The European Union 5th framework T cells in aging (T-
CIA). The group of Barnett has collaborated with the Tuebingen Ageing and Tumor 
Immunology group, led by Professor Graham Pawelec for nearly ten years.  
 
T cell models ex vivo and in vitro have been invaluable in immunological research, 
enabling the generation of huge amount of information about physiological and 
pathological T cell behaviours. Studies with T cell models enable the mimicking of in 
vivo conditions. Most of the experiments carried ex vivo and in vitro are with 5% CO2, 
95% air (20% O2) (Hyland et al., 2000; 2001; de Souza, 2007). The percentage of O2 in 
these systems is much higher than that encountered by T cells in vivo. The O2 levels in 
peripheral blood are much lower than in air. The levels of O2 also depend on the size of 
the arteries. The smaller the arteries the lower the O2 level. Regardless of the existing 
discrepancies, there is a consensus that the O2 level experienced by T cells may vary 
from 1% to 10% (Caldwell et al., 2001; Atkuri et al., 2007).  
 
ROS have been implicated to be responsible for the intrinsic oxidative damage in cells, 
ultimately playing an important role in ageing and the development of age related 
pathologies. Many different studies have elaborated the importance of O2 tension to 
cellular senescence and lifespan (Chapter-1, summarised in section 1.1.6.4). Previous 
work from the group of Barnett demonstrated a shorter lifespan and reduced 
proliferative capacity in T cell clones derived from young and old human donors when 
cultured in fewer than 6% O2 tension, compared to clones cultured fewer than 20% O2 
tension (Chapter-1, Table 1.13 & Table 1.14). The oxidative damage to DNA in T cell 
clones cultured at 6% O2 tension remained low throughout their lifespan, compared to 
the clones cultured at 20% O2 tension due to lower levels of ROS (Chapter-1, Figure 
1.16;  Duggan et al., 2004). Even though ROS are pre-dominantly associated with 
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causing detrimental effects on cellular molecules, they do act as signals / mediators of 
cell division within T cells (summarized in chapter-1, Section 1.1.6.4). Limited ROS 
levels, fewer than 6% O2 may have led to the reduction in proliferation in T cell clones 
compared to clones maintained at 20% O2 tension. Other studies have also reported loss 
of T cell proliferative capacity with low O2 levels (Atkuri et al., 2007). In the study 
reported in this chapter the impact of low O2 tension on human peripheral blood 
mononuclear cells ex vivo was investigated. 
7.1.2. Materials and Methods 
7.1.2.1. Culture of human peripheral blood mononuclear cells (work 
carried out by Larbi et al., as part of the collaboration) 
Blood samples derived from three different healthy middle aged individuals at the 
University Hospital Blood Bank, courtesy of Prof. D. Wernett, were processed using 
FicoLite-H (Linaris, Germany) to separate human peripheral blood mononuclear cells. 
The ex vivo human peripheral blood mononuclear samples were then re-suspended in 
serum free culture medium X-Vivo 10 at concentrations of 1-5 x 106 cells/ml. The 
samples were left unstimulated or stimulated with anti-CD3 and anti-CD28 coated 
beads (Dynabeads, Karlsruhe). Stimulation of T cells were carried out to enhance their 
growth. Samples were prepared in duplicates, with half being placed in the hypoxia 
work station in 2% O2 balanced with nitrogen and the other half in a regular incubator 
where cells were grown in air supplemented with 5% CO2 for 1 to 4 days. The samples 
were frozen down for analysis at the end of every day (Chapter-2, Section 2.1.1.2). 
7.1.2.2. Assessment of levels of oxidative DNA damage 
The levels of oxidative DNA damage in human peripheral blood mononuclear samples 
ex vivo maintained for 1 to 4 days at 2% or 20% O2 tension culture conditions were 
measured at NTU using the modified alkaline comet assay (Chapter-2, Section 2.1.10). 
7.1.2.3. GSH:GSSG ratio 
The GSH:GSSG ratio in human peripheral blood mononuclear samples ex vivo under 
both O2 tensions was measured at NTU using the GSH:GSSG ratio assay kit (Chapter-2, 
Section 2.1.11). 
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7.1.3. Results 
7.1.3.1. The effect of low O2 tension on levels of oxidative DNA damage 
in human peripheral blood mononuclear cells ex vivo  
Aliquots of unstimulated or stimulated human peripheral blood mononuclear samples ex 
vivo were taken from culture maintained at 2% or 20% O2 tension conditions at the end 
of each day from day 1 to day 4. Figure 7.1A shows the oxidative DNA damage levels 
at the end of each day from day 1 to 4 of human peripheral blood mononuclear cells 
stimulated with beads. Figure 7.1B shows the oxidative DNA damage levels at the end 
of each day from day 1 to 4 of unstimulated human peripheral blood mononuclear cells.  
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7.1A 
7.1B 
 
Figure 7.1 The impact of 2% or 20% O2 tension on oxidative DNA damage levels 
at the end of each day, days 1 to 4 of culture, in human peripheral blood 
mononuclear cells derived from three different middle aged donors stimulated (A) 
and unstimulated (B) cells. The bars indicate the mean ± S.D. Values statistically 
different from their controls (Student’s t-test, 95% confidence level) are indicated 
with an asterix. 
* p < 0.05 - Significantly higher than damage levels in samples maintained at 20% 
O2. 
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Figure 7.1A and 7.1B shows a significantly higher level of oxidative DNA damage in 
human peripheral blood mononuclear cells maintained at 2% O2 tension culture 
conditions compared 20% O2 tension culture conditions. Significantly higher levels of 
oxidative damage to DNA were observed in stimulated (Figure 7.1A) and unstimulated 
samples (Figure 7.1B) maintained at 2% O2, at the end of each day from 1 to 4. There 
was no significant difference in the percentage of DNA in the comet tail in unstimulated 
and stimulated samples for any of the culture conditions.  
7.1.3.2. The effect of low O2 tension on the GSH:GSSG ratio in human 
peripheral blood mononuclear cells 
Aliquots of unstimulated or stimulated human peripheral blood mononuclear samples ex 
vivo were taken from culture maintained at 2% or 20% O2 tension conditions at the end 
of day 2 and day 4. Figure 7.2A shows the results of the effect of 2% or 20% O2 tension 
on the GSH:GSSG ratio at the end of day 2 and day 4 of human peripheral blood 
mononuclear cells stimulated with beads. Figure 7.2B shows the results of the effect of 
2% or 20% O2 tension on the GSH:GSSG ratio at the end of day 2 and day 4 of 
unstimulated human peripheral blood mononuclear cells.  
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7.2A 
7.2B 
 
 
Figure 7.2 The impact of 2% or 20% O2 tension on the GSH:GSSG ratio of human 
peripheral blood mononuclear cells derived from three different middle aged 
donors  stimulated (A) and unstimulated (B) cells at the end of day 2 and day 4 in 
culture. The bars indicate the mean ± S.D. Values statistically different from their 
controls (Student’s t-test, 95% confidence level) are indicated with an asterix. 
* p < 0.05, *** p < 0.001 - Significantly lower GSH:GSSG ratio compared to cells 
maintained at 20% O2 tension culture conditions. 
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Figures 7.2A and 7.2B shows a significantly lower level of GSH:GSSG ratio in human 
peripheral blood mononuclear cells maintained at 2% O2 tension culture conditions 
compared 20% O2 tension culture conditions. Significantly lower level of GSH:GSSG 
ratio were observed in stimulated (Figure 7.2A) and unstimulated samples (Figure 7.2B) 
maintained at 2% O2, at the end of days 2 and 4. There was no significant difference in 
the GSH:GSSG ratio in stimulated samples when compared to untreated samples in any 
of the culture conditions.  
7.1.4. Discussion 
Prior to this investigation being carried out, there was little information in the scientific 
literature on the impact of low O2 tension culture conditions in human peripheral blood 
mononuclear cells ex vivo and in vitro. It is important to study the effect of low O2 
tension in studies investigating the effect of oxidative stress considering the fact that the 
intracellular O2 level is much lower than the O2 level in the cells maintained in an 
extracellular environment. Previous studies have shown that cell culture media in air 
contained 2% of O2 as rapidly as 4 hours after they were transferred from air (20% O2) 
to a 2% O2 incubator proving that extracellular environment of cells rapidly equilibrated 
to the ambient O2 level on tranfer to low O2 conditions (Newby et al., 2005).  
 
The results of the study reported in this chapter revealed a significantly lower levels of 
oxidative DNA damage and significantly higher GSH:GSSG ratio in human peripheral 
blood mononuclear cells (stimulated or unstimulated) maintained at 20% O2 tension 
culture conditions, compared to cells maintained at 2% O2 tension culture conditions.  
 
In addition to the two markers of T cell integrity investigated in NTU as part of this 
study, other markers of T cell integrity and function were also investigated as part of the 
overall investigation in The University of Tuebingen by the group of Professor Graham 
Pawelec. Cell adaptation to a low O2 level is associated with the up-regulation of 
hypoxia inducible factor-1α (HIF-1α). HIF-1α pathway is known to have different 
effects on the post-translational modification of proteins and can influence a broad 
range of cellular pathways by acting at the transcription level (Lukashev et al., 2006). 
The results showed high antioxidant capacity in the culture media evidenced by an up-
regulation of HIF-1α under low O2 tension determined by western blotting. The high 
antioxidant capacity observed in the culture media was not reflected in the function of T 
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cells. T cells had significantly lower proliferative capacity and stimulated cells were 
significantly more susceptible to apoptosis at low O2 tension, compared to 20% O2 
tension. Proliferative capacity and the rate of apoptotis were investigated by carrying 
out carboxyfluorescein succinimidyl ester (CFSE) and Annexin staining respectively. 
The reason for the differences in antioxidant capacity of the media, compared to those 
inside the cells, could be due to the differences in molecular exchanges between the 
cells and the environment at different O2 levels. The results of this investigation 
contradicted the earlier findings by other studies (Atkuri et al., 2005) where the O2 level 
did not influence the proliferative capacity of human peripheral blood mononuclear 
cells stimulated by phytohemagglutinin (PHA) or the cell viability in unstimulated cells.  
 
Furthermore, investigations were carried out on the intracellular redox status 
(GSH:GSSG ratio) and whether the intracellular antioxidant capacity protected against 
oxidative damage to proteins. Reduced GSH is a low molecular weight thiol playing an 
important role in cellular defense system in the body scavenging peroxide radicals and 
reduces oxidised sites of proteins, DNA and lipids. The GSH:GSSG redox couple 
maintains the redox environment of the cell and GSH is abundant in the cell (Schafer 
and Buettner, 2001) serving as an indicator of the cellular redox environment. Redox 
status of the cell is hindered on oxidation of even a small amount of GSH. This 
oxidation results in the formation of GSSG and mixed disulfides between protein 
sulfhydryl groups in biological systems. It will also decrease the levels of GSH resulting 
in an increase in levels of GSSG and so lowering the GSH:GSSG ratio, which has been 
suggested to be responsible for several human diseases (Bonnefont Rousselot et al., 
2000; Kharb, 2000; Lang et al., 2000; Mills et al., 2000; Pastore et al., 2001). The 
results showed (as shown in figures 7.2A & 7.2B) a significantly lower GSH:GSSG 
ratio in human peripheral blood mononuclear cells ex vivo maintained at low O2 tension 
compared to 20% O2 tension. Of further interest were the results of the carbonyl group 
formation (an index of global protein oxidation leading to oxidative damage in proteins) 
on intracellular proteins using oxy blot technique. This technique revealed significantly 
higher levels of carbonyl group formation in stimulated human peripheral blood 
mononuclear cells ex vivo maintained at low O2 levels compared to 20% O2 levels. 
 
The significantly higher oxidative damage to proteins was later explained by the 
reduced Msr and proteasome activities using their respective enzyme assay kits. Msr A 
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and Msr B catalyze the reversion of methionine-S-sulfoxide and methionine-R-
sulfoxide, respectively to the reduced form of methionine within proteins. Methionine 
can be easily oxidized into methionine sulfoxide and its reduction by methionine 
sulfoxide reductase (Msr) A (Yermolaieva et al., 2004) and Msr B2 (Carbreiro et al., 
2008) could represent an efficient antioxidant system, because in proteins, the surface-
exposed methionine residues can act as scavengers of a variety of oxidants (Levine et 
al., 1996). The proteasome system has been implicated in the degradation of oxidatively 
modified proteins (Poppek and Grune, 2006). The proteasome is also involved in 
regulating protein content and degrading misfolded proteins. The loss of efficiency of 
intracellular protective and repair mechanisms of proteins has been implicated in 
cellular senescence in vitro (Petropoulos et al., 2005). At the protein level, only a slight 
up-regulation of Msr and proteasome subunit expression was observed following 
activation under low O2 tension. The increased carbonylation of proteins was associated 
with the increased amount of DNA damage under low O2, suggesting overall increased 
oxidation in the presence of low O2 tension. The increase in oxidation may be due to the 
inefficient Msr and proteasome activities. The results of the study of human peripheral 
blood mononuclear cells ex vivo under low O2 tension, suggested a problem in molecule 
exchange between T cells and the extracellular milieu. It is possible that antioxidants 
present in the media are not available any longer to T cells at low O2 because of a still 
unknown mechanism. It could be due to changes in membrane potential, fluidity or 
integrity. The increased intracellular protein and DNA damage observed under 
decreased O2 may be due to free radical production resulting in changes to the 
respiratory chain and signalling processes. Other studies have revealed the increased 
free-radical cytotoxicity to Jurkat cells under lower O2 levels (Chen et al., 2008) 
evidenced by increased lipid peroxidation, release of cytochrome c and apoptosis under 
low O2. Activated cells may experience even more free radical production, as suggested 
by the increased apoptotic rate, compared to resting cells, in the present study. T cells in 
vivo are normally exposed to O2 tension conditions of less than 20%. Even though they 
proliferate better at 20% O2, this does not reflect their real physiology. The results 
suggest a far more complicated mechanism yet to be fully unveiled. 
 
Further investigations are being performed by the group of Pawelec in order to 
understand how T cell intracellular redox homeostasis is modulated at physiological O2 
level. 
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8.1. General discussion 
Age-related deterioration and dysregulation of T cell function, termed 
‘immunosenescence’, may lead to increased mortality and morbidity in humans through 
greater susceptibility to infections and disease. Previous research from the group of 
Barnett, suggested that oxidative stress may play a role in the immunosenescence 
process, through causing genomic instability and cell cycle delay and arrest. Previous 
work has demonstrated an age-related increase in oxidative DNA damage and mutations 
in T lymphocytes (in vitro T cell clones and also ex vivo cells) (Barnett & Barnett, 1998; 
Hyland et al., 2000). 
 
The aim of this research program was to investigate the effect of antioxidants on T cell 
function and integrity using T cell clones and peripheral blood mononuclear cells from 
human donors of different ages. The effect of different concentrations of the 
antioxidants, ebselen or NAC or mitoQ on: the life span and proliferative capacity; 
levels of oxidative damage to DNA; intracellular redox tone status (GSH:GSSG ratio); 
total glutathione levels; mitochondrial integrity and function and the effect of low O2 
tension culture conditions on human peripheral blood mononuclear cells ex vivo has 
been examined. 
 
The monoclonal human in vitro T cell clone model is well established (Pawelec et al., 
2000) and has been pre-dominantly useful for the study of age associated changes in 
individual T cells over their lifespan and for the study of factors contributing to T cell 
senescence (Pawelec et al., 2002). Previously, the in vitro T cell clone model has been 
successfully and extensively used by the group of Barnett (Barnett et al., 1999; Hyland 
et al., 2000; 2001; Duggan et al., 2004; Annett et al., 2004; 2005). The use of this 
monoclonal model enables the manipulation of immunosenescence in vitro which may 
in future lead to the manipulation of immunosenescence in vivo due to the similarities 
between T cells in vivo and the in vitro T cell clone model (Chapter-1, Section 1.1.3.8). 
The monoclonality of T cell clones is a distinct advantage, the changes observed in 
polyclonal systems may be due to the alterations in the proportions of the different cells 
present (Pawelec et al., 2002) and thus results from polyclonal systems are difficult to 
intepret. For example, in a polyclonal population only the longevity of the last surviving 
clone from the original polyclonal population can be measured. The use of the 
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monoclonal in vitro model alongside ex vivo derived polyclonal cells in this study 
permitted a comparison of the effect of antioxidants on a range of cellular biomarkers 
detailed above, within both systems. 
 
The results of previous studies gave further insight into the growth characteristics of T 
cell clones and revealed that all CD4+ T cell clones undergo apoptosis at the end of their 
lifespan, resulting in complete deletion of a clone within a single culture cycle (Pawelec 
et al., 2002). The results of this current study revealed that T cell clones had 
considerably higher levels of growth (determined by analysing population doublings 
undergone) at the start of the culture compared to the later stages of their life span in 
culture (Appendix-I, Figures 1-12). The regression analysis data determining the 
relationship between PD per week and the in vitro age of the T cell clones (as revealed 
in table 3.2), suggested a decreased PD capacity with age evidenced by a significant 
downward slope reaching statistical significance for the complete lifespan data, in the 
regression analysis curve. However, after the initial peak values, the remainder of the 
lifespan of the clones transitioned into a steady state, demonstrating the maintenance of 
PD capacity throughout the lifespan of the clones. The results of this investigation were 
in line with the previous findings of the group of Barnett and also the group of Pawelec 
using human peripheral blood derived CD4+ T cell clones (Hyland et al., 2000; Pawelec 
et al., 2002). 
 
All twelve CD4+ T cell clones examined in this investigation, grew in waves of 
maximal and minimal rates of proliferation variable from one to several growth cycles 
in length during the early part of their lifespan (as indicated in figure 3.1 and figures 1-
12 in appendix-I). However, the size or length of the waves decreased with increase in 
wave frequency towards the later stages of their lifespan. This finding was similar to 
that previously reported (Hyland et al., 2000). The decrease in size and length of the 
waves observed in T cell clones towards the later stages of their lifespan may be an 
indication of a frequency in cell cycle arrest due to the age-related accumulation of 
oxidative DNA damage in T cell clones in vitro (Barnett and Barnett, 1998; Hyland et 
al., 2000; 2001; Chapter-4). Thus, if in sufficient levels, DNA damage could result in 
DNA damage mediated cell cycle arrest halting the proliferation of the T cells to give 
the cells time to repair their damage and finally high enough levels of DNA damage 
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may result in apoptosis (Barnett and Barnett, 1998). The increase in frequency of the 
waves towards the later stages of a T cell clone’s lifespan data is evidence of their 
ability to retain their responsiveness to proliferative stimulation (Hyland et al., 2000; 
Pawelec et al., 2002). 
 
T cells are supposed to undergo rapid clonal expansion upon antigenic stimulation to 
produce an effective immune response. There are seveal factors which may affect the 
ability of T cells to undergo clonal expansion. Accumulation of genetic damage within 
T cells is one of the factors and this may contribute to an age related decline in T cell 
replicative capacity through cell cycle arrest, apoptosis or selection against T cells 
containing mutations (Barnett and Barnett, 1998). Previous findings from the group of 
Barnett suggested maintenance of low levels of oxidative DNA damage in vivo and 
significantly higher plasma antioxidant capacity in Swedish nonagenarian (people 
between 90 and 100 years of age) subjects compared to controls (Hyland et al., 2002), 
further emphasising the importance of a relationship between intact immune function 
and longevity. If oxidative damage to DNA in T cells results in a decline of function 
with age, it would be of benefit to identify interventions to counteract the age related 
increase in oxidative damage to DNA in vivo. Theoretically, one way to do this is to use 
antioxidant administration. Previous findings from the group of Barnett, successfully 
demonstrated the antioxidant capability of carnosine and PBN in human T cell clones. 
Carnosine, at physiological concentrations of 20mM significantly increased the lifespan 
and lowered the levels of oxidative DNA damage in T cell clones derived from a 
healthy young subject and which were exposed to carnosine throughout their lifespan 
(Hyland et al., 2000). 250µM PBN increased the longevity and significantly lowered the 
levels of DNA damage in T cell clones compared to controls. 
 
In this current PhD investigation, the impact of long term exposure (throughout the 
lifespan of clones or from the midpoint of their in vitro lifespan) of a range of 
concentrations of the in vivo relevant antioxidants, ebselen or NAC on markers of T cell 
function (proliferative capacity and lifespan) and integrity (levels of oxidative DNA 
damage, GSH:GSSG ratio and total glutathione levels) in human peripheral blood 
derived CD4+ T cell clones was investigated. In spite of the well documented 
antioxidant potential of ebselen or NAC which had been reported for several cell types 
(explained in detail in chapter-1, Section 1.1.6.1, 1.1.6.2; Chapter-4, Section 4.1.2.4), 
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the impact of ebselen or NAC in human peripheral blood derived CD4+ T cell clones in 
vitro had been determined.  
 
The results of this investigation revealed that, from the range of concentrations of 
ebselen or NAC investigated, 30µM ebselen or 7.5mM NAC significantly extended the 
lifespan (cumulative PD at the end of the lifespan) of CD4+ T cell clones derived from a 
healthy 26 year old donor and a healthy 45 year old donor when supplemented from a 
young in vitro age. T cell clones derived from a healthy 26 year old donor and a healthy 
45 year old donor supplemented with 30µM ebselen survived for an additional three and 
two weeks respectively before apoptosis, compared to non-supplemented clones. 
7.5mM NAC supplementation extended the lifespan of clones for 2 additional weeks in 
culture before apoptosis, compared to the non-supplemented clones. Furthermore, 
30µM ebselen or 7.5mM NAC significantly decreased the levels of oxidative damage to 
DNA and the GSH:GSSG ratio  was significantly higher after 14 weeks of 
supplementation in both CD4+ T cell clones when supplemented from their young in 
vitro age, compared to non-supplemented clones. The antioxidant potential of ebselen 
evident by their effect on markers of T cell integrity and function investigated above is a 
sign of fewer radicals present in culture or the radical scavenging capacity of ebselen. In 
terms of NAC, cysteine amino acid present is a derivative of GSH formation explaining 
the increase in GSH:GSSG ratio. The significantly higher GSH:GSSG ratio on 
supplementation with ebselen or NAC, represents an increased antioxidant state. The 
increase in antioxidant status further explains the decrease in levels of oxidative DNA 
damage that in turn explains a lower apoptotic state explained by the extended lifespan 
of the clones on antioxidant supplementation. In terms of total glutathione levels, 
neither of the antioxidants significantly altered the total glutathione levels in either of 
the CD4+ T cell clones (detailed in results section 4.1.3.3 in chapter-4). This result 
reveals that none of the antioxidant supplementations had an impact on glutathione 
pathways in any way resulting in the lack of significant changes in glutathione levels, in 
the T cell clones examined. 
 
Of further interest was the lack of a significant change in proliferative capacity or 
lifespan in T cell clones derived from either age groups of donors on supplementation 
from the midpoint of their in vitro age (58.7 & 63.4 Initial PD) with any of the 
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concentrations of ebselen or NAC. In terms of the levels of oxidative damage to DNA 
and the GSH:GSSG ratio, neither of the antioxidant’s supplementation significantly 
altered the levels of DNA damage or the GSH:GSSG ratio in T cell clones, compared to 
non-supplemented clones, at any of the time points examined during their span in 
culture. This pattern of results were in line with the previous findings from the group of 
Barnett that revealed no significant changes in longevity in CD4+ T cell clones on long 
term culture with 20mM Carnosine from the midpoint of their in vitro lifespan (Hyland 
et al., 2000). The suggested reason for the failure of carnosine to reveal its antioxidant 
potential may have been the high background of biomolecule damage that already 
existed in these T cells accumulated during earlier stages of their lifespan under 
conditions of 20% O2 that may have decreased the antioxidant or free radical 
scavenging potential of carnosine. There may be more radicals in older T cell clones 
that may affect the function of mitocondria and other defense systems in the body. So 
the antioxidants at specific concentrations, able to reveal an antioxidant potential in T 
cell clones supplemented from a young in vitro age may not be enough to reveal an 
antioxidant potential in old aged T cell clones. This could be the reason for the failure of 
ebselen or NAC at specific concentrations to reveal an antioxidant potential in clones 
when supplemented from the midpoint of their lifespan. It would also be worth noting 
the decrease in other markers of T cell integrity with age revealed in the existing 
scientific literature for example: DNA repair capacity and HSPs. The DNA repair 
capacity in T cells in vitro has been shown to decline with age, revealed in previous 
studies by the group (Annett et al., 2004; 2005; Chapter-1, Section 1.1.5.5.1 & 
1.1.5.5.2). Furthermore, HSPs activity has been demonstrated to decline in response to 
age making the body more susceptible to stress induced damage (Favatier et al., 1997; 
Chapter-1, Section 1.1.5.2). 
 
Higher concentrations of ebselen (60-100µM) or NAC (10mM) in human peripheral 
blood derived CD4+ T cell clones from a healthy young or middle aged donor 
completely inhibited the growth of T cell clones. The reason for this inhibition could be 
the complete scavenging of intracellular oxygen free radicals, contributing to the 
inhibition of the growth of the CD4+ T cell clones. Although, in excessive amounts ROS 
can be harmful molecules, at less critical levels they have an important role in T cell 
signalling events such as protein tyrosine phosphorylation and activation of JNK (Pani 
et al., 2000), which has been previously explained elsewhere in this thesis (Chapter-1, 
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Section 1.1.6.4). Previous studies have demonstrated a significant increase in 
intracellular GSH depletion with an increase in ebselen concentration in HepG2 cells 
(Yang et al., 2000). Ebselen has the ability to bind with GSH to form ebselen selenyl 
sulphide (Haenen et al., 1990). Ebselen selenyl sulphide reacts with excess of GSH to 
form ebselen selenol intermediate that in turn reacts with peroxides (Morgenstern et al., 
1992). Ebselen selenol intermediate can further react with ebselen selenyl sulphide to 
form ebselen diselenide. Ebselen diselenide can further react with peroxides resulting in 
intracellular GSH depletion that leads to induction of apoptosis (Yang et al., 2000) or 
cells succumbing to stress (Maher, 2005). In terms of NAC, supplementation with high 
concentrations of 10mM, may have completely scavenged the ROS which are important 
in less critical levels for cell proliferation and differentiation, which explains the 
complete inhibition of the growth of the clones at 10mM NAC concentration. 
 
The impact of 30µM Ebselen or 7.5mM NAC revealing antioxidant potential in human 
peripheral blood derived CD4+ T cell clones in vitro, a monoclonal population (Chapter-
4) lead to the investigation of the impact of these specific concentrations of ebselen or 
NAC in human peripheral blood mononuclear cells ex vivo, a polyclonal population 
(Chapter-5). Preliminary studies in human peripheral blood derived CD4+ T cell clones 
supplemented from the midpoint of their in vitro lifespan with 5mM NAC revealed 
higher lifespan compared to clones supplemented with other concentrations of NAC 
(Chapter-4). This factor was also taken into consideration before choosing the dose 
range of ebselen or NAC. Since the clones used in the previous part of the investigation 
in this study were human CD4+ T cell clones (Chapter-4), the impact of ebselen (30µM) 
or NAC (5mM / 7.5mM) on CD4+ T cells ex vivo were also investigated (Chapter-5) to 
compare the effect of the antioxidants on CD4+ T cells ex vivo and in vitro. In addition, 
the study has facilitated the investigation of the impact of age of the donors on markers 
of T cell integrity and function by comparing the proliferative capacity, the levels of 
oxidative DNA damage, GSH:GSSG ratio and total glutathione levels. 
 
The results of this part of the investigation revealed that the supplementation of human 
peripheral blood mononuclear cells and CD4+ T cells ex vivo derived from donors from 
either age groups, with 30µM ebselen or 5mM/ 7.5mM NAC resulted in a significantly 
higher GSH:GSSG ratio, total glutathione levels and proliferative capacity at various 
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time points during their span in culture compared to non-supplemented human 
peripheral blood mononuclear cells (detailed in results section 5.1.3 in chapter-5). The 
elevation of the GSH:GSSG ratio on supplementation with 30µM ebselen or 5mM / 
7.5mM NAC is of significance considering the important role of intracellular redox 
status (GSH:GSSG ratio) as a mediator of apoptosis in many cell systems (Cotgreave 
and Gerdes, 1998; Hall, 1999; Chapter-1, Section 1.1.4.1). The significantly higher 
GSH:GSSG ratio represents an improved antioxidant state for the ebselen or NAC 
treated cells. Previous studies have demonstrated the ability of ebselen at concentrations 
of 1-25µM to stimulate cell growth, inhibit H2O2 induced suppression, significantly 
reduce LDH leakage and lipid peroxidation and significantly reduced intracellular ROS 
levels in HepG2 cells in a concentration dependent manner, due to its ability to scavenge 
hydroxyl radicals and other ROS (Yang et al., 1999). In terms of NAC, other studies 
investigating the effect of a range of NAC concentrations (0.5-2mM) in HeLa cells have 
shown that 2mM NAC increased intracellular GSH by 15% compared to controls after 
24hrs of incubation (Hansen et al., 2004). In HepG2 cells, the increase in intracellular 
GSH level was highest after 5mM NAC supplementation for 24hrs (Yang et al., 2000) 
(detailed in the discussion section 5.1.4 in chapter-5). 
 
The results of this investigation also revealed a significant decrease in the levels of 
oxidative DNA damage at various time points in human peripheral blood mononuclear 
cells and CD4+ T cells ex vivo during their span in culture, when compared to non-
supplemented peripheral blood mononuclear cells, when supplemented with either of 
the antioxidants. The ability of ebselen to almost completely inhibit oxidative DNA 
damage has been previously demonstrated in HepG2 cells (Yang et al., 1999) and HL-
60 cells (Ji et al., 2000) attributed to their ability to scavenge hydroxyl and peroxide 
radicals. Of further interest is a study in PC-12 cells where NAC supplementation (100-
300µM) significantly lower than the concentrations used in this investigation, reduced 
the DNA damage compared to controls (Yan and Greene, 1998). The differences in 
concentration range of the same antioxidant revealing optimum free radical scavenging 
capacity may be due to the difference in cell types. 
 
The significant increase in total glutathione levels on supplementation with 5mM / 
7.5mM NAC demonstrates the ability of NAC to contribute glutathione to the cell 
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thereby supplementing the in vivo antioxidant status. A significant increase in total 
glutathione levels was also observed on supplementation with 30µM ebselen. Ebselen is 
a GPx mimetic. GPx has the ability to scavenge organic and inorganic peroxides using 
GSH as substrate. GSH is depleted during peroxide accumulation. Ebselen has a proven 
ability to scavenge hydroxyl radicals and ROS that initiates lipid peroxidation as a result 
of peroxide accumulation. In this study, ebselen may have scavenged the radicals 
present in the cell system. The fewer the radicals, the lesser will be the need for GSH to 
scavenge them. Since the GSH is not consumed to scavenge the radicals, levels of GSH 
may appear greater in the cell system on supplementation with ebselen.  
 
The results of the study of the effect of 30µM ebselen or 7.5mM NAC on CD4+ T cell 
clones / peripheral blood mononuclear cells / CD4+ T cells ex vivo reveal a significant 
antioxidant potential against endogenously generated oxidants and those associated with 
the 95% air, 5% CO2 culture conditions at various time points during their span in 
culture. The significantly higher GSH:GSSG ratio represents an increased antioxidant 
state on supplementation with either of the antioxidants. The increase in antioxidant 
status explains the decrease in levels of oxidative DNA damage that further explains a 
lower apoptotic state explained by the increase in proliferative capacity of the cells on 
antioxidant supplementation.  
 
5mM or 7mM NAC supplementation had similar antioxidant potential in human 
peripheral blood mononuclear cells and CD4+ T cells ex vivo. Furthermore, the effects 
of 30µM ebselen or 7.5mM NAC in human CD4+ T cells ex vivo compared to the 
effects on human peripheral blood derived CD4+ T cell clones in vitro, were not 
significantly different evidenced by their effect on the markers of T cell integrity and 
function investigated. 5mM NAC supplementation did not reveal any significant 
antioxidant potential in CD4+ T cell clones in vitro (Chapter-4), unlike the antioxidant 
potential demonstrated in the ex vivo polyclonal peripheral blood mononuclear cell 
population and CD4+ T cells ex vivo. Human T cell clones are maintained in culture 
throughout their lifespan over several months. This is not the case in cells ex vivo. It 
may be that the longer span of culture in vitro may have altered certain aspects of the 
biochemical / molecular status of the cells. Under these extensive culture conditions, 
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antioxidant or free radical scavenging effects of NAC at 5mM concentrations may be 
insufficient to reveal any significant antioxidant potential in T cell clones in vitro.  
 
Previous findings from the group of Barnett revealed that human peripheral blood 
mononuclear cells derived from donors of 65-69 years had higher levels DNA damage 
compared to cells derived from donors aged 35-39 years (Barnett and Barnett, 1998) as 
explained in chapter-5, section 5.1.4. The results of the investigation reported in this 
study demonstrated no significant differences between the levels of oxidative DNA 
damage in untreated human peripheral blood mononuclear cells or CD4+ T cells ex vivo 
derived from donors of 25-30 years age group, compared to T cells derived from donors 
of 55-60 years age group. The difference in results from the previous study could be due 
to the differences in sensitivity of assay used and differences in age group of the donors 
(explained in detail in chapter-5, Section 5.1.4). 
 
Considering the antioxidant potential of 30µM ebselen or 7.5mM NAC in T cells ex 
vivo and in vitro, their free radical scavenging ability may be more pronounced under 
physiological O2 conditions that will likely reveal any in vivo anti-immunosenescent 
potential. Previous work from the group of Barnett investigating the effect of low O2 
tension on several pathways involved with ROS such as JNK phosphorylation and P38 
phosphorylation in T cell clones (Duggan et al., 2004), generated interesting results as 
discussed in chapter-1, section 1.1.6.4. Other studies have revealed inhibition of H2O2 
induced P38 MAP kinase activation and cytochrome c release by 0.3µM ebselen 
supplementation in HUVECs and inhibition of the H2O2 induced activation of JNK 
signalling pathway by ebselen in PC-12 cells (Yoshizumi et al., 2002). JNK and P38 
MAP kinase has been proven to be activated on cytotoxic insult and are often associated 
with apoptotis on activation (Ali et al., 2004). ERK signalling pathway is known to be 
activated by growth factors involved in mitogenesis and is effective for cell proliferation 
and differentiation. Ebselen has previously been demonstrated to activate ERK pathway 
in rats (Baljinnyam et al., 2003). On the otherhand, in PC-12 cells, NAC activated ERK 
pathway (Yan and Greene, 1998) and inhibited JNK activity (Park et al., 1996). It will 
be interesting to examine the impact of ebselen or NAC on these pathways involved 
with cell proliferation, differentiation and apoptosis in CD4+ T cells ex vivo and CD4+ T 
cell clones in vitro. 
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The importance of mitochondria in human cell and ageing has been previously 
explained (Chapter-1, Section 1.1.1.2, 1.1.1.2.1). Mitochondrial dysfunction has been 
implicated as a major contributor to a range of diseases (Chapter-1, Section 1.1.6.3; 
Chapter-6, Section 6.1.1). The main drawback in treating these diseases is the inability 
to target an antioxidant in vivo to the mitochondria. This can be achieved with the use of 
a mitochondria targeted antioxidant mitoQ (mechanism explained in detail in chapter-1, 
Section 1.1.6.3; Chapter-6, Section 6.1.1). In this part of the investigation, the effect of 
mitoQ on certain markers of T cell integrity in human peripheral blood mononuclear 
cells was investigated.  
 
The results of this investigation conducted on the effect of mitoQ in human peripheral 
blood mononuclear cells revealed that 0.5µM or 1µM mitoQ supplementation decreased 
the levels of free radicals in cell samples, from the donors of both age groups evidenced 
by the significantly higher GSH:GSSG ratios, compared to controls. Further results in 
cell samples derived from both age groups revealed the ability of mitoQ 
supplementation to decrease the levels of endogenous oxidative DNA damage. The 
results revealing the antioxidant potential of 1µM mitoQ was in line with the previous 
findings revealing that 1µM mitoQ blocked 150µM H2O2 induced caspase activation in 
Jurkat cells (Kelso et al., 2001). Lower concentrations of mitoQ (0.1µM or 0.25µM) did 
not have any impact on the levels of free radicals (unchanged GSH:GSSG ratio) or in 
the levels of endogenous oxidative DNA damage, in human peripheral blood 
mononuclear cell samples from the donors of both age groups.  
 
All the concentrations of mitoQ used in this investigation (0.1µM, 0.25µM, 0.5µM  or 
1µM) revealed an antioxidant potential against exogenously applied ROS evidenced by 
a significantly higher GSH:GSSG ratio and a significant decrease in oxidative DNA 
damage levels following treatment with H2O2 in mitoQ supplemented cell samples. The 
results were of interest considering the significant antioxidant potential of mitoQ in the 
cytosol, even though it is a mitochondria targeted antioxidant. The reason for the 
antioxidant potential outside the mitochondria may be that the mitochondria took up as 
much mitoQ as possible and the excess mitoQ accumulated in the cytosol with 
consequent radical lowering effects. The results also revealed the presence of 
endogenous oxidative DNA damage even at saturating concentrations of mitoQ. This 
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result reveals that even though mitochondria are the major site for the production of 
ROS in cells, there are other sources of contributors to genomic DNA damage. Another 
reason could be that lower concentrations of mitoQ may be taken up by the 
mitochondria, but were not able to reduce free radical release from the mitochondria 
explaining no significant differences in endogenous DNA damage levels and is reflected 
in the lack of changes to GSH:GSSG ratio. 
 
The ability of mitoQ at specific concentrations to scavenge free radicals, resulting in a 
significantly higher GSH:GSSG ratio compared to controls, is invaluable considering 
the role of intracellular redox status (GSH:GSSG ratio) as a mediator of apoptosis in 
several cell systems (Slater et al., 1996; Cotgreave and Gerdes, 1998; Hall, 1999; 
Chapter-1, Section 1.1.4.1). Higher GSH:GSSG ratio on mitoQ supplementation 
represents an increased antioxidant status in cells that further explains the decrease in 
levels of oxidative DNA damage in cells on mitoQ supplementation. 
 
DTPP has a similar structure to mitoQ, except for the ubiquinone derivative in mitoQ 
responsible for the antioxidant potential, as explained in chapter-6. Unexpectedly, 
DTPP (0.5µM or 1µM) decreased the levels of free radicals (evidenced by significantly 
higher GSH:GSSG ratio) and significantly decreased the DNA damage levels, following 
treatment with H2O2 (treatment after 3 or 6 hours of supplementation with DTPP) in 
peripheral blood mononuclear cell samples from both age groups. The antioxidant 
potential of DTPP may be due to stimulation or up-regulation of other cellular 
antioxidants in the cell on DTPP supplementation, although there is no scientific 
evidence to support this hypothesis. In the existing scientific literature, only one 
previous study has revealed the ability of 1µM DTPP to reduce succinate (a complex I 
substrate) driven ROS in isolated bovine aortic endothelial mitochondria in rats (Malley 
et al., 2006), without the mechanism being explained. Lower concentrations of DTPP 
(0.1µM or 0.25µM) did not have any significant impact on both the markers examined 
in this study, with and without H2O2 treatment in cell samples from both age groups 
examined. 
 
Furthermore, in this investigation, the impact of 37µM or 74µM concentrations of 
vitamin E (a non-mitochondria targeted antioxidant) on the levels of free radicals 
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(determining the GSH:GSSG ratio) and oxidative DNA damage, in human peripheral 
blood mononuclear cells, was investigated as a control for mitoQ. Recent studies 
revealing the ability of vitamin E at a concentration of 37µM to reduce toxicity in 
murine splenocytes (Horton et al., 2007) was taken into condiseration before chosing 
the dose levels. None of the concentrations of vitamin E resulted in significant changes 
in GSH:GSSG ratio or the levels of oxidative DNA damage in human peripheral blood 
mononuclear cells treated + / - H2O2. Although vitaimin E at 37µM concentration was 
able to reduce toxicity in murine cells, the concentrations used in this study may not be 
enough to reveal an antioxidant potential or free radical scavenging potential in human 
peripheral blood mononuclear cells ex vivo. The reason for the lack of effect of vitamin 
E supplementation in human peripheral blood mononuclear cells compared to the 
murine cells could be due to the differences in cell types. Investigations could be carried 
out using a broader range of vitamin E concenrations and analyse their impact on the 
markers of T cell integrity used, in this study. Of further interest would be determining 
the ROS production for different concentrations of vitamin E supplementations in CD4+ 
T cells ex vivo using FACS analysis of samples subjected to DCFDA staining. 
 
The impact of a range of concentrations of mitoQ / DTPP / vitamin E on total 
glutathione levels, a marker of T cell integrity, was also investigated as part of this 
study. The results revealed a lack of consistent changes in levels of total glutathione on 
administration of any of the concentrations of mitoQ or DTPP (0.1µM, 0.25µM, 0.5µM 
or 1µM) or vitamin E (37µM or 74µM) in human peripheral blood mononuclear cells 
derived from donors of both age groups. This result reveals that none of these 
supplements in any way had an impact on glutathione pathways, and therefore the lack 
of significant changes in glutathione levels, in the peripheral blood mononuclear cells 
examined. 
 
Impact of mitoQ on mitochondrial membrane potential, another marker of T cell 
integrity, playing an important role in apoptosis was also investigated (Chapter-2, 
Section 2.1.8). The results indicated no significant changes in mitochondrial membrane 
potential in human peripheral blood mononuclear cells on treatment with 0.1µM or 
0.5µM mitoQ. However, 0.1µM or 0.5µM mitoQ treatment resulted in a significant 
increase in mitochondrial membrane potential on treatment with a range of doses of 
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H2O2 in cells derived from donors of both age groups. In the existing scientific literature 
there is only one other study demonstrationg the effect of 1µM mitoQ on mitochondrial 
membrane potential. This study was performed in vitro in isolated mitochondria in rat 
models where 1µM mitoQ treatment decreased ROS production, thereby, protecting the 
mitochondria from damage and resulted in maintenance of the mitochondrial membrane 
potential (Lowes et al., 2008). The results of this study also revealed that mitoQ 
suppressed the release of pro-inflammatory cytokines and increased the release of anti-
inflammatory cytokines from the cells. 
 
In this investigation the impact of chronic exposure of 10-30nM concentrations of 
mitoQ / DTPP in human peripheral blood mononuclear cells derived from donors of 
both age groups was also investigated. Previous studies have revealed antioxidant 
potential on chronic exposure to mitoQ at concentrations of 10-20nM in MRC-5 
fibroblasts evident by telomere shortening (Saretzki et al., 2003). The result of that 
study was taken into consideration before chosing the dose range in this investigation. 
None of the concentrations of mitoQ or DTPP (10nM, 20nM or 30nM) caused any 
significant alterations which was reflected in a lack of change to free radical (unchanged 
GSH:GSSG ratio), oxidative DNA damage and total glutathione levels. From the 
information in the existing scientific literature, on the effects of chronic exposure of 
mitoQ in cells in vitro and ex vivo, only one other recent study investigated the effects 
of chronic exposure of mitoQ. However, the study was performed in isolated 
mitochondria and the results revealed the antioxidant potency of 1µM mitoQ after a 
week of supplementation, evidenced by a decrease in mitochondrial damage and 
maintenance of mitochondrial membrane potential in isolated mitochondria in human 
achilles tendon cells on mitoQ supplementation (Lowes et al., 2009). 
 
Furthermore, in terms of the effect of mitoQ, the impact of the selected doses of mitoQ, 
on the superoxide production in the mitochondria in human peripheral blood 
mononuclear cells ex vivo could also be investigated.  
 
Finally, the effect of reduced O2 tension as a defense system in human peripheral blood 
mononuclear cells ex vivo was investigated (Chapter-7). There was little information in 
the scientific literature on the impact of low O2 tension culture conditions in T cells ex 
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vivo and in vitro before the start of this investigation. The fact that intracellular O2 level 
is much lower than the O2 level in the cells maintained in an extracellular environment 
makes this study very important. Previous work from the group of Barnett demonstrated 
a shorter lifespan and reduced proliferative capacity in T cell clones derived from young 
and old aged human donors when cultured under 6% O2 tension, compared to clones 
cultured under 20% O2 tension (Chapter-1, Table 1.13 & Table 1.14; Chapter-7, Section 
7.1.1). But the clones cultured at 6% O2 had significantly lower levels of oxidative 
DNA damage compared to clones cultured at 20% O2 tension. The results of this 
investigation revealed significantly higher levels of oxidative DNA damage and lower 
GSH:GSSG ratio in human peripheral blood mononuclear cells ex vivo, when cultured 
at 2% O2 tension compared to cells cultured at 20% O2 tension (Chapter-7, Section 
7.1.3). The results reveal the increase in levels of free radicals at 2% O2 (evidenced by 
significantly lower GSH:GSSG ratio) contributing to increase in levels of DNA damage. 
 
Apart from the two markers of T cell integrity investigated in NTU as part of this study, 
other markers of T cell integrity and function were also investigated as part of the 
overall investigation in The University of Tuebingen by the group of Professor Graham 
Pawelec. The results showed high antioxidant capacity in the culture media evidenced 
by an up-regulation of HIF-1α under low O2 tension. The high antioxidant capacity 
observed in the culture media was interestingly not reflected in the function of T cells. It 
may be due to differences in molecular exchanges between the cells and the 
environment at different O2 levels. T cells had significantly lower proliferative capacity 
and stimulated cells were significantly more susceptible to apoptosis at low O2 tension, 
compared to 20% O2 tension. The results of this investigation contradicted the earlier 
findings by other studies (Atkuri et al., 2005) where the O2 level did not influence the 
proliferative capacity of human peripheral blood mononuclear cells stimulated by 
phytohemagglutinin (PHA) or the cell viability in unstimulated cells. Furthermore, there 
was significantly higher levels of carbonyl group formation (an index of global protein 
oxidation leading to oxidative damage in proteins) in stimulated human peripheral blood 
mononuclear cells ex vivo maintained at low O2 levels compared to 20% O2 levels 
which was later explained by the reduced Msr and proteasome activities revealed under 
low O2 tension. The results are further explained in detail in chapter-7, section 7.1.4. 
Previously, other studies have revealed the increased free-radical cytotoxicity to Jurkat 
cells under lower O2 levels (Chen et al., 2008). The increased apoptotic rate of activated 
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cells at 2% O2 tension suggests an increase in free radical production in cells. Even 
though, T cells proliferate better at 20% O2, this does not reflect their real physiology 
where they are exposed to low levels of O2. The results suggest complicated mechanism 
yet to be fully explored. 
8.1.1. Conclusion  
The aim of this PhD programme was to investigate the effects of antioxidants (ebselen 
or NAC or mitoQ) or low O2 tension on T cell integrity and function using T cell clones 
and human peripheral blood mononuclear cells from donors of different age groups.  
 
The findings of this novel investigation revealed that for a limited set of conditions, 
30µM ebselen or 7.5mM NAC supplementation among a range of concentrations of 
ebselen or NAC investigated, showed antioxidant potential, evidenced by the significant 
increase in lifespan; significantly higher GSH:GSSG ratio and a significant decrease in 
levels of oxidative damage to DNA in CD4+ T cell clones (a monoclonal model system), 
when supplemented from a young in vitro age. Further studies of supplementation of 
human peripheral blood mononuclear cells and CD4+ T cells ex vivo (both polyclonal 
model systems) derived from donors of both age groups, with 30µM ebselen or 5mM / 
7.5mM NAC, demonstrated a significant antioxidant potential evidenced by the 
significant increase in proliferation capacity; significantly higher GSH:GSSG ratio and 
total glutathione levels, and significant decreases in levels of oxidative damage to DNA.  
 
Furthermore selected concentrations of mitoQ, a mitochondria targeted antioxidant, 
revealed significant antioxidant potential in human peripheral blood mononuclear cells 
in this investigation. A well functioning mitochondria is a pre-requisite for human life 
and mitochondria dysfunction has been attributed to a wide range of diseases in humans. 
However, this study has shown that the use of mitoQ may be a viable strategy to 
increase the antioxidant defenses in human peripheral blood mononuclear cells ex vivo 
to help manage oxidative stress levels. 
 
In terms of low O2 tension studies, 2% O2 tension revealed an increase in free radical 
production in human peripheral blood mononuclear cells ex vivo compared to cells 
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cultured at 20% O2 tension evidenced by their effect on a range of markers of T cell 
function and integrity investigated.  
 
From the results of this study revealing the antioxidant potential of carefully selected 
concentrations of ebselen or NAC or mitoQ, evidenced by their ability to alleviate 
oxidative stress, may play an important role in its use as an in vivo antioxidant and in 
potential anti-immunosenescent interventive strategies in vivo. 
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APPENDIX-I 
 
Growth records of human CD4+ T cell clones 
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1) 
 
 
Figure 1 Proliferative capacity of 385-2a clone (derived from a 45 year old overtly 
healthy laboratory worker) throughout its lifespan. The points represent the PD 
achieved during successive seven day growth cycles and a spline curve has been 
used to illustrate growth rhythms. The mean PD per seven day growth cycle - 0.8, 
Maximum PD achieved - 50.5 
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2) 
 
 
Figure 2 Proliferative capacity of 385-2b clone (derived from a 45 year old overtly 
healthy laboratory worker) throughout its lifespan. The points represent the PD 
achieved during successive seven day growth cycles and a spline curve has been 
used to illustrate growth rhythms. The mean PD per seven day growth cycle - 0.7, 
Maximum PD achieved – 48.1 
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3) 
 
 
Figure 3 Proliferative capacity of 385-7a clone (derived from a 45 year old overtly 
healthy laboratory worker) throughout its lifespan. The points represent the PD 
achieved during successive seven day growth cycles and a spline curve has been 
used to illustrate growth rhythms. The mean PD per seven day growth cycle - 0.9, 
Maximum PD achieved – 44.4 
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4) 
 
 
Figure 4 Proliferative capacity of 385-7b clone (derived from a 45 year old overtly 
healthy laboratory worker) throughout its lifespan. The points represent the PD 
achieved during successive seven day growth cycles and a spline curve has been 
used to illustrate growth rhythms. The mean PD per seven day growth cycle – 1.0, 
Maximum PD achieved – 47.2 
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5) 
 
 
Figure 5 Proliferative capacity of 385-7c clone (derived from a 45 year old overtly 
healthy laboratory worker) throughout its lifespan. The points represent the PD 
achieved during successive seven day growth cycles and a spline curve has been 
used to illustrate growth rhythms. The mean PD per seven day growth cycle – 1.1, 
Maximum PD achieved – 78.2 
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6) 
 
 
Figure 6 Proliferative capacity of 385-7d clone (derived from a 45 year old overtly 
healthy laboratory worker) throughout its lifespan. The points represent the PD 
achieved during successive seven day growth cycles and a spline curve has been 
used to illustrate growth rhythms. The mean PD per seven day growth cycle – 0.9, 
Maximum PD achieved – 74.4 
 
 
 
 
 
 
 
 
  
 222
7) 
 
 
Figure 7 Proliferative capacity of 400-5a clone (derived from a 26 year old overtly 
healthy laboratory worker) throughout its lifespan. The points represent the PD 
achieved during successive seven day growth cycles and a spline curve has been 
used to illustrate growth rhythms. The mean PD per seven day growth cycle – 0.9, 
Maximum PD achieved – 57.0 
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8) 
 
 
Figure 8 Proliferative capacity of 400-5b clone (derived from a 26 year old overtly 
healthy laboratory worker) throughout its lifespan. The points represent the PD 
achieved during successive seven day growth cycles and a spline curve has been 
used to illustrate growth rhythms. The mean PD per seven day growth cycle – 0.8, 
Maximum PD achieved – 53.2 
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9) 
 
 
Figure 9 Proliferative capacity of 400-23a clone (derived from a 26 year old overtly 
healthy laboratory worker) throughout its lifespan. The points represent the PD 
achieved during successive seven day growth cycles and a spline curve has been 
used to illustrate growth rhythms. The mean PD per seven day growth cycle – 0.7, 
Maximum PD achieved – 44.9 
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10) 
 
 
Figure 10 Proliferative capacity of 400-23b clone (derived from a 26 year old 
overtly healthy laboratory worker) throughout its lifespan. The points represent 
the PD achieved during successive seven day growth cycles and a spline curve has 
been used to illustrate growth rhythms. The mean PD per seven day growth cycle – 
0.9, Maximum PD achieved – 49.1 
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11) 
 
 
Figure 11 Proliferative capacity of 400-23c clone (derived from a 26 year old 
overtly healthy laboratory worker) throughout its lifespan. The points represent 
the PD achieved during successive seven day growth cycles and a spline curve has 
been used to illustrate growth rhythms. The mean PD per seven day growth cycle – 
1.1, Maximum PD achieved – 83.6 
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12) 
 
 
Figure 12 Proliferative capacity of 400-23d clone (derived from a 26 year old 
overtly healthy laboratory worker) throughout its lifespan. The points represent 
the PD achieved during successive seven day growth cycles and a spline curve has 
been used to illustrate growth rhythms. The mean PD per seven day growth cycle – 
0.8, Maximum PD achieved – 77.6 
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As explained in chapter-3, section 3.1.3, all the twelve clones examined in this 
investigation, grew in waves of maximal and minimal rates of proliferation variable 
from one to several growth cycles in length during the early part of their lifespan (as 
indicated in figure 3.1 and figures 1-12 in appendix-I). But towards the later stages of 
their lifespan, the size or length of the waves decreased and the wave frequency 
increased. This type of growth of the T cell clones (as explained in detail in chapter-3, 
Section 3.1.3) was in line with the previous findings from the group of Barnett (Hyland 
et al., 2000). The increase in frequency towards the later stages of a T cell clone’s 
lifespan can be implied as their ability to retain their responsiveness to proliferative 
stimulation (Hyland et al., 2000; Pawelec et al., 2002). 
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APPENDIX-II 
 
Summary tables showing the effect of acute exposure 
of mitoQ or DTPP or vitamin E on human peripheral 
blood mononuclear cells ex vivo 
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Appendix-II, Table 1. Summary of the results of the effect of different 
concentrations of mitoQ supplementation, on the levels of oxidative DNA damage 
in human peripheral blood mononuclear cells isolated from fresh human blood 
derived from ten different healthy donors, five each in the age groups of 25-30 
years and 55-60 years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of mitoQ 
supplementation 
Length of mitoQ 
supplementation 
Endogenous 
DNA damage 
levels in 
mitoQ treated 
cells 
compared to 
untreated 
cells 
(controls) 
DNA damage 
levels in 
mitoQ treated 
cells subjected 
to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 1µM mitoQ 3 hours Significantly 
reduced 
Significantly 
reduced 
25-30 1µM mitoQ 6 hours Significantly 
reduced 
Significantly 
reduced 
55-60 1µM mitoQ 3 hours Significantly 
reduced 
Significantly 
reduced 
55-60 1µM mitoQ 6 hours Significantly 
reduced 
Significantly 
reduced 
25-30 0.5µM mitoQ 3 hours Significantly 
reduced 
Significantly 
reduced 
25-30 0.5µM mitoQ 6 hours Significantly 
reduced 
Significantly 
reduced 
55-60 0.5µM mitoQ 3 hours Significantly 
reduced 
Significantly 
reduced 
55-60 0.5µM mitoQ 6 hours Significantly 
reduced 
Significantly 
reduced 
25-30 0.25µM mitoQ 6 hours No significant 
changes 
Significantly 
reduced 
55-60 0.25µM mitoQ 6 hours No significant 
changes 
Significantly 
reduced 
25-30 0.1µM mitoQ 6 hours No significant 
changes 
Significantly 
reduced 
55-60 0.1µM mitoQ 6 hours No significant 
changes 
Significantly 
reduced 
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Appendix-II, Table 2. Summary of the results of the effect of different 
concentrations of DTPP supplementation, on the levels of oxidative DNA damage 
in human peripheral blood mononuclear cells isolated from fresh human blood 
derived from ten different healthy donors, five each in the age groups of 25-30 
years and 55-60 years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of DTPP 
supplementation 
Length of DTPP 
supplementation 
Endogenous 
DNA damage 
levels in 
DTPP treated 
cells 
compared to 
untreated 
cells 
(controls) 
DNA damage 
levels in 
DTPP treated 
cells subjected 
to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 1µM DTPP 3 hours No significant 
changes 
Significantly 
reduced 
25-30 1µM DTPP 6 hours No significant 
changes 
Significantly 
reduced 
55-60 1µM DTPP 3 hours No significant 
changes 
Significantly 
reduced 
55-60 1µM DTPP 6 hours No significant 
changes 
Significantly 
reduced 
25-30 0.5µM DTPP 3 hours No significant 
changes 
Significantly 
reduced 
25-30 0.5µM DTPP 6 hours No significant 
changes 
Significantly 
reduced 
55-60 0.5µM DTPP 3 hours No significant 
changes 
Significantly 
reduced 
55-60 0.5µM DTPP 6 hours No significant 
changes 
Significantly 
reduced 
25-30 0.25µM DTPP 6 hours No significant 
changes 
No significant 
changes 
55-60 0.25µM DTPP 6 hours No significant 
changes 
No significant 
changes 
25-30 0.1µM DTPP 6 hours No significant 
changes 
No significant 
changes 
55-60 0.1µM DTPP 6 hours No significant 
changes 
No significant 
changes 
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Appendix-II, Table 3. Summary of the results of the effect of different 
concentrations of vitamin E supplementation, on the levels of oxidative DNA 
damage in human peripheral blood mononuclear cells isolated from fresh human 
blood derived from ten different healthy donors, five each in the age groups of 25-
30 years and 55-60 years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of vitamin E 
supplementation 
Length of 
vitamin E 
supplementation 
Endogenous 
DNA damage 
levels in 
vitamin E 
treated cells 
compared to 
untreated 
cells 
(controls) 
DNA damage 
levels in 
vitamin E 
treated cells 
subjected to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 37µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
25-30 37µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
55-60 37µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
55-60 37µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
25-30 74µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
25-30 74µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
55-60 74µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
55-60 74µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
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Appendix-II, Table 4. Summary of the results of the effect of different 
concentrations of mitoQ supplementation, on the GSH:GSSG ratio in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years and 55-60 
years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of  mitoQ 
supplementation 
Length of mitoQ 
supplementation 
Basal 
GSH:GSSG 
ratio in mitoQ 
treated cells 
compared to 
untreated 
cells 
(controls) 
GSH:GSSG 
ratio in mitoQ 
treated cells 
subjected to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 1µM mitoQ 3 hours Significantly higher 
Significantly 
higher 
25-30 1µM mitoQ 6 hours Significantly higher 
Significantly 
higher 
55-60 1µM mitoQ 3 hours Significantly higher 
Significantly 
higher 
55-60 1µM mitoQ 6 hours Significantly higher 
Significantly 
higher 
25-30 0.5µM mitoQ 3 hours Significantly higher 
Significantly 
higher 
25-30 0.5µM mitoQ 6 hours Significantly higher 
Significantly 
higher 
55-60 0.5µM mitoQ 3 hours Significantly higher 
Significantly 
higher 
55-60 0.5µM mitoQ 6 hours Significantly higher 
Significantly 
higher 
25-30 0.25µM mitoQ 6 hours No significant 
changes 
Significantly 
higher 
55-60 0.25µM mitoQ 6 hours No significant 
changes 
Significantly 
higher 
25-30 0.1µM mitoQ 6 hours No significant 
changes 
Significantly 
higher 
55-60 0.1µM mitoQ 6 hours No significant 
changes 
Significantly 
higher 
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Appendix-II, Table 5. Summary of the results of the effect of different 
concentrations of DTPP supplementation, on the GSH:GSSG ratio in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years and 55-60 
years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of DTPP 
supplementation 
Length of DTPP 
supplementation 
Basal 
GSH:GSSG 
ratio in DTPP 
treated cells 
compared to 
untreated 
cells 
(controls) 
GSH:GSSG 
ratio in DTPP 
treated cells 
subjected to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 1µM DTPP 3 hours No significant 
changes 
Significantly 
higher 
25-30 1µM DTPP 6 hours No significant 
changes 
Significantly 
higher 
55-60 1µM DTPP 3 hours No significant 
changes 
Significantly 
higher 
55-60 1µM DTPP 6 hours No significant 
changes 
Significantly 
higher 
25-30 0.5µM DTPP 3 hours No significant 
changes 
Significantly 
higher 
25-30 0.5µM DTPP 6 hours No significant 
changes 
Significantly 
higher 
55-60 0.5µM DTPP 3 hours No significant 
changes 
Significantly 
higher 
55-60 0.5µM DTPP 6 hours No significant 
changes 
Significantly 
higher 
25-30 0.25µM DTPP 6 hours No significant 
changes 
No significant 
changes 
55-60 0.25µM DTPP 6 hours No significant 
changes 
No significant 
changes 
25-30 0.1µM DTPP 6 hours No significant 
changes 
No significant 
changes 
55-60 0.1µM DTPP 6 hours No significant 
changes 
No significant 
changes 
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Appendix-II, Table 6. Summary of the results of the effect of different 
concentrations of vitamin E supplementation, on the GSH:GSSG ratio in human 
peripheral blood mononuclear cells isolated from fresh human blood derived from 
ten different healthy donors, five each in the age groups of 25-30 years and 55-60 
years 
 
Donor 
(Age group- 
yr olds) 
Concentration 
of vitamin E 
supplementation 
Length of 
vitamin E 
supplementation 
Basal 
GSH:GSSG 
ratio in 
vitamin E 
treated cells 
compared to 
untreated 
cells 
(controls) 
GSH:GSSG 
ratio in 
vitamin E 
treated cells 
subjected to 
exogenously 
applied ROS 
(H2O2 
treatment) 
compared to 
cells treated 
only with 
exogenously 
applied ROS 
(controls) 
25-30 37µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
25-30 37µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
55-60 37µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
55-60 37µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
25-30 74µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
25-30 74µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
55-60 74µM vitamin E 3 hours No significant 
changes 
No significant 
changes 
55-60 74µM vitamin E 6 hours No significant 
changes 
No significant 
changes 
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